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Abstract 
Sub-critical water (SCW) hydrolysis has previously been used in the extraction of 
antioxidant compounds from a variety of food wastes, in-particular those which are 
rich in protein. The brewing industry generates high volumes of waste. The most 
abundant component, brewers’ spent grain (BSG), is high in protein content. The work 
presented in this thesis aimed to investigate the SCW extraction of antioxidant 
compounds from BSG.  
Whilst SCW hydrolysis has proved effective in the extraction of antioxidants from a 
wide range of compounds its mechanism of action has not been thoroughly 
investigated. High performance liquid chromatography (HPLC) coupled to tandem 
mass spectrometry (MS/MS) was used to analyse peptide production from the SCW 
hydrolysis of proteins. Sites of cleavage were identified and a mechanism of action of 
SCW on proteins was postulated. The results from this analysis also raised the 
possibility of using SCW as an alternative proteolytic reagent in proteomics 
experiments.  Approaches for SCW-based proteomics were further explored by 
investigating SCW induced amino acid side chain modifications to aid peptide 
identification. Additionally, HPLC, MS/MS and search parameters were also carefully 
optimised to provide maximum peptide identifications. 
To assess the antioxidant capacity of mixtures generated via SCW hydrolysis oxygen 
radical absorbance capacity (ORAC), reducing power (RP) and comet assays were used. 
The decomposition products responsible for antioxidant capacity were characterised 
using MS/MS.
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Chapter 1: Introduction 
1.1 Overview 
Subcritical water (SCW) is a highly versatile solvent [1]. Under certain conditions, SCW 
can display synthetic and catalytic properties. Growing evidence suggests that SCW can 
be used as a tool in the treatment of food industrial waste to create mixtures of 
biological value, e.g. with antioxidant properties. Food industry wastes are often rich in 
proteins and SCW has been widely used to generate antioxidant mixtures from these 
wastes. In this thesis I aim to demonstrate the SCW extraction of antioxidant 
compounds from the major by-product of the brewing industry, brewers spent grain 
(BSG).  
The mechanisms of SCW hydrolysis are not well established. In the work presented in 
Chapter 3, the specificity of subcritical water with respect to the production of 
peptides from three model proteins is investigated. Tandem mass spectrometry 
(MS/MS) coupled with high performance liquid chromatography (HPLC) is an effective 
method of identifying the components of a complex mixture. In the work presented in 
Chapter 4, modifications induced during SCW hydrolysis using a model peptide 
approach are investigated, with the aim of aiding peptide identification during 
automated searches. The work presented in Chapter 5 aimed at identifying the 
decomposition products responsible for antioxidant capacity generated during SCW 
hydrolysis. Antioxidant capacity of SCW hydrolysates was assessed using Oxygen 
Radical Absorbance Capacity (ORAC), comet and reducing power assays. The fractions 
with the most powerful antioxidant capacity were analysed using MS/MS.  
In the course of this work, the possibility of using SCW as an alternative proteolytic 
reagent during a proteomic workflow was raised in Chapters 3 and 4. This aspect was 
further explored in Chapter 6 where HPLC, MS/MS and search parameters were 
investigated. 
In this introduction an overview of mass spectrometry (MS) (section 1.1), SCW 
hydrolysis (section 1.2), brewer’s waste production (section 1.3), a brief summary of 
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oxidative stress, antioxidant function and antioxidant assays (section 1.4) and existing 
strategies in proteomics (section 1.5) is provided. 
 
1.2 Mass spectrometry 
1.2.1 Introduction to mass spectrometry 
Mass spectrometry is an analytical technique that is used to measure the mass-to-
charge (m/z) ratio of molecules that have been converted to ions.   
The first step in a typical MS analysis is the production of gas-phase ions. The charged 
ions are separated in accordance to their m/z ratio using electric and/or magnetic 
fields to control the motion of the ions before the final stage which is detection of the 
separated ions. These steps are performed under a high vacuum, as molecular 
collisions reduce instrument accuracy and sensitivity. 
1.2.2 Ionization 
Ionization enables molecules to gain charge through interaction with chemicals, light 
or electrons. Prior to the 1980s, the ionization of molecules in mass spectrometry was 
primarily dependent upon either electron impact ionization (EI) or chemical ionization 
(CI). In EI a heated filament provides a source of electrons, which collide with the 
gaseous molecules of the analysed sample injected into the source. Under sufficient 
energy, this causes an electron to be expelled from the analyte, resulting in a positively 
charged ion. In contrast, CI produces ions through collisions between the analyte and 
primary ions present in the source. These methods were unsuitable due to 
biomolecular degradation and fragmentation that occurs during gas phase transition 
[2]. 
The first move towards analysing biomolecules was the development of ‘soft’ 
ionization techniques. Fast atom bombardment (FAB) uses a beam of high energy 
atoms to desorb ions from a surface [3]. This method yields little fragmentation of 
molecular ions, therefore facilitating analysis of larger biomolecules. A modification on 
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this technique, using highly energetic ions instead of atoms, was developed termed 
liquid secondary ion mass spectrometry (LSIMS). [4] 
The advent of novel ionisation techniques such as matrix assisted laser desorption 
ionisation (MALDI) [5] and electrospray ionisation (ESI) [6], has further enabled the 
measurement of high molecular weight (MW) compounds such as proteins, peptides 
and oligonucleotides.  
Figure 1.1 depicts a schematic of ESI. This occurs in three broad steps a) formation of 
charged droplets at the capillary tip, b) disintegration into smaller highly charged 
droplets and c) the final conversion of droplets into the gas phase. 
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Figure 1. 1 - Schematic of electrospray ionisation demonstrating ion evaporation, 
charge residue and chain ejection models.  
+ve       -ve 
Counter electrode Capillary Taylor cone 
Ion evaporation model (IEM) 
Charge Residue Model (CRM) 
Analyte inlet 
+ + + + + + + 
+ + + + + + + 
Chain Ejection Model (CEM) 
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In the first step the sample is dissolved in an appropriate solvent, which typically 
consists of a combination of organic solvent and water with <1% acid/base to enhance 
protonation/ deprotonation. The omission is the protein analysis of native states. Here 
organic solvents are not used as they cause the protein to lose its tertiary structure [7]. 
The solution is passed through a capillary tube at a flow rate of ~1-10 μlmin-1.  A 
potential difference is applied between the capillary and the counter electrode which 
creates an electric field. This field induces an accumulation of charge at the capillary 
tip liquid surface. The repulsive forces created at the capillary push the liquid away 
whilst being counteracted by the surface tension at the liquid air boundary which pulls 
the droplet back. The droplet at the end of the tip becomes distorted. This 
phenomenon was described by Taylor in 1964 [8], and was hence termed the Taylor 
cone. 
The emerging solution exits as a fine mist of charged droplets. These droplets are 
attracted to the counter electrode of the mass spectrometer, which is held at a 
negative potential, generating a small current [9]. The reduction in droplet size causes 
an increase in surface charge density. The organic component of the solvent 
evaporates at a faster rate, causing an increase in water percentage [10-12]. The 
increase in surface charge density is counteracted by Coulombic repulsion. The point 
where these two forces are equal is referred to as the Rayleigh limit. Once this limit is 
reached droplets burst via jet fission to produce smaller droplets. The process repeats 
until the droplet reaches a critical point where it is thermodynamically favourable for 
the ions at the surface to enter the gaseous phase.  
Species are transferred into the gas phase through different mechanisms. Low MW 
species are hypothesised to be transferred into the gas phase via the ion evaporation 
model (IEM)  [13, 14], whilst it is widely accepted that large globular species, of high 
MW, are thought to be transferred into the gas phase via the charged residue model 
(CRM) [15]. More recently a third model has been proposed, the charge ejection model 
(CEM) [16, 17]. 
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The IEM model was originally conceived by Iribarne and Thomson in the late 
1970s  [13, 14]. The ion evaporation model assumes that the charged droplets shrink 
by evaporation until the charge density becomes so great that the repulsive forces are 
sufficiently large to expel solvated ions from the droplet.   
The charge residue model (CRM) was originally proposed by Dole and co-workers in 
1968 [15]. This model is applicable to higher molecular weight species, such as 
proteins. Since proteins are likely to contain multiple protonation sites (from basic 
amino acids), proteins often have multiple charge states. This model assumes that 
droplets contain one single analyte ion, and the solvent evaporates until the charge is 
retained on the non-volatile solute molecule [18]. 
The chain ejection model (CEM) has recently been proposed by Konermann and co-
workers [16, 17]. In solution, proteins typically adopt a compact globular field where 
polar and charged residues are positioned on the outside of proteins, maximising 
favourable water interactions, whereas hydrophobic residues are positioned in the 
interior of proteins. This model assumes proteins become partially unfolded in the 
liquid phase by e.g. exposure to an acidic LC mobile phase. The core hydrophobic 
residues are now exposed, making it unfavourable for proteins to reside within the 
droplet interior. Instead, unfolded proteins migrate to the surface of droplets and one 
chain terminus gets expelled from the droplet to the vapour phase and the rest of the 
protein soon follows.  
In this thesis the Advion TriVersa Nano Mate was used as an ionisation source. This 
technology utilises nano-electrospray ionization (nano-ESI). This follows the same 
fundamental principles outlined above, however the flow rates at which the samples 
are introduced are in the region of nlmin-1 rather than mlmin-1 used for standard ESI 
[19]. Nano-ESI has been favourably compared against conventional electrospray in 
protein analysis.  Juraschek et al. showed analytes were better detected in nano-ESI in 
samples with salt contamination [20]. This was attributed to the reduced droplet size 
in nano-ESI compared with electrospray at higher flow rates. Furthermore, the lower 
flow rates used in nano-ESI allow for smaller quantities of sample to be analysed. 
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The Triversa Nanomate infuses samples using a small conductive pipette tip via a 
microfabricated chip composed of monolithic silicon, comprising 400 nozzles. The 
pipette tip is controlled by a robot which aspirates the solution and is sealed against 
the chip. A gas and voltage are then applied which electrospray the solution through 
the nozzles. This chip based approach produces highly stable ESI currents [21, 22].  
The increasing mass range and mass accuracy of modern mass analysers has also been 
instrumental in the application of MS to biological samples. Mass analysers can either 
be used individually or in tandem within a mass spectrometer. 
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1.2.3 Mass Spectrometers 
Two mass spectrometers were used in the work carried out in this thesis. These were 
the Orbitrap Elite and the Q-Exactive HF mass spectrometers. 
1.2.3.1 Orbitrap Elite Mass Spectrometer  
The Orbitrap Elite mass spectrometer is a hybrid mass spectrometer that consists of a 
dual-pressure linear ion trap (the linear trap quadrupole) (LTQ)) and an Orbitrap mass 
analyser. The LTQ-Orbitrap offers high resolving power (240,000) and excellent mass 
accuracy (specified as 2-5 ppm) [23]. These parameters are vital in providing de novo 
identifications of MS/MS spectra [24, 25], as well as excellent identification of 
fragment ions and localisation of post translational modifications (PTMs).   
Figure 1.2 displays a detailed cross section of the Orbitrap Elite. Here, ions are injected 
into the mass spectrometer via a nano-ESI source, focused by a stacked ring ion guide 
(S-lens) and transferred to a dual-pressure ion trap mass analyser.  
 
 
Figure 1. 2 - Schematic of LTQ-Orbitrap Elite. Adapted from [26]. 
 
ESI source 
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Figure 1.3 shows a cross section of a typical 2-d ion trap. Upon entering the trap, 
collisions with an inert gas cause ions to cool as they progress along the z axis, whilst 
the application of an RF –only potential causes them to simultaneously oscillate along 
the xy plane. The rods are commonly divided into three segments. The application of a 
DC voltage to the ends facilitates ion trapping in the z direction. 
The RF voltage applied allows the ions to be destabilised sequentially. Ions leave the 
trap in increasing m/z ratio, via axial ejection between two of the planar rods. This 
method of separation is referred to as the “mass-selective axial instability mode” as 
developed by Stratford et al. in the 1980s [27].  
 
 
 
 
 
 
 
 
 
 
 
Figure 1. 3 - Schematic of an ion trap. Figure adapted from [28]. 
 
The Orbitrap Elite makes use of a dual pressure ion trap. A single aperture lens is used 
to separate two linear cells to allow differential pumping between the two portions. 
Helium is introduced into the high pressure cell (5.0 x 10-3 torr), whilst some portion 
leaks into the low pressure cell via the lens (3.5 x 10-4 torr). The high pressures in the 
first cell facilitate improved ion trapping as well as better isolation of precursor ions 
and subsequent fragmentation efficiencies. Furthermore, the presence of ejection 
Ion path 
Ejection slit 
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slots in all four rods facilitates ion ejection to occur at higher voltages, whilst also 
applying isolation waveforms.  This means only ions of a specified m/z fill the trap, 
which vastly improves detection of low-abundant species.  The low pressure cell is 
used as a mass analyser, which facilitates faster scan rates and higher resolution 
compared to less advanced versions of the Orbitrap Elite [29]. 
Ions are then transferred to a curved linear trap (C-trap) via a gas-free RF- only 
octapole. Upon entering the C-trap, ions collide with a nitrogen bath gas, lose kinetic 
energy and form a long, thin thread across the curved axis of the trap. The thread is 
compressed axially by apertures at the entrance and exit of the C-trap which have an rf 
voltage to provide a potential difference across the trap axis [23].  
Ions are extracted by switching off the rf voltage of the C-trap and instead applying 
extracting dc pulses across the electrodes. Ions are ejected orthogonally to the axis of 
the C-trap via a slot in the pull out electrode. The ion beam then converges on the 
entrance of the orbitrap mass analyser [23].  
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Figure 1.4 shows the face view of the orbitrap. The device consists a coaxial, barrel-
like, outer electrode, with an axial central electrode that is run through [30]. The outer 
electrode consists of two halves with a small interval. The maximum diameter of the 
inner electrode is 8mm and the outer electrodes 20 mm [31]. Ions are injected laterally 
between the two parts of the outer electrode. An appropriate voltage is applied to the 
central electrode, which is held at an opposite potential to the mode of ionization, and 
the outer electrode is held at ground potential. This creates a centrifugal force 
facilitating ion trapping. 
 
 
 
 
Figure 1. 4 - Cross section of the Orbitrap mass analyser. Figure adapted from [32]. 
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The electrostatic field between the two electrodes creates a static electrical field which 
is described in Equation 1.1, where U is the electrostatic potential; r and z are the 
cylindrical co-ordinates; C is a constant, k is the field curvature and Rm is the 
characteristic radius. 
 
 
Equation 1. 1 - Equation describing the electrostatic field of the orbitrap cell. 
As ions orbit the spindle, they are free to move independently along the z-axis, such 
that the orbit around the central electrode becomes a series of complicated spirals. 
Each ion has a characteristic oscillation frequency that is dependent on its m/z . The 
motion along the z axis can be described as a simple harmonic oscillator, like a 
pendulum. Equation 1.2 explains this motion and Equation 1.3 shows that the 
frequency is directly linked to the m/z ratio and is independent of the kinetic energy of 
the injected ions, where ω= the frequency of axial oscillations in radians/ per second, 
Ez = energy characteristic of ion motion along the z axis, k is the field curvature of the 
orbitrap cell, q = ion charge and m = ion mass [33]. 
a) 𝑧(𝑡) = 𝑧0𝑐𝑜𝑠𝜔𝑡 + √(
2𝐸𝑧
𝑘
)𝑠𝑖𝑛𝜔𝑡     
b)  𝑤 = √(
𝑞
𝑚
)𝑘         
Equation 1. 2 - Equations describing the axial ion oscillations along the z axis of the 
orbitrap spindle electrode a) equation of motion, b) calculating the charge to mass 
ratio of an ion from frequency of osciallations. 
 
 
𝑈(𝑟 ,𝑧) =
𝑘
2
 𝑧2 −
𝑟2
2
 +
𝑘
2
(𝑅𝑚 )
2 ln  
𝑟
𝑅𝑚
 + 𝐶 
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1.2.3.2 Q-Exactive HF 
A second hybrid mass spectrometer that was used in this thesis was the Q-Exactive 
mass spectrometer. This is a hybrid quadrupole-orbitrap instrument. Figure 1.5 depicts 
a schematic of the Q-Exactive HF. Briefly; ions are injected via a nano-ESI source and 
focused using a S-lens. Ions are then transferred via a bent flatpole that facilitates the 
ejection of solvent droplets and other neutral species, preventing them from entering 
further into the instrument. Ions then enter a segmented quadrupole (HyperQuad 
Mass Filter with Advanced Quadrupole Technology (AQT)), which acts as a mass filter. 
 
 
 
 
  
 
 
 
 
Figure 1. 5 - Schematic of Q-Exactive HF mass spectrometer. Figure adapted from [34].  
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Figure 1.6 shows a schematic of a quadrupole. Quadrupoles are devices which use the 
stability of the trajectories in oscillating fields to separate ions based on their m/z 
ratios. A quadrupole consists of four hyperbolic rods, each with an alternating 
radiofrequency applied to it [32].   
 
 
 
 
 
 
 
 
Figure 1. 6 - Schematic diagram and axis of motion of ions in a quadrupole. 
 
Ions travelling along the z axis are subjected to a quadrupolar alternative field 
superposed on a constant field supplied via the four rods. These are described in 
Equation 1.3, where φ0 is the potential of the rods, ω is the angular frequency of the 
field in radians per second, t is any time point, U is the DC voltage and V is the zero to 
peak amplitude of the RF voltage. 
Φ0 = +(𝑈 − 𝑉 cos 𝜔𝑡) and − Φ0 = − (𝑈 − 𝑉𝑐𝑜𝑠𝜔𝑡)                                     
Equation 1. 3 - Equation describing the quadrupolar field. 
A ion entering the space between the rods will be drawn towards rod of an opposite 
charge. If the potential of the rod changes sign before the ion is discharged, the ion will 
change trajectory. The trajectory of ions through the quadrupole is determined by 
their m/z, so ions can be selectively transmitted by adjusting the strength of the 
y 
x 
z 
 - (U + Vcos𝜔t) 
+ (U + Vcos𝜔t) 
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electric and RF fields. Ions of differing m/z will be have an unstable path and will be 
deflected towards one of the rods and be discharged [35].  
The Q-Exactive offers the opportunity to select ions at a much faster rate due to the 
switching time of the quadrupole. This is advantageous compared to the orbitrap, 
where the LTQ system only allows a certain population of ions to remain stable within 
the trap [36].  
 
1.2.4 Tandem Mass Spectrometetry 
Tandem mass spectrometry is conducted by performing two separate mass analysis 
events, in a single instrument. Through the fragmentation of an intact ion it is possible 
to predict its structure, based on predictable bond cleavages. This method of analysis 
is commonly used for the analysis of proteins, peptides and PTMs [36].  
In MS based proteomic analyses, MS/MS can be used to peptide sequence as well as 
localise structural modifications. In the example of peptides, fragmentation most 
commonly occurs along the peptide backbone (Figure 1.7). The fragments observed 
depend on the fragmentation technique used. There are different fragmentation 
techniques available. These include collision induced dissociation (CID), electron 
transfer dissociation (ETD) and HCD [37]. CID and HCD fragmentation predominantly 
produce b and y product ions as well as occasional a ions. ETD fragmentation mostly 
forms c and z ions as well as occasional a,b or y ions [38]. 
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Figure 1. 7 - The chemical structure of a peptide, together with the designation for 
fragment ions (the Roepstorff–Fohlmann–Biemann nomenclature) [39]. Adapted from 
[40]. 
1.2.4.1 Collision induced dissociation (CID) 
CID is achieved through collisions between the precursor ion and an inert gas. Some of 
the kinetic energy that is gained during the collision is converted into internal energy 
within the ion that results in bond dissociation, generating a fragment ion and a 
neutral loss molecule. 
In proteomics, research is focused on peptide fragmentation. The mobile proton model 
describes the mechanisms of fragmentation in the CID of peptides [41]. The model 
assumes the energy imparted in the collision results in the transfer of a proton in a 
more basic region e.g. basic amino acid side chains or the N-terminus, can transfer to 
the amide nitrogen atoms,  producing bn and yn ions. By finding the difference in mass 
between sequential b and y ions, it is possible to calculate the peptide sequence. 
Whilst b and y fragments represent the most common fragmentation pathways, other 
possibilities do exist. Neutral losses from ions are common and include the removal of 
small molecules such as H2O, NH3, and CO from peptides. Including these losses into 
criteria when searching for fragments can act as an additional source of information 
when assigning MS/MS spectra to peptide sequences [42]. 
x2                   y2                      z2                        x1                    y1                     z1     
a1                     b1                     c1                        a2                  b2                     c2    
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1.2.4.2 Electron Mediated Dissociation  
Whilst CID is effective at producing sequence information, this mechanism of 
fragmentation results in the dissociation of the most labile bonds. Post translational 
modifications (PTMs) are often lost during this method of fragmentation and therefore 
prove impossible to localize during sequencing analysis. For example, in the case of 
phosphopeptides, the phosphate backbone competes with the peptide backbone as 
the preferred site of cleavage. Phosphoric acid is often displaced from the peptide, 
losing localisation information [43].  
In 1998 electron capture dissociation (ECD) was reported as an alternative method to 
analyse peptide structures and was later found to be effective at retaining PTMs on 
fragments [44-46]. This technique is not without its limitations in that the precursor 
ions need to be completely immersed in near thermal electrons, effectively limiting 
this technique to analysis using a Fourier transform ion cycolotron resonance (FT-ICR) 
mass analyser [47, 48]. Six years later Syka and co-workers developed a methodology 
to enable peptide fragmentation, without the need for thermal electrons, termed 
electron transfer dissociation (ETD) [49]. ECD and ETD ions typically form c and z 
fragments (Figure 1.7).  There are two major accepted theoretical mechanisms for the 
fragmentation of peptides using ECD/ETD: the Cornell mechanism [50]and the Utah-
Washington mechanism [51] (Scheme 1.1). 
The Cornell mechanism was developed by McLafferty and co-workers [50]. This 
mechanism suggests that initial electron capture will occur on a protonated amino acid 
side chain, typically that of a basic amino acid (lysine, arginine, histidine), forming a 
hypervalent radical N-species. Hydrogen atom ejection and transfer to the amide 
oxygen allows the formation of a carbon-centred amino-ketyl radical intermediate. 
Cleavage at the adjacent N-Cα bond occurs and c and z fragments are subsequently 
formed. Whilst the Cornell mechanism explains the formation of these specific 
fragments where mobile hydrogen atoms are present, it fails to explain the 
observation of these fragments in examples where peptides do not carry fixed charge 
derivatives or metal adducts [52, 53].  
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The Utah-Washington mechanism was conceived by Simons et al. from the University  
of Utah [51], and then furthered by Turecek et al. from the University of Washington 
[54, 55]. This theory works on the principle that an electron is captured in a Coulomb-
stabilised amide π orbital, forming an aminoketyl radical anion. This anion is superbasic 
with a proton affinity in the range of 1100–1400 kJ mol–1 [54, 56]. The amide anion 
then abstracts a proton from an accessible site to become neutralized resulting in the 
formation of c and z fragments.  
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Scheme 1. 1 a) Cornell mechanism for N–Ca bond cleavage in ExD of peptides and 
proteins with charge solvation from a C-terminal donor amine group and b) the Utah–
Washington mechanism for ExD. Scheme adapted from [57]. 
e- 
e- 
a) 
b) 
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1.2.4.3 Higher energy collision dissociation (HCD) 
HCD provides beam type CID MS/MS to effect vibronic dissociation. This approach 
differs from the collisional dissociation via resonant excitation of a trapped precursor 
population [58]. In the context of the Orbitrap mass analyser, ions are passed through 
the C-trap into an adjacent multipole, which acts as a collision cell. Fragments are 
passed back through the C-trap and into the orbitrap for high resolution analysis. HCD 
is advantageous to the ion-trap CID fragmentation described previously in that there is 
no low-mass cut off, the data is of higher resolution and increased ion fragments are 
transferred leading to a better signal-to-noise ratio [59].  
Whilst these three fragmentation techniques are effective in the identification of 
peptides, they can also be used to aid the identification of small molecules such as 
drugs, toxins and metabolites [60-62].  
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1.3 Subcritical water  
Figure 1.8 represents a phase diagram of water as a function of temperature and 
pressure. Under atmospheric pressure water melts at 0 oC and boils at 100 oC. In 
addition to the three phases of solid, liquid and gas, water can exist in a supercritical 
phase under conditions >373.9 oC and 220.6 bar [1]. Supercritical is a defined as ‘the 
state of a substance where there is no clear change between the liquid and gas phase’ 
[63]. In this thesis, the focus is on the use of subcritical water. This refers to liquid 
water at temperatures between the atmospheric boiling point and the critical 
temperature of water. 
 
 
 
Figure 1. 8 - Phase diagram of water with respect to pressure and temperature. 
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1.3.2 Physical-chemical properties of SCW 
Under ambient conditions water has an extremely high dielectric constant (εr) of ~80 
Fm-1 at 20 oC and 0.1 MPa. This property refers to waters ability to electrostatically 
bind to surrounding molecules. The dielectric constant of water decreases as it 
approaches the critical point (14.07 Fm-1 at 350 oC and 20 MPa) [64]. Therefore there 
are reduced interactions between water molecules and surrounding ions as well as an 
increased movement of water molecules. Under these increased temperature and 
pressure conditions, where the hydrogen bonding network is disrupted, water is able 
to dissolve non-polar compounds. As a comparison, under subcritical conditions of 
~200 – 275 oC, the dielectric constant of water is comparable to that of methanol and 
ethanol at 20 oC (33.30 and 25.02 Fm-1) [65].  
Under ambient conditions water dissociates to form hydronium and hydroxide 
conditions. This is described in Equation 1.4 where Kw = ionic product of water. 
Kw =
[H3O
+][OH−]
[H2O]
 
Equation 1. 4 - Equation describing the ionic product of water.  
Under subcritical conditions the ionic product of water (Kw) increases by ~100 orders of 
magnitude under subcritical conditions (from 10-14 to 10-12 mol.dm-3). The increase in 
hydrogen and hydroxide ion concentration raises the reactivity of water and enables 
SCW to catalyse chemical reactions [66]. 
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1.3.3 Subcritical water extraction  
Over recent years an increasing amount of research has focused on the use of SCW for 
the recovery of valuable compounds from food waste [67]. The extraction of valuable 
compounds, from a sample traditionally discarded as waste, has significant economic 
potential. Food industry wastes are often rich in proteins and SCW has been widely 
used in the recovery of amino acids and peptides from these wastes [68, 69].  
The fish industry is considered to be one of the most wasteful food industries, with 
~40-50% of total weight contributing towards waste [70]. Tayokoli and Yoshida 
investigated the recovery of amino acids from scallop viscera [71]. The optimum yield 
of amino acids was observed at 240 oC, and temperatures above this showed 
degradation of amino acids into organic acids. Here, amino acids content was 
measured using an amino acid HPLC column with a post-column labelling method and 
amino acids quantity was analysed using a fluorescence detector. 
Sereewatthanawut et al. demonstrated efficient recovery of amino acids and protein 
from deoiled rice bran [72]. Here, the protein and free amino acid content was 
analysed using spectrophotometric methods. The protein content was analysed by 
Lowry’s assay, using bovine serum albumin (BSA) as a standard and amino acid content 
was analysed by Ninhydrin assays using L-glutamic acid as a standard.  The yield of 
both protein and amino acids using SCW extraction from deoiled rice bran compared 
favourably to using alkali hydrolysis extraction, a more traditional method. 
Additionally, in this study, the antioxidant capacity of the SCW hydrolysates was 
assessed using the 2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS) assay. 
Hydrolysates showed a positive correlation between residency temperature and 
antioxidant capacity. 
SCW has been reported as an excellent solvent in the recovery of other antioxidant 
compounds [73-76]. The recovery of these compounds is of great interest to cosmetic 
and food industries. Various extraction techniques have previously been applied in the 
withdrawal of bioactive compounds from biological mixtures, including Soxhlet 
extraction and maceration [77]. Whilst these techniques can offer effective recovery, 
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they do have many disadvantages, including exposure to hazardous and flammable 
liquid organic solvents [78]. Furthermore, they are not considered “green” procedures 
and may contribute towards pollution. Interestingly, Khajenoori et al. favourably 
compared subcritical extraction (SCE) against traditional approaches for the extraction 
of essential oils from the Iranian flower, Zataria multiflora Boiss [79]. 
Giray et al. investigated the products of the SCE of Lavandula stoechas flowers against 
those obtained following the more traditional extraction techniques of 
hydrodistillation and organic solvent extraction under ultrasonic irradiation [80]. Both 
heavy and light oxygenated compounds were shown to be extracted more efficiently 
using SCE. Here, both qualitative analysis of all mixtures as well as quantitative analysis 
of specified compounds was performed using gas chromatography (GC)-MS.  
 
1.3.4 SCW Processing Models 
Subcritical treatment has been carried out using both continuous [81] and batch [82] 
processing models. In the continuous flow model, water is passed through a pump and 
transferred into an extraction cell. The extraction cell is situated within a convection 
oven that contains the reactant. The resulting hydrolysate stream then exits through a 
cooling coil and the mixture is collected. 
In the work presented in this thesis a batch mode SCW apparatus was used. In contrast 
to the continuous flow model, this set up is simpler in design. Figure 1.9a shows a 
typical processing tube. The pre-requisite volume of water and biomass are placed in 
the reactor and appropriately tightened (air tight). The mixture is heated up to 
temperature for the desired reaction time using a convection oven (Figure 1.9b). For 
reaction termination, the reactor is immersed into an ice bath. The temperature of the 
reaction can be monitored via a thermocouple where required, which can be injected 
into a reaction tube (Figure 1.9c).
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Figure 1. 9 - Apparatus used for SCW hydrolysis a) reaction tube, b) convection oven, c) 
thermocoupler. 
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1.3.5 The influence of SCW parameters 
There are many parameters involved in the SCE of compounds. A subtle change in each 
one could result in a large shift in the extraction yield. Some of these parameters are 
discussed below. 
1.3.5.1 Temperature 
The residency temperature has a high degree of influence on the physiochemical 
properties of water and therefore choosing which temperature to use for extraction is 
of critical importance. A temperature too low will result in inefficient extraction, whilst 
using a temperature too high often risks its degradation [79]. Additional reactions may 
occur under these elevated temperatures i.e. the production of by-products or the 
decomposition of compounds. This was demonstrated by Vergara-Salinas et al. in the 
extraction of polyphenol from grape pomace extracts [83]. Here increasing the 
residency temperature above 150 ⁰C resulted in the production of by-products and an 
overall decrease in yield due to polyphenol degradation.  
1.3.5.2 Solid: water ratio 
The importance of choosing an appropriate solid: water ratio in the efficient recovery 
of chosen compounds using subcritical water hydrolysis is disputed. Wang et al. 
studied the extraction of ursolic acid from the herb, hedyotis diffusa [84]. A sharp 
increase in yield was observed when 1g of sample was dissolved in 25 ml of water, 
compared to that obtained when dissolved in 20 ml water. A gradual decrease in yield 
was observed when the amount of water was increased incrementally to 40 ml. 
Lei et al. investigated the recovery of resveratrol from grape seeds under a variety of 
conditions [85]. A surface response methodology was employed to identify the 
optimum extraction conditions for temperature, time, pressure and solid: water ratio. 
Here, the yield of resveratrol was constant under the different solid: water ratios 
employed. 
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1.3.5.3 Time  
The residency time of the reaction is critical in extraction efficiency. Xu et al. 
investigated the effect of a variety of parameters on phenolic extraction from marigold 
flower residues [76].  The highest level of phenolic compounds could be obtained after 
45 minutes of hydrolysis. An increase in extraction time beyond this resulted in a 
significant decrease in extraction efficiency. The authors speculated this may have 
been due to degradation of the phenolic compounds, or else polymerisation of the 
compounds under these extended residency times. Furthermore Awaluddin et al. 
studied the extraction of carbohydrates from Chlorella vulgaris [86]. Here, longer 
reaction times were shown to increase carbohydrate yield. In this study a maximum 
reaction time of 20 minutes is used.  
 
1.3.5.4 Pressure 
The influence of pressure on SCE efficiency has been disputed [87-89]. Under 
temperatures less than 300 oC an increasing pressure has little effect on the physical 
characteristics of water [1, 90]. Only under temperatures above this do the properties 
of water alter with respect to pressure [91]. Kartina et al. investigated hemicellulose 
extraction from oil palm (Elaeis guineensis) [92]. When the extraction pressure was 
increased from 500 psi to 800 psi the yield of hemicellulose showed a ~3 fold increase. 
This particular parameter is of little practical use as it is not one that can be directed 
using batch processing. 
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1.4 Brewers’ waste 
Barley is widely considered one of the world’s most important cereals and is used as a 
raw material in the manufacturing of beer, one of the most consumed beverages 
globally. Beer brewing generates a variety of waste residues and by-products. SCW has 
previously been applied in the recovery of valuable compounds, such as antioxidant 
compounds, from industrial wastes [73-76]. In the work presented in this thesis, the 
aim is to develop SCE of antioxidant compounds from brewers’ waste.  
  
1.4.1 The brewing process 
Figure 1.10 provides an overview of the brewing process. Whole barley grains consist 
of ~65% starch, 10-17% protein, 4-9% β-glucan and 2% lipids as well as small amounts 
of various minerals [93-95]. The barley grain consists of a germ (embryo), the 
endosperm and a grain coat. During the preparation of the barley feedstock it is 
cleaned and separated according to its size. The barley grain is then left for upwards of 
a month prior to malting.   
The process of malting comprises three steps – 1) steeping, to allow absorption of 
water; 2) germination to initiate enzymatic breakdown; and 3) kilning, to ensure 
product stability.  
In steeping, cleaned grains are incubated in ‘steeping tanks’ for 40-48 hours. The grains 
are held in water between 5-18oC. Over this period, the raw barley alternates between 
being submerged and drained until its moisture content increases from ~12% to ~44%. 
This hydration allows the initiation of germination [96, 97].  
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Figure 1. 10 - Flow diagram of beer manufacturing. 
 
Steeped grains are transferred to a germination vessel which is maintained at 15 - 21oC 
with humid air. Germination results in the degradation of protein and carbohydrates, 
resulting in the opening up of starch reserves and activation of enzymes that are 
present in the barley endosperm. The grains are kiln dried with a finish heat of ~80 oC 
[97]. The changing of the kiln time, temperature and humidity allows different flavours 
to develop. Kilning is also efficient at removing microbial contamination [98, 99]. Dried 
malt is then stored for a period prior to the second half of the brewing process. 
Barley malt is crushed in a process referred to as ‘milling’. This step occurs over 1-2h at 
22oC. This step is important in exposing the starch centre of the barley seed in such a 
way that the husk is left substantially intact whilst the rest becomes a coarse powder. 
This causes enzyme release and an increase in reaction surface area.   
Brewers spent grain
Filtration
0.5-1.5h >98oC
Mashing
1-2h 30-72oC
Milling
1-2h 22oC
Barley Malt
Kilning
24-48h 80oC
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3-5 days 15-21oC
Steeping
48h 5-18oC
Barley
Wort
Malting 
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Beer is produced through careful mixing of crushed barley malt with hot water, in a 
process referred to as ‘mashing’.  In the brewery, the malted barley is periodically 
subjected to a range of temperatures, each one facilitating the activation of different 
malt enzyme. Enzymes primarily break down starch, but some breakdown of protein 
also occurs. The final step is the heating of the mixture to ~78 oC, which causes 
inactivation of the enzymes involved. Following mashing, a sweet liquid known as wort 
is produced. This fraction is removed and will go on to be fermented and conditioned 
before final filtration and bottling. There is also a residual, insoluble portion that is 
produced within the mash. This typically accounts for 25-30% of the mixture, and is 
removed immediately following mashing - this is referred to as ‘brewers spent grain’ 
(BSG) [97].  
BSG is rich in cellulose, hemicellulose, lignin and proteins and therefore is of high 
nutritional value [100]. Despite the large amounts that are generated throughout the 
year, the use of spent grain is rather one dimensional, with 95% of all BSG being used 
as an animal feed [97]. Whilst this effectively reduces associated feeding costs as well 
as creating a suitable use for the material, rather than disposal [101, 102], there are 
several other characteristics of BSG which imply its potential in other fields. 
1.4.2 Brewers’ spent grain (BSG) characterisation 
Around 12% of spent grain is made up of protein [103],  where the prolamin family 
constitutes the main storage proteins. These are characterised by a high degree of 
glutamine and proline residues [104], as well as solubility in alcohol. The dominant 
protein present is the hordein family, of which four classes have been established, 1) D 
hordeins (100 kDa+), 2) C (sulfur-poor) (49-72 kDa), 3) B (sulfur rich) (28-45 kDa), and 
4) γ-hordeins. A fifth class also exist, the A hordeins, but these are no longer 
considered true storage proteins. The B and C fractions account for 70-80% and 10-
12%, respectively, of the total hordein, while the D and γ fractions are minor 
components [105, 106].  
The production of antioxidants mixtures from protein based waste using SCW was 
discussed in Section 1.3.3. 
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As discussed in Chapter 1.2.3, SCW is effective at producing antioxidant mixtures from 
protein based mixtures. In the work presented in this thesis, SCW has been applied to 
BSG.  Furthermore, peptides containing high levels of hydrophobic residues have been 
shown to have strong antioxidant activity, through the inactivation of reactive oxygen 
species (ROS) and scavenging of free radicals [107, 108]. Hordeins distinctively high 
levels of non-polar residues (Pro, Leu, Val); make them ideal candidates in the search 
for peptides with antioxidant activity. Bamdad and Chen have previously investigated 
the antioxidant effects of hordein hydrolysates [109]. In that study, a mixture of 
hordeins was digested using alcalase and the resulting peptides were analysed for 
antioxidant activity. Peptides with MW <1KDa were shown to have the highest 
antioxidant power. 
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1.5 Oxidative stress 
Antioxidants role in homeostasis is to combat oxidative stress. Oxidative stress occurs 
when the body’s normal homeostatic functions fail, and the balance between pro-
oxidants and anti-oxidant systems are disrupted. Oxidative stress can result in damage 
to DNA, protein, lipids and mitochondrial function [110]. The effects of oxidative stress 
are variable. In the majority of instances a cell is able to combat the increased level of 
pro-oxidants and return to its original state [111]. In more severe cases, pro-oxidants 
can trigger apoptotic and necrotic pathways [112].  
  
1.5.1 Pro-oxidants 
Pro-oxidants include ROS, reactive nitrogen species (RNS) and reactive sulphur species 
(RSS) [113, 114]. ROS, such as hydrogen peroxide (H2O2), superoxide (O2 −) and peroxyl 
radicals (ROO.), consist of both radical and non-radical species formed from the partial 
reduction of oxygen. ROS are primarily produced by mitochondria, cell membranes, 
the endoplasmic reticulum (ER) and peroxisomes [115], through both enzymatic and 
environmental stimuli. RNS derive from the metabolism of nitric oxide (NO) to 
generate molecules such as nitrogen monoxide (NO.), nitrite (NO2-), nitrogen dioxide 
(NO2.), nitroxyl anion (NO−) and peroxynitrate (O2NOO−). RSS arise from the 
metabolism of sulphur-containing molecules, particularly where sulphur atoms are in 
higher oxidation states [114, 116]. RSS include the thiyl radical (RS.), glutathione (GSH), 
sulfenate (RSO−), sulfinate (RSO2−), sulfonate (RSO3−) and hydrogen sulfide (H2S).  
The non-radical species that are generated above are prone to reacting with metal 
catalysts forming free radicals. For example, the Fenton Reaction (see below) describes 
hydroxyl radical formation from hydrogen peroxide [117]. 
Fe2+ + H2O2                             Fe3+ + OH- + OH. 
If there is an excess of pro-oxidants, these can non-specifically attack biomolecules 
such as lipids, protein and DNA, leading to cell disorders including neurodegeneration 
and cancer [118-121]. 
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1.5.2 Antioxidants 
Antioxidants are substances that retard the action of pro-oxidants. These molecules 
help prevent oxidative damage to important biological molecules such as proteins, 
lipids, carbohydrates or DNA.  
1.5.2.1 Enzymatic antoxidants 
The cell possesses enzymatic anti-oxidants to combat prooxidants in order to maintain 
cellular function. Examples include superoxide dismutase (SOD), catalase (CAT) and 
glutathione peroxidase (GSHPx) [122]. 
The reactions below describe the reactions catalysed by some of these enzymatic 
antioxidants. SOD is an enzyme with a generalized presence in the body that targets 
the superoxide anion by de-radicalising it to form the much less reactive hydrogen 
peroxide. H2O2 can be further detoxified to form water by either CAT, which is found in 
peroxisomes or GSHPx, which is present in the cytosol [123].   
 
2O2. - + 2H+                             H2O2 + O2 
2H2O2                    2H2O + O2 
H2O2                              2H2O + GSSG 
 
 
 
 
 
 
 
SOD 
CAT 
GSHPx 
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1.5.2.2 Non-enzymatic antioxidants 
 
Figure 1. 11 - Vitamin C mechanism of antioxidant action. 
As well as enzymatic antioxidants that are part of a healthy cells make-up, antioxidants 
can be introduced via dietary uptake. Common non-enzymatic antioxidants include 
Vitamin C, flavonoids and carotenoids. 
Vitamin C (or ascorbic acid) is a water-soluble free radical scavenger and powerful 
antioxidant. Vitamin C functions by reducing free radicals via hydrogen donation and 
forming the stable compound dehydroascorbate. The electron is now shared within 
the ring structure of Vitamin C and is relatively stable (Figure 1.11) [124]. 
Flavonoids and carotenoids are common in fruits and vegetables and form a major part 
of dietary antioxidants. These compounds are effective in combatting ROS [125, 126]. 
Flavonoids and carotenoids actively bind free metal ions which otherwise can serve to 
catalyse hydroxyl radical formation. Furthermore, they have also shown to be effective 
at directly reducing free radicals via hydrogen atom donation. 
An aim of this work presented in this thesis was to produce synthetic antioxidant 
compounds using SCW treatment of proteins. To evaluate the anti-oxidant activity of a 
various compounds a number of anti-oxidant assays have been implemented. 
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1.5.4 Antioxidant assays  
To assess the antioxidant potential of mixtures, numerous antioxidant assays can be 
applied. There are two main mechanisms by which in vitro antioxidant assays work to 
assess the global antioxidant power of a substance. These are hydrogen atom transfer 
(HAT) – where a free radical is quenched via hydrogen donation and single electron 
transfer (SET) - where target compounds are reduced via electron transfer [127]. HAT 
based assays involve an antioxidant and substrate competing for degradation via 
peroxyl radicals (often generated by azo compounds) [127]. Oxygen Radical 
Absorbance Capacity (ORAC) [128], Total Radical Trapping Antioxidant Parameter 
(TRAP) [129], and crocin bleaching assays [130] are common HAT based assays. SET-
based assays are commonly monitored by a colour change. Folin-Ciocalteu Reagent 
(FCR) [131], Trolox Equivalence Antioxidant Capacity (TEAC) [132], Ferric ion Reducing 
Antioxidant Power (FRAP)[133] and reducing power (RP) [134]assays are common SET-
based assays. Antioxidant assays can also be performed by directly measuring 
oxidative damage to cells that have been incubated with a test substance and a free 
radical generator. These include the cellular antioxidant activity (CAA) [135] and the 
comet assay [136]. 
1.5.4.1 ORAC assay  
The ORAC assay was initially developed by Glazer and Ghiselli [128, 129]. In the original 
form of the assay β- phycoerythrin was used as a fluorescent probe and AAPH as a free 
radical generator. The amount of fluorescence detected via absorbance was 
proportional to the degradation of the probe. Cao and co-workers quantitated the 
total antioxidant capacity (TAC) of a substance by calculating the area under the 
fluorescence decay curve (AUC) of the sample compared to a negative control which 
did not contain any antioxidant [137].  These are described in Equation 1.5, where AUC 
is the area under the curve and fx is the frequency at a given time point. β- 
phycoerythrin was later replaced as a probe by fluorescein, which was much more 
stable [138] and the process was subsequently automated [139]. 
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𝐴𝑈𝐶 = 0.5 + 
𝑓1
𝑓0
+⋯
𝑓𝑖
𝑓0
+⋯
𝑓59
𝑓0
+ 0.5 (
𝑓60
𝑓0
) 
Equation 1. 5 - Equation for calculating the area under the curve for ORAC assays.
  
Cao et al. introduced the Vitamin E analogue, 6-hydroxy-2,5,7,8-tetramethylchroman-
2-carboxylic acid (Trolox) into the ORAC assay. The antioxidant capacity of Trolox is 
monitored over a range of concentrations using the ORAC assay and used to generate 
a calibration curve. The ORAC values obtained for the test substances are given 
relative to Trolox concentration. The has allowed test substances to be directly 
compared to the ORAC  values obtained for commercial standards [137]. The ORAC 
assay has previously been applied to microalgae[140], plasma [141] and vegetables 
[142]. 
The assay is not without its drawbacks, reaction rates of various antioxidants can 
significantly differ [143, 144]. Reaction measurements are incomparable if the reaction 
is not completed within the reaction time specified. Moreover, the ORAC assay is 
performed in an aqueous solution, which means antioxidant components that are 
insoluble will not be measured using this assay. 
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1.5.4.2 Reducing Power assay 
The reducing power assay is a spectrophotometry based assay where antioxidant 
activity is monitored via absorbance. The assay was developed by Oyaizu in 1986 [134]. 
This is an example of a SET-based assay. Here, a Fe3+/ferricyanide complex 
[FeCl3/K3Fe(CN)6] is mixed with a test substance. A substance exhibiting reducing 
power will cause the complex to be reduced to the ferrous (Fe2+) form. An overall 
colour change of yellow to green is noted. An increasing correlation between 
substances of high reducing power and overall colour change is observed. This is 
monitored by measuring absorbance at 700nm. This assay has previously been used to 
assess the antioxidant power of plant extracts from M. serratulum and Eichhornia 
crassipes [145, 146].    
 
1.5.4.3 Comet assay 
The comet assay is a widely used assay for quantifying DNA damage and repair at a 
single cell level [136]. Briefly, the amount of damage that the DNA of a cell has 
undergone will affect its migration pattern under gel electrophoresis. The concept of 
using electrophoresis to measure DNA damage was first conceived by Ostling and 
Johnson in 1984 [147]. The authors showed that migration was more pronounced in 
radiation damaged DNA compared to control cells. This method was an improvement 
on the previously established methods of quantifying DNA damage due to the small 
number of cells that are required in the assay as well as no radiolabelling being 
required, thus allowing the use of any nucleated cell. A few years later, a modified 
protocol was introduced by Singh et al. who completed the protocol under alkaline 
conditions [148]. 
Both the neutral and alkaline variations of this assay have potential to differentiate 
between types of DNA damage. In the neutral comet assay, cellular DNA maintains its 
double stranded structure, which allows the detection of double stranded DNA breaks 
only. The more sensitive alkaline comet assay is the more widely used variant of the 
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assay [136]. This variant of the assay allows the detection of both single and double 
stranded DNA breaks, as well as alkali labile sites.  
In contrast to the ORAC and reducing power assays outlined above the comet assay is 
performed on live cells. Cells can be extracted either from in vitro cell culture or 
directly from test subjects in vivo [149]. The in vivo comet assay is most commonly 
used as a method of supplementing and confirming results that were previously 
identified in vitro. The comet assay offers advantages over other in vivo tests due to its 
high sensitivity and that it can be applied to virtually any organ of interest. 
Subsequently, it has been taken into account by health authorities in the development 
of drugs. For example, the genotixicity of the drugs Cyanomethyl-carbamoylcyclohexyl-
propylpiperazinyl-benzamide and Carbonyl-amino-indanylcarbamic acid ester was 
assessed using the in vitro comet assay on V79 cells (Chinese hamster cell line) and 
then confirmed by the in vivo comet assay by European health authorites  prior to 
further human testing [150].  
Figure 1.12 shows the workflow followed to complete the comet assay in this thesis. a) 
Cells are allowed to grow in 6 or 12 well plates until ~70% confluent and then b) 
incubated with the test substance. Cells are then exposed to an oxidising agent, 
commonly via H2O2 addition or UV light [151]. In this thesis H2O2 treatment was used. 
c) Cells are detached from the well via trypsin and d) pelleted using centrifugation.     
e) To ensure cells have not died as a result of trypsinisation or incubation with the test 
substance a cell viability assay is often employed [152]. In this assay a solution of 
trypan blue is added to a suspension of cells. Healthy cells maintain membrane 
integrity and do not uptake the die, whereas dead cells do not have an intact 
membrane and take up the dye. Cells can be visualised using a standard light 
microscope and the live: dead cell ratio can be recorded. Most literature reports cell 
viability >90% prior to completing the comet assay [153, 154].  
f) A sample of cells is then dissolved in low melting point (LMP) agarose at 37 oC and 
layered over a glass slide. The agarose is considered to be osmotic neutral, which 
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allows solutions to enter the gel and affect the DNA chemically without altering its 
position in the gel. 
g) The slides are then submerged in a lysis solution that is either neutral or alkaline 
dependent on the variation of the assay being used. The lysis solution typically 
contains detergent to enable solubilisation of the cell membrane. All proteins, RNA and 
organelles freely diffuse into the agarose matrix. The lysis solution also uses a high salt 
concentration. This enables solubilisation of the nuclear histones.   
h) Slides are subsequently immersed in either a neutral or alkaline electrophoresis 
buffer. The slides are incubated at 4 oC for a time period to allow the DNA supercoils to 
unwind and in the case of the alkaline comet assay - the nucleoid to become single 
stranded.  Electrophoresis is performed where the amount of damage that a molecule 
of DNA has undergone, i.e. how many strand breaks have been induced, is 
proportional to the migration distance of the DNA. Strand breaks lead to increasingly 
relaxed DNA from its supercoiled structure and the electric current supplied allows 
DNA to extend from the nucleoid. The phosphate backbone of the DNA provides a 
negative charge which ensures net migration towards the anode. Slides are then 
neutralised, before dehydration with alcohol, which allows for long term storage. 
i) The slides are then stained using a DNA-binding fluorescent dye. Common reagents 
include ethidium bromide, SYBR gold, SYBR green or alternatively by a non-fluorescing 
dye e.g. silver nitrate [155]. The comets are then visualised by fluorescent microscopy. 
The overall structure resembles a comet, with a circular ‘head’ of undamaged DNA 
followed by a ‘tail’ of damaged DNA. The brightness of the tail is measured relative to 
that of the head as an indication of overall DNA damage. 
A major pitfall in the use of the comet assay is the lack of standardised inter-laboratory 
protocol. Although several guidelines have been published [156, 157], there are 
considerable differences between individual papers, making comparisons between 
results impossible. 
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Figure 1. 12 - Workflow of comet assay outlining key protocol stages. 
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Many of the parameters used in the comet assay protocol are subject to change 
between different groups that have substantial effects on the eventual results. These 
include the density of the agarose gels, the strength of the alkaline used, incubation 
time and electrophoretic parameters. Furthermore, cells which have become necrotic 
or apoptotic during the incubation period may also be detected during the comet 
assay, resulting in comets with non-existent heads and large diffuse tails, resulting in 
so called ‘hedgehog comets’. These are often excluded from scoring, although they can 
be regularly seen when treating cells with a non-lethal dose of an oxidising reagent. A 
particular point of variation in protocols is the electrophoretic step. Whilst most 
protocols employ a fixed voltage of 25 V and current of 300 mA, even a small change in 
the amount of buffer placed in the tank can have large effects on the voltage across 
the gel as well as the overall temperature [158].  
 
 
 
 
 
 
 
 
 
 
 
 
42 
 
1.6 Proteomics 
Proteomics studies the protein component of cells, including interactions, 
modifications, quantification and localisation of proteins [159]. The progress of 
proteomics has been driven by development in technologies for protein/peptide 
separation[160], mass spectrometry analysis[23] as well as data analysis tools [161]. 
There are two main strategies in MS-based proteomics: top-down [162]and bottom-up 
[163]. The latter will be the focus of this thesis. Bottom up proteomics relies on 
complex mixtures of proteins being digested via enzymatic cleavage, most commonly 
using trypsin. Peptide identification is achieved by comparing theoretical MS/MS data 
generated from in silico digestion of a protein database against that of the 
experimental data. Whilst investigating the cleavage mechanisms of SCW on proteins 
in Chapter 3, the results suggested SCW could be used as an alternative reagent for 
proteolytic digestion. Proteolysis of standard proteins using SCW was shown to 
generate more peptides and greater sequence coverage than corresponding tryptic 
digests. 
  
1.6.1 Sample preparation 
Due to the complex nature of samples that are frequently required in proteomics, e.g. 
cell lysates, samples are often pre-fractionated prior to analysis. Proteins can be 
separated using sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-
PAGE) via both one and two-dimensional electrophoresis (1-DE and 2-DE). 
In SDS-PAGE samples are dissolved in SDS, an anionic detergent, which denatures a 
proteins secondary structure and applies a negative charge to each protein 
proportional to its mass (~ 1 negative charge to each 2 amino acids). An electric field is 
applied to the gel and the charged proteins migrate towards the positive electrode 
[164]. A proteins migration distance is proportional to the logarithm of its MW. 
In 1-DE proteins are separated according to their MW only, however 2-DE offers 
separation by each proteins isoelectric point followed by MW separation. Proteins are 
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typically visualised using coomassie blue staining [165], although glutaraldehyde-free 
silver staining protocols and colloidal Coomassie staining have also been employed 
[166, 167]. 
Proteins are destained, reduced and alkylated in-gel, prior to enzymatic digestion, 
using a suitable protease. This is commonly trypsin, although in certain cases, for 
example where a protein lacks abundant arginine or lysine residues, other enzymes 
may be employed.  
Gel-based approaches offer the advantage that low molecular impurities, including 
detergents and buffers, which often mask protein signal in downstream analyses, are 
removed during this approach. 
Gel-free approaches are also used in pre-fractionation. In this approach samples are 
directly digested and subsequently fractionated at the peptide level. Many different 
off- and on-line peptide fractionation methods have been used. 
Off-line fractionation methods have the advantages of being practically more simplistic 
to perform as well as the ability to use large amounts of starting material. Methods can 
be customarily selected. For example, charge based separation, such as strong cation 
exchange (SCX) is effective in enriching phosphopeptides due to the associate charge 
of the phosphate groups [168-172]. Whereas, fractionation based on hydrophobic 
interactions typically offers higher resolving power and provides a more effective 
separation of peptides, for example high-pH Reversed-Phase Fractionation [173].   
The ultimate goal of both gel-based and gel-free approaches is to maximize the 
number of protein identifications, which greatly depends on how long the data 
acquisition is performed by the mass spectrometer. 
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1.6.2 Liquid chromatography 
Peptides are eluted into the mass spectrometer via high-performance liquid 
chromatography (HPLC). Most HPLC separations are performed using reversed phase 
chromatography (RPLC) because of its compatibility with MS solvent systems. Figure 
1.13 shows the basic workflow of RPLC. The high resolution separation offered by this 
technology greatly reduces the number of co-eluting peptides, thereby reducing ion 
suppression. 
 
Figure 1. 13 - Workflow of reversed phase liquid chromatography. 
The RPLC column consists of hydrophobic ligands linked to a beaded matrix. Silica is 
commonly used as a matrix due to its stability during the acidic and high organic 
conditions that are used for RPLC [174]. Silica-based matrices can be customised to 
effectively separate different types of molecules. The associated carbon chain lengths 
can be changed to facilitate effective separation of small molecules, peptides or 
proteins.   
Loading  
Adsorbtion 
Desorbtion 
Regeneration 
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The mobile phase of RPLC contains a mixture of water an organic solvent, typically 
acetonitrile or ethanol. A small amount of trifluoroacetic acid (TFA) is commonly added 
to protonate peptides.  
The separation mechanism in HPLC depends on each peptide hydrophobically 
interacting with the stationary phase. The initial mobile phase conditions are 
predominantly aqueous, which favours adsorption between the solute and the 
stationary phase. The polarity of the initial mobile phase (mobile phase A) is controlled 
to dissolve hydrophobic solute as well as ensuring binding to the chromatographic 
matrix. The sample, dissolved in mobile phase A, is then loaded onto the column at an 
appropriate flow rate to ensure proper binding.  
RPLC of the loaded biomolecules is performed using gradient elution. In this method 
an increasing amount of organic solvent (mobile phase B) is added to the mobile phase 
i.e. decreasing its polarity. The solutes are desorbed from the column according to 
their individual hydrophobicities. All samples are eventually eluted as the gradient is 
increased to 100% mobile phase B.  
Despite this basic workflow facilitating the rapid analysis of peptide mixtures, a 
population of peptides are still not interrogated during analysis. Several studies have 
focused on optimising the parameters used in RPLC, including changing column and 
gradient lengths [175, 176]. 
MacCoss et al. investigated the effects of using both a longer column and longer 
gradient lengths on the number of peptides that could be identified from a C. 
elegans lysate [177]. The use of a longer gradient had a marked effect upon the 
amount of successful peptide IDs. The use of longer columns also showed increased 
peptide IDs, but only when longer gradients were also used. It is worth noting that the 
use of longer gradients will substantially decrease sample throughput, so these two 
factors need to be balanced when planning a proteomics experiment.  
Recently, Kocher et al. demonstrated the use of very long 10 hour RPLC gradients for 
the identification of proteins from a HeLa lysate [178]. Whilst this gradient is 
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substantially longer than those typically used in proteomics the authors suggest that 
this method can remove the need for pre-fractionation, thereby making this a more 
efficient and easier method of peptide analysis overall.  
  
1.6.3 Analysis   
Following HPLC separation peptides are introduced into the mass spectrometer. The 
abundance and m/z of all ions eluting at a given time are measured (MS1 scan). 
Fragmentation data can be collected in either data-dependent or data independent 
acquisition modes (DDA or DIA). In DDA, (a preselected number of ) the most abundant 
ions from each MS1 scan are isolated and subsequently fragmented [179]. Whilst this 
is efficient for the global identification of peptides, low abundant ions are often not 
detected. Alternatively, in DIA the fragmentation is independent of abundance. Instead 
of selecting the most abundant ions, these methods select only precursors and 
fragments with pre-specified m/z and elution profiles. 
In the work presented in this thesis MS/MS data was acquired using data-dependent 
acquisition mode (DDA). In this methodology LC-MS/MS data are submitted to a 
protein database search algorithm, such as SEQUEST [180], Mascot [181], OMSSA 
[182], and X!Tandem [183]. Each protein is digested in-silico and the intact masses of 
the generated peptides are listed. The identity of a peptide is confirmed by comparing 
the peaks in the MS/MS experimental data against those of the in-silico digest. 
Whilst many proteins that were present in sample prior to digestion will be assigned 
correctly, there will be inevitably some proteins that are incorrectly identified. A 
number of factors can lead to false PSMs, including low quality spectra and incomplete 
databases. The false discovery rate (FDR), is a statistical value that evaluates the 
number of false positive identifications. 
A target-decoy method is widely used to calculate the FDR. In this method a decoy 
database is designed which contains proteins with non-genuine sequences. A common 
method of achieving this is to reverse all the protein sequences. Indeed, this is the 
47 
 
method using Proteome discoverer- the application used in this thesis. To calculate the 
FDR the number of peptides identified from the decoy database is given as a ratio 
against the real dataset. Commonly the FDR is set at 1% [184]. 
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1.7 Aims and objectives 
The overarching aim of the work in this thesis was to determine the products of SCW 
treatment of brewers’ spent grain. To achieve that aim it was necessary to: 
1) determine the specificity of SCW with respect to production of peptides from 
proteins (Chapter 3) 
2) determine amino acid side chain modifications induced by SCW (Chapter 4) 
3) determine the nature of small molecule products of SCW treatment of proteins 
and this antioxidant activity (Chapter 5). 
In the course of this work, it became apparent that SCW may have a role to play in 
proteomic workflows and this aspect was further explored (Chapter 6). 
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Chapter 2: Methods 
2.1 Samples 
Protein 
Protein standards human haemoglobin, bovine serum albumin (BSA),  bovine β-casein, 
bovine cytochrome C, chicken lysozyme, E. coli  β-galactosidase, bovine apo-transferrin 
and S. cerevisiae alcohol dehydrogenase were purchased from Sigma-Aldrich 
(Gillingham, UK) and used without further purification. 
Non treated grains (NTG) and brewers’ spent grain (BSG) hordein extracts were 
provided by Phytatec (UK). Briefly, extraction was performed by suspending the grain 
in 55% v/v 2-propanol, 1% v/v acetic acid, 2% v/v mercaptoethanol in water at 60 ⁰C 
for 1 hour. The precipitates were recovered by centrifugation (2000 rpm), and 
lyophilized. 
Peptide 
Three lyophilized model peptides, VQSIKCADFLHYMENPTWGR, VCFQYMDRGDR, and 
VQSIKADFLHYENPTWGR, were synthesized by Genic Bio Ltd. (Shanghai, China) and 
used without further purification.  
Amino acid 
Lyophilized amino acids were supplied by Phytatec (UK).  
 
2.2 SCW Mediated Hydrolysis 
Fifteen mg of protein (Chapters 3 and 5), 15 µM peptide (Chapter 4) or 15 µM total 
amino acid (Chapter 6) were dissolved in 15 mL of deionized water (J. T. Baker, 
Deventer, The Netherlands) and placed inside a reaction tube consisting of stainless 
steel metal piping, 200 mm × 16.3 mm (internal diameter), total volume 42 cm3, 
capped using SS Tube Fitting, Reducing Union, 3/4 in. × 1/4 in. (Swagelok, UK). SCW 
mediated hydrolysis was performed at temperatures of 160, 207, 253, and 300 ⁰C on 
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proteins. SCW mediated hydrolysis was performed at temperatures of 140, 160, 180 
and 200 ⁰C on peptides.  
Reaction tubes were placed in a gas chromatography (GC) oven pre-set to 30 ⁰C and 
allowed to equilibrate for at least 10 min prior to increasing the temperature of the 
oven. The reaction temperature was monitored by use of a thermocouple attached to 
one of the reaction tubes. It took 5 min 10 s to reach 140 ⁰C, 6 min 40 s to reach 160 
⁰C, 7 min 0 s to reach 180 ⁰C, 7 min 30 s to reach 200 ⁰C, 7 min 40 s to reach 207 ⁰C, 10 
min 30 s to reach 253 ⁰C and 16 min 45 s to reach 300 ⁰C. The selected residency, i.e., 0 
and 20 min, began after reaching the chosen temperature. Each experiment was 
performed in triplicate. The reaction was quenched by placing the reaction tubes into a 
bucket of ice for 5 min. One ml aliquots of the hydrolysate were then stored at −20 ⁰C 
until analysis.  
 
2.2.1 Additional experiments in Chapter 3  
Smaller protein: solvent ratio - 1.5 and 0.15 mg of haemoglobin (Sigma-Aldrich) was 
dissolved in 15 mL of deionized water (J.T., Baker) and treated as above with SCW 
conditions of 160 °C for 20 min. 
Reduction of BSA Pre-SCW Processing - Fifteen mg of BSA was added to 8.75 mL of 100 
mM ammonium bicarbonate (Fisher Scientific, Loughborough, UK). 3.13 mL of 48 mM 
dithiothreitol (DTT) (Sigma-Aldrich) in 100 mM ammonium bicarbonate was added to 
the sample and incubated for 30 min at 56 °C. A further 3.13 mL of 264 mM 
iodoacetamide (IAM) (Sigma-Aldrich) in 100 mM ammonium bicarbonate was added to 
the sample and incubated for 20 min at room temperature in the dark. Samples were 
introduced into the SCW reaction vessel directly.  
Reduction of BSA Post-SCW Processing - Fifty μL of hydrolyzed BSA was added to 50 μL 
of 10 mM dithiothreitol (Sigma-Aldrich, Gillingham, UK) in 100 mM ammonium 
bicarbonate (Fisher Scientific) and incubated for 30 min at 56 °C. Fifty μL of 55 mM 
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iodoacetamide (Sigma-Aldrich) in 100 mM ammonium bicarbonate was added to the 
sample and incubated for 20 min at room temperature in the dark. 
2.2.1 Additional experiments in Chapter 4  
Reduction of peptide Pre-SCW Processing - a 15 mL solution containing ~15 μM 
peptide, ~14 mM iodoacetamide (Sigma-Aldrich), and 100 mM ammonium bicarbonate 
(Fisher Scientific) was incubated for 20 min at room temperature in the dark. In 
experiments where a thiol was introduced as a quenching agent, ~14 mM DTT (Sigma-
Aldrich) was added following alkylation, and incubated in the dark at room 
temperature for 30 min. 
Benzyl bromide conjugation - a 15 mL solution containing ~15 μM peptide and ~15 μM 
Benzyl bromide (Sigma-Aldrich) was incubated at room temperature for 10 and 60 
minutes and 140 °C for 10, 30 and 60 minutes 
 
2.3 Enzymatic digestion 
Fifty μg of protein was made up in 90 μL of 100 mM ammonium bicarbonate (Fisher 
Scientific). Fifty μL of 10 mM DTT (Sigma-Aldrich) in 100 mM ammonium bicarbonate 
was added and incubated for 30 min at 56 °C. Fifty μL of 55 mM IAM (Sigma-Aldrich) in 
100 mM ammonium bicarbonate was added to the sample and incubated for 20 min at 
room temperature in the dark. Samples were digested overnight with Tryspin Gold 
(Promega, Madison, WI) or for 2 hours with Proteinase K (Promega) in 50 mM 
ammonium bicarbonate (protein/enzyme 50:1) at 37 °C, pH 8. Proteolysis was 
quenched by addition of 0.5% TFA. 
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2.4 Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS 
PAGE)  
NTG and BSG solutions for SDS page were dissolved in an 8M urea solution. Twenty µl 
of sample and 5 µl of 4X LDS sample buffer (Expedon, Cambridge, UK) were mixed 
heated to 95˚C for 5 minutes and centrifuged at 13,000 rpm for 1 minute, prior to 
loading onto a NuPAGE 10% Bis-Tris gel (Expedon). Gels were immersed in 
TrisHCl/tricine SDS running buffer with 60 mM TrisHCl, 80 mM tricine, 2.5mM sodium 
bisulphate and 0.1% SDS Fisher Scientific). Samples were electrophoresed for 20 
minutes at 100kV, followed by 50 minutes at 150kV.  
2.4.1 In gel digestion  
Briefly, each band in the gel was cut using a scalpel and the pieces were further excised 
into 1mm x 1mm x 1mm cubes. The pieces were washed with 100 mM ammonium 
bicarbonate (Fisher Scientific) for 5 min and then with 60µl acetonitrile (ACN) 
(J.T.,Baker) for a further 5 minutes. This solution was removed and the gel pieces were 
rehydrated with 50µl 100 mM NH4HCO3 for 5 min. An equal volume of ACN was added 
to the solution and it was incubated for 30 minutes. This washing solution was then 
removed and the gel pieces were dried using a vacuum centrifuge. 50µl of 10mM DTT 
(Sigma-Aldrich) in 100mM NH4HCO3 was then added and incubated at 56oC for 30 
minutes. This liquid was then removed and replaced with 55mM IAM (Sigma-Aldrich) 
in 100mM NH4HCO3 and incubated at room temperature in the dark for 20 minutes. 
The bulk of the solution was removed via a pipette and the gel pieces were dried in a 
vacuum centrifuge. The gel pieces were rehydrated with 13 ng/µl of Proteinase K 
(Promega) and incubated at room temperature for 30 minutes. The samples were then 
diluted with 20µl 100mM NH4HCO3, and then incubated for 2 hours at 37oC. Peptides 
were extracted with the addition of 30µl of 2% ACN and 1% formic acid (FA) (Sigma-
Aldrich), and then with 30µl of 40% ACN and 1% FA. The pooled extracts were dried in 
a vacuum centrifuge and resuspended in 0.1% FA.  
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2.5 Peptide Purification 
Both enzymatic and SCW generated peptides were desalted using ZipTip C18 pipette 
tips (Millipore, Bedford, MA, USA) according to manufacturers’ instructions. The 
desalted samples were dried and resuspended in 10 μL of FA (Thermo Fisher,  Bremen, 
Germany) prior to MS analysis. 
 
2.6 Direct infusion Mass Spectrometry  
Samples were diluted to a concentration of ~3 μM in 50:50 water: methanol (J.T., 
Baker), 0.1% formic acid (Fisher Scientific), and introduced to the mass spectrometer 
by electrospray ionisation. 
All direct infusion ESI-MS experiments were performed on a Thermo Fisher Orbitrap 
Elite (Thermo Fisher). Data acquisition was controlled by Xcalibur 2.1 (Thermo Fisher). 
All mass spectra and tandem mass spectra were recorded in the Orbitrap at a 
resolution of 240,000 at m/z 400. 
CID - The automatic gain control (AGC) target was 5 × 104 charges with maximum 
injection time of 300 ms. CID was performed in the ion trap using helium at normalized 
collision energy of 35% and the fragments were detected in the Orbitrap. The 
normalised collision energy sets the collision energy relative to the parent mass prior 
to fragmentation. Width of the precursor isolation window was 1.5 m/z.  
ETD - The AGC target was 5 × 104 charges with maximum injection time 300 ms. 
Supplemental activation (sa) ETD was performed in the ion trap with fluoranthene 
reagent ions (AGC target for reagent ions was 1 × 105 charges with a maximum 
injection time of 100 ms) and a normalized collision energy  of 25%. Width of the 
precursor isolation window was 1.5 m/z. Fragment ions were detected in the Orbitrap 
HCD - Ions were transferred to the HCD cell and subjected to fragmentation with 75% 
normalized collision energy. The automatic gain control (AGC) target was 5 x 104 
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charges with maximum injection time of 300 ms. and the fragments were detected in 
the orbitrap. Width of the precursor isolation window was 1 m/z. 
 
2.7 Liquid Chromatography Tandem Mass Spectrometry (LC MS/MS) 
LC MS/MS experiments were performed on a Thermo Fisher Orbitrap Elite or the Q-
Exactive (both Thermo Fisher). Data acquisition was controlled by Xcalibur 2.1 (Thermo 
Fisher). All direct infusion electrospray mass spectra and tandem mass spectra were 
recorded in the Orbitrap at a resolution of 240,000 at m/z 400. 
Peptides were separated using online reversed phase LC (Dionex Ultimate 3000), using 
a binary solvent system consisting of mobile phase A (water (J.T., Baker)/0.1% formic 
acid (Fisher Scientific) and mobile phase B (acetonitrile (J.T., Baker)/ 0.1% formic acid 
(Fisher Scientific)). Peptides were loaded onto a PepMap C18 column 75µm (diameter) 
x 150 mm (length) (LC Packings, Sunnyvale, CA), in mobile phase A. The percentage of 
mobile phase B increased in a linear gradient from 0 to 3.2% between 0 and 6 minutes 
and then to 44% between 6 and 30 minutes. The column was then washed with 90% 
mobile phase B between 30minutes and 40 minutes before re-equilibrating at 3.2% 
mobile phase B between 40 minutes and 56 minutes. A flow rate of 0.350 nL/min was 
applied. 
Samples eluted directly via a Triversa Nanomate nanoelectrospray source (Advion 
Biosciences, Ithaca, NY) into the mass spectrometer.  
 
2.7.1 Additional experiments in Chapter 5 
Longer gradients - Peptides were loaded onto a C18 column (LC Packings), in mobile 
phase A. The percentage of mobile phase B increased in a linear gradient from 0 to 
3.2% between 0 and 6 minutes and then to 44% between 6 and 230 minutes. The 
column was then washed with 90% mobile phase B between 230minutes and 252 
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minutes before re-equilibrating at 3.2% mobile phase B until 270 minutes. A flow rate 
of 0.350 nL/min was applied. 
Longer column- For specified experiments an Acclaim PepMap C18 75µm (diameter) x 
500 mm (length) column was used (LC Packings).  
 
2.7.2 Orbitrap Elite 
CID - The mass spectrometer performed a full MS scan (m/z 380–1800) and 
subsequent MS/MS scans of the seven most abundant ions that had a charge state >1. 
Survey scans were acquired in the Orbitrap with a resolution of 60,000 at m/z 400. The 
AGC target for the survey scans was 106 charges with maximum injection time of 1 s. 
CID was performed in the ion trap using helium at normalized collision energy of 35%, 
and the fragments were detected in the Orbitrap (resolution 60,000 at m/z 400). Width 
of the precursor isolation window was 2 m/z. AGC target for CID was 5 × 104 charges 
with a maximum injection time of 100 ms. 
ETD - The mass spectrometer performed a full MS scan (m/z 380–1800) and 
subsequent MS/MS scans of the seven most abundant ions that had a charge state >1. 
Survey scans were acquired in the Orbitrap with a resolution of 60,000 at m/z 400. The 
AGC target for the survey scans was 106 charges with maximum injection time of 1 s. 
ETD was performed in the linear ion trap with fluoranthene ions with a maximum fill 
time of 100 ms. The fragments were detected in the Orbitrap (resolution 60,000 at m/z 
400). Width of the precursor isolation window was 2 m/z. Precursor ions were 
activated for 100 ms (charge-dependent activation time was enabled). The AGC target 
for ETD was 5 × 104 charges. Supplemental activation was used with normalized 
collision energy of 25%. 
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2.7.3 Q-Exactive 
HCD - The mass spectrometer performed a full MS scan (m/z 380–1800) and 
subsequent MS/MS scans of the twenty most abundant ions that had a charge state 
>1. Survey scans were acquired in the Orbitrap with a resolution of 120,000 at m/z 
200. The AGC target for the survey scans was 3 x 106 charges with maximum injection 
time of 50 ms. HCD was performed in the HCD cell using HCD at normalized collision 
energy of 28%, and the fragments were detected in the Orbitrap (resolution 15,000 at 
m/z 200). Width of the precursor isolation window was 1.2 m/z. AGC target for HCD 
was 1 × 105 charges with a maximum injection time of 50 ms. 
  
2.8 Database Search Parameters  
Raw MS/MS data files from Xcalibur software (version 3.0.63; Thermo Fisher) were 
submitted to Proteome Discoverer software (version 1.4.1.14; Thermo Fisher) for 
SEQUEST searches against the relevant protein sequence as obtained from uniprot. 
Two missed cleavages were allowed for tryptic digests. Database searches for SCW 
hydrolysed samples were searched using “nonspecific enzyme”. Precursor mass 
tolerance was 10 ppm, and MS/MS tolerance was 0.5 Da. For trypsin digests of 
hemoglobin and BSA, carbamidomethylation of cysteines was set as a static 
modification, while deamidation and oxidation were set at variable modifications. For 
the trypsin digest of β- casein, phosphorylation was introduced as a further variable 
modification. For database searches of SCW hydrolyzed hemoglobin, deamidation and 
oxidation were set as variable modifications. For database searches of SCW hydrolyzed 
β- casein: deamidation, oxidation, and phosphorylation were set as variable 
modifications. For SCW hydrolysis of BSA, deamidation and oxidation were set as 
variable modifications. When BSA was treated with DTT and iodoacetamide (both prior 
to and following SCW hydrolysis), carbamidomethylation was included as a static 
modification. In subsequent searches (see text), database searches were performed 
with additional variable modifications: dehydration of Asp, Glu, Thr, and Ser and 
pyroglutamic acid formation. All other search parameters remained the same.  
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2.9 Antioxidant analysis 
2.9.1 ORAC assay 
The protocol used in this assay was based on the protocol developed by Huang et al., 
[139]. Phosphate buffer stock solutions (100mM) were prepared by dissolving 2.75g 
monosodium phosphate (Fisher Scientific) and 21.5 g of dipotassium phosphate (Fisher 
Scientific) in 1L of water (J.T. Baker) and maintained at room temperature. Fluorescein 
stock solutions (6.6µM) (Sigma-Aldrich) in 100 mM phosphate buffer were maintained 
at 4 oC in the dark. Stock solutions of 100mM phosphate buffer were maintained at 
room temperature. Stock solutions of 20mM 6-hydroxy-2,5,7,8-tetramethylchroman-2-
carboxylic acid (Trolox) (Sigma-Aldrich) in ethanol were maintained at -20 0C. 
Prior to the ORAC assay the following were freshly prepared: 300 nm fluorescein 
solution 100 mM phosphate buffer. 50 µM Trolox, 300mM of 2,2′- Azobis(2-
methylpropionamidine) dihydrochloride (AAPH) (Sigma-Aldrich) in 100 mM phosphate 
buffer. 
Twenty five μL of antioxidant (Trolox or sample or phosphate buffer in control 
experiments), 150 μL of fluorescein (0.3 µM) and were placed in black 96-well 
microplates (Thermo Fisher). The mixture was incubated at 37 °C for 30 minutes. Thirty 
µl of AAPH (300mM) was added to each well using a multichannel pipette. 
Fluorescence was recorded every minute for 1 hour. Fluorescent values were 
determined in the Infinite F200 PRO Microplate reader (Tecan, Männedorf, 
Switzerland). Excitation and emission wavelengths were set as 485 (25) nm and 535 
(25) nm. Each assay was repeated three times independently on different days. Within 
every assay each sample had a minimum of 3 replicates. Results are quoted relative to 
Trolox concentration. 
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2.9.2 Comet assay 
SCW incubation solutions - All extracts were filter sterilised using a 0.2µm 
Polyethersulfone (PES) Filters (Milipore, Massachusetts, USA) prior to use in cell 
culture. Each solution was resuspended to a final concentration of 0.05 mg/ml in 
Dulbecco’s Modified Eagles Medium (DMEM) (Lonza, Basel, Swizerland). 30% 
H2O2 (Sigma-Aldrich) was added to a final concentration of 50µM in DMEM with 4.5 
g/L glucose with L-glutamine and supplemented with 10% fetal calf serum. 
Cell culture - HaCaT keratinocyte cells from adult human skin were cultured in DMEM 
(Lonza). Cells were routinely split once per week and seeded at a density of 1 x 104 
cells/ml into 6 well tissue culture plates (Fisher Scientific). Following 24 hours of 
growth DMEM was replaced with incubation solutions and incubated for a further 24 
hours. For the last 30 minutes of incubation time the incubation solutions were 
removed and replaced with 50 µM H2O2 (Sigma-Aldrich). A control was included where 
cells were not incubated in hydrolysates. 
 
Comet assay - The comet assay was performed under alkaline conditions (pH > 13) 
according to the procedure of Singh et al [148]. Following the incubation period cells 
were twice washed with PBS and detached with trypsin. Cells were washed with PBS 
and then suspended in 200 µl fresh PBS. 15µl cells were resuspended in 150 µl 0.75% 
low melting point (LMP) agarose (Bioline, London, UK) in PBS (pH 7.4), and placed on 
microscope slides precoated with 0.8% normal melting point (NMP) agarose (Bioline). 
The slides were covered with a glass cover slip (22x64mm, VWR) avoiding bubbles 
formation, placed on a metallic tray over ice and left in the cold room (at 4 oC) for 
approximately 20min to allow the agarose to set. Cells were lysed overnight at 4 oC in 
the dark in a buffer containing 2.5 M NaCl, 100 mM Na2-EDTA, 1% Triton X-100, 10 mM 
Tris-HCl (all Fisher Scientific). Later, the slides were incubated in an electrophoresis 
unit in a buffer containing 300mM NaOH (Fisher Scientific) and 1mM Na2-EDTA, pH≥13 
for 20 minutes to unwind the DNA and then electrophoresed for 30 minutes (32V, 
300mA) using a Bio-Rad power pack 200 power supply (Bio-Rad Laboratories, Hercules, 
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USA). Slides were washed in a buffer containing 400 mM Tris base before fixing with -
20 oC ethanol.  
Slides were then stained with 50µl DNA-specific SYBR gold (1:1000 in dH2O, Invitrogen, 
Paisley, UK) before placing new glass cover slips and storing slides in the cold room in a 
foil-wrapped moist box for analysis (within 24h). 
Visualisation - Slides were visualised using a fluorescence microscope with a zenon arc 
lamp (Zeiss Axio lab, (Cambridge, UK). Excitation and emission filters were set at 490 
nm and 520 nm respectively. The images were analysed using Cometscore image 
analysis software (version 1.5) (Tritek corp, Virginia, USA). The % tail DNA was 
calculated as explained in Chapter 1. For the comet assay results, the mean was 
calculated using 50 separate comets from two independent slides.  
 
2.9.3 Reducing power assay 
This assay protocol was adapted from that reported by Oyazi [185]. Phosphate buffer 
stock solutions (0.2 M) were prepared by dissolving 16.84 g monosodium phosphate 
(Fisher Scientific) and 20.88 g of dipotassium phosphate (Fisher Scientific) in 1l of 
water (J.T. Baker) and maintained at room temperature. Test solutions were 
suspended in 0.2 M phosphate buffer containing 0.17 M NaCl and 3.35 mM KCl at a 
concentration of 0.05 mg/ml. 1 ml of each was added to a further 2.5 ml of 0.2 M 
phosphate buffer and 2.5 ml potassium ferracyanide (5%) (Sigma-Aldrich). The mixture 
was incubated at 50 oC for 30 minutes. The reaction was stopped by the addition of 2.5 
ml 10% trichloroacetic acid (TCA) (Fisher Scientific) followed by centrifugation at 3000 
rpm for 10 minutes. The upper supernatant (2.5 ml) was mixed with distilled water (2.5 
ml) and 0.1% ferric chloride (0.5 ml) and incubated at room temperature for 10 
minutes. The absorbance was measured at 700 nm. Increased absorbance reflects 
increased reducing power. 
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Chapter 3:  Sub-critical water hydrolysis of proteins: 
specificity and post translational modifications 
 
The work presented in this chapter has been published in part as an article in 
Analytical Chemistry on which I am first author [186]. 
3.1 Overview 
The aim of the work presented in this chapter was to investigate the mechanism by 
SCW hydrolysis of proteins occurs, through the identification of peptide hydrolysis 
products by liquid chromatography tandem mass spectrometry (LC MS/MS). The 
specificity of SCW with respect to the production of peptides from three model 
proteins, haemoglobin (molecular weight (MW) 15 117 Da α-globin; 15 857 Da β-
globin), bovine serum albumin (BSA) (MW 66 389 Da), and β-casein (MW 23 568 Da) 
was explored. If the position of cleavage can be directed and SCW is efficient at 
generating peptides, the feasibility of using SCW hydrolysis as an alternative technique 
for proteolysis in proteomics studies was explored. 
Trypsin is currently the protease of choice in the majority of these studies; however 
this approach has various limitations. In cases where Arg or Lys are inconveniently 
placed along the amino acid sequence i.e. too far apart or too close together, 
segments of the proteome can be missed. In these instances, this limited sequence 
information makes it impossible to localise PTMs in unmapped regions [187].This is in 
addition to the lengthy time periods and high costs associated with enzymatic 
digestion [188]. Using SCW may overcome these difficulties. In order to achieve this 
goal, the sequence coverage and number of peptides generated from the enzymatic 
digestion of the three proteins with trypsin were compared with those obtained 
following SCW treatment.  
Lastly, the effect of SCW treatment on two protein post-translational modifications, 
disulphide bonds (in BSA) and phosphorylation (in β-casein), was investigated.  
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3.2 Specificity of SCW Mediated Hydrolysis of Model Proteins 
To investigate the specificity of SCW hydrolysis, experiments were performed on three 
purified model proteins, haemoglobin, BSA and β-casein. Figure 3.1 shows the amino 
acid sequence of each protein. Disulphide bonds and phosphosites are highlighted. 
Hydrolysis was performed at 160 °C for 0 and 20 minutes, 207 °C for 20 minutes, 253 
°C for 20 minutes and 300 °C for 20 minutes as described in Chapter 2.1. Peptides were 
desalted (as described in Chapter 2.5), analysed using LC MS/MS (as described in 
Chapter 2.7) and identified using an automated search (as described in Chapter 2.8). 
Figure 3.2 shows plots of the percentage of peptides resulting from SCW treatment at 
160 for 0 and 20 minutes and 207 °C for 20 minutes versus the amino acid residue in 
the protein sequence immediately preceding the N-terminus of the resulting peptide, 
i.e., the amino acid residue adjacent to the peptide’s N-terminus. No specificity was 
observed in the amino acid residue adjacent to the peptide’s C-terminus (Figure 3.3). 
Peptide summary maps are shown in Appendix Figure 3.1. SCW treatment at 160 °C 
for 0 min showed preferential cleavage toward the N-terminus of aspartic acid in α- 
and β-globin. The percentage of identified peptides which follow an aspartic acid 
residue was 30.9 ± 9.4% in the α-globin and 23.1 ± 13.4% in the β-globin, several fold 
higher than the natural abundance of aspartic acid residues in both α- and β-globins 
(5.7% in both cases). Similar results were seen for BSA where 31.5 ± 6.5% of peptides 
were preceded by an aspartic acid residue, significantly higher than the natural 
abundance of aspartic acid in the BSA sequence (6.9%). The percentage of SCW 
peptides which follow an aspartic acid residue in β-casein was 17.4 ± 7.5%, again 
several fold greater than the natural abundance of the residue in the protein (1.9%). 
No favoured cleavage adjacent to the structurally similar glutamic acid residue was 
observed. At this temperature favoured cleavage toward arginine in BSA (19.4 ± 5.9%) 
and lysine in β-casein (17.4 ± 5.9%) was also observed.  
Similar results were seen following treatment at 160 °C for 20 min. The percentage of 
peptides with N-terminus adjacent to an aspartic acid residue was 31.1 ± 5.0% (α-
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globin), 42.4 ± 4.2% (β-globin), 44.3 ± 3.7% (BSA), and 23.4 ± 2.6% (β- casein). For β-
casein, there appears to be some preferential cleavage adjacent to glutamic acid. 
a 
VLSPADKTNVKAAWGKVGAHAGEYGAEALERMFLSFPTTKTYFPHFDLSHGSAQV
KGHGKKVADALTNAVAHVDDMPNALSALSDLHAHKLRVDPVNFKLLSHCLLVTLA
AHLPAEFTPAVHASLDKFLASVSTVLTSKYR 
 
b 
VHLTPEEKSAVTALWGKVNVDEVGGEALGRLLVVYPWTQRFFESFGDLSTPDAVM
GNPKVKAHGKKVLGAFSDGLAHLDNLKGTFATLELHCDKLHVDPENFRLLGNVLVC
VLAHHFGKEFTPPVQAAYQKVVAGVANALAHKYH 
 
Figure 3. 1 - Amino Acid sequences for a) α-globin, b) β-globin, c) BSA, d) β-casein.
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c) 
DTHKSEIAHRFKDLGEEHFKGLVLIAFSQYLQQCPFDEHVKLVNELTEFAKTCVADES
HAGCEKSLHTLFGDELCKVASLRETYGDMADCCEKQEPERNECFLSHKDDSPDLPK
LKPDPNTLCDEFKADEKKFWGKYLYEIARRHPYFYAPELLYYANKYNGVFQECCQAE
DKGACLLPKIETMREKVLASSARQRLRCASIQKFGERALKAWSVARLSQKFPKAEFV
EVTKLVTDLTKVHKECCHGDLLECADDRADLAKYICDNQDTISSKLKECCDKPLLEKS
HCIAEVEKDAIPENLPPLTADFAEDKDVCKNYQEAKDAFLGSFLYEYSRRHPEYAVSV
LLRLAKEYEATLEECCAKDDPHACYSTVFDKLKHLVDEPQNLIKQNCDQFEKLGEYG
FQNALIVRYTRKVPQVSTPTLVEVSRSLGKVGTRCCTKPESERMPCTEDYLSLILNRL
CVLHEKTPVSEKVTKCCTESLVNRRPCFSALTPDETYVPKAFDEKLFTFHADICTLPDT
EKQIKKQTALVELLKHKPKATEEQLKTVMENFVAFVDKCCAADDKEACFAVEGPKL
VVSTQTALA 
 
 
Figure 3. 1 (continued)  - Amino Acid sequences for a) α-globin, b) β-globin, c) BSA, d) 
β-casein.
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d) 
RELEELNVPGEIVEpSLpSpSpSEESITRINKKIEKFQpSEEQQQTEDELQDKIHPFAQT
QSLVYPFPGPIPNSLPQNIPPLTQTPVVVPPFLQPEVMGVSKVKEAMAPKHKEMPF
PKYPVEPFTESQSLTLTDVENLHLPLPLLQSWMHQPHQPLPPTVMFPPQSVLSLSQ
SKVLPVPQKAVPYPQRDMPIQAFLLYQEPVLGPVRGPFPIIV 
 
Figure 3. 1 (continued) - Amino Acid sequences for a) α-globin, b) -globin, c)BSA, d) β-
casein.
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Figure 3. 2 - Specificity of SCW hydrolysis: Plots of the % of peptides identified against the amino acid residue immediately preceding 
the peptide N terminus for proteins haemoglobin, BSA, and β-casein under SCW treatment at 160 °C (0 min), 160 °C (20 min), and 207 
°C (20 min). n = 3. Error bars represent one standard deviation. 
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Figure 3. 3  - Specificity of SCW hydrolysis: Plots of the % of peptides identified against the amino acid residue immediately preceding the 
peptide C terminus for proteins haemoglobin, BSA, and β-casein under SCW treatment at 160 °C (0 min), 160 °C (20 min), and 207 °C (20 
min). n = 3. Error bars represent one standard deviation. 
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residue (27.2 ± 2.9%), much higher than the natural abundance of glutamic acid (9.1%). 
At this temperature, favoured cleavage toward arginine in BSA (0.5 ± 0.5%) or lysine in 
β-casein (2.8 ± 0.0) was not observed. At 207 °C, there appears to be a reduction in 
specificity toward the C-terminus of aspartic acid residues, and a more uniform 
distribution among the amino acid residues is observed. The percentages of peptides 
whose N-terminus was adjacent to aspartic acid in the full length protein are 17.1 ± 
3.4% (α-globin), 4.3 ± 6.3% (β-globin), 25.7 ± 19.1% (BSA), and 14.1 ± 8.6% (β-casein). 
The large standard deviation seen in BSA is due to an outlier in the data: in one 
replicate, 7.2% of peptides were preceded by an aspartic acid. There also appears to 
be some specificity toward glutamic acid residues in β-globin (16.5 ± 4.2), BSA (23.9 ± 
7.0%), and β-casein (22.1 ± 11.5%), higher than the natural abundance of glutamic acid 
residues in β globin (5.5%), BSA (10.1%), and β-casein (9.1%).  
Above temperatures of 207 oC there was a significant reduction in the number of 
peptides that were identified. This is discussed further in Chapter 3.3. SCW specificity 
was not assessed at these temperatures. 
These results both support and contrast work by Kang and Chun which demonstrated 
that SCW treatment of fish waste at 200 °C results in liberation of aspartic acid and 
serine in high quantities relative to the other amino acids, indicating that these 
residues are more susceptible to hydrolysis by SCW [189]. My results show favoured 
cleavage at aspartic acid residues but not serine residues. 
Partridge and Davis showed that weak acid hydrolysis of proteins results in preferential 
release of aspartic acids [190]. In the presence of weak acids, neutral carboxyl groups 
in the aspartate side chain act as proton donors in the hydrolysis of the adjacent 
peptide bonds. The production of aspartic acid rather than glutamic acid was 
attributed to the lower pKa of aspartate. Similarly, Fisher and co-workers showed that 
chemical treatment of proteins with formic acid results in specific cleavage at aspartic 
acid residues [191]. The results described above suggest that weak acid hydrolysis of 
proteins occurs under SCW conditions. Scheme 3.1 shows the proposed mechanism 
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for cleavage of the Asp-X bond [192, 193]. Weak acid hydrolysis of proteins has also 
been observed in studies employing microwave-assisted non-enzymatic digestion. 
Microwave assisted acid hydrolysis of proteins was first demonstrated by Li and co-
workers using 6 M HCl [194] and subsequently trifluoroacetic acid [195]. Hua et al. 
showed that use of dilute formic acid resulted in specific cleavage C-terminal of 
aspartic acid residues [196], a finding echoed by Swatkoski et al. in their work using 
acetic acid [197]. 
The optimum pH for weak acid hydrolysis of Asp-X is ~2 [192, 197]. The pH of 
subcritical water is between 5.5 and 5.7 in the temperature range used in this work 
[198]. It may be possible therefore to mediate the reaction by addition of a weak acid 
to the protein solution prior to SCW treatment; however, that was not attempted 
here.  
 
 
 
Scheme 3. 1 - Proposed mechanism for weak acid hydrolysis of the Asp-X bond. 
Adapted from [192, 193]. 
69 
 
It is worth noting that the SCW peptide summary maps shown in Appendix Figure 3.1 
suggest that, following initial cleavage of the peptide bond, secondary cleavage of the 
peptide products occurs. That occurrence would explain the “blocklike” appearance of 
the summary map (which is not evident in the results obtained for trypsin). 
3.3 Protein sequence coverage: SCW hydrolysis as an alternative 
proteolytic reagent? 
In Section 3.2, the action of SCW hydrolysis was identified with regards to its 
specificity. SCW was efficient at generating peptides and in Section 3.3 I analyse its 
potential as an alternative proteolytic reagent, by comparing the peptides identified 
from the SCW hydrolysis of the three proteins against those obtained using a 
conventional tryptic digest. Appendix Figure 3.1 shows the peptides identified for each 
protein under each hydrolysis condition. 
The reliable identification of a protein is closely linked to the percentage of the protein 
sequence covered by identified peptides, or protein sequence coverage. Figure 3.4 
shows the effect of SCW reaction temperature and time on mean % protein sequence 
coverage from haemoglobin, BSA, and β-casein, compared with enzymatic digestion of 
the proteins with trypsin. SCW reaction conditions were 160 °C for 0 min, 160 °C for 20 
min, 207 °C for 20 min, 253 °C for 20 min, and 300 °C for 20 min.  
3.3.1 Peptides identified from the SCW hydrolysis of haemoglobin 
The trypsin digestion of haemoglobin (Figure 3.4 A) gave high sequence coverage for 
both the α-globin (88.9 ± 3.6%) and β-globin (92.7 ± 4.0%). SCW hydrolysis at 160 °C 
for 0 min gave comparable protein coverage: 91.5 ± 5.6% for α-globin and 87.9 ± 3.3% 
for β- globin. Extending the SCW reaction time to 20 min resulted in increased 
sequence coverage: 97.4 ± 3.9% for α-globin and 96.2 ± 0.8% for β-globin. The 
sequence coverage obtained following SCW treatment at 207 °C was 82.3 ± 11.2% for 
α-globin and 76.7 ± 9.9% for β-globin. A sharp reduction in protein coverage was 
observed following SCW treatment at 253 °C (33.6 ± 0.8% for α-globin and 41.2 ± 
16.1% for β-globin), presumably due to decomposition of the peptides to component 
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amino acids. This is discussed further in Chapter 5 where lower MW compounds are 
identified.  
 
 
 
 
 
 
 
 
. 
 
 
 
Figure 3. 4 - Mean sequence coverage obtained for trypsin digests and SCW hydrolysis 
at 160 °C for 0 min, 160 °C for 20 min, 207 °C for 20 min, 253 °C for 20 min, and 300 °C 
for 20 min for (A) α-globin and β-globin, (B) BSA, (C) β-casein, and (D) combined 
coverage for haemoglobin α-chain, haemoglobin β-chain, BSA, and β-casein at 160 °C 
for 20 min. ∗ = p < 0.05 as determined by students’ t test. n = 3. Error bars represent 
one standard deviation.  
No peptides were identified following SCW treatment at 300 °C for 20 min. The 
decrease in protein coverage observed between 253 and 300 °C supports previous 
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work by Espinoza et al. which showed a decrease in the amount of peptides produced 
following SCW treatment of whey protein isolate above 220 °C due to conversion into 
amino acids [199]. 
 
3.3.2 Peptides identified from the SCW hydrolysis of BSA 
The average protein coverage obtained following SCW mediated hydrolysis (160 °C, 0 
min) of BSA (Figure 3.4 B) was 32.1 ± 3.4%, significantly lower than the coverage seen 
for haemoglobin under the same conditions. Maximum sequence coverage was 
obtained following SCW treatment at 160 °C for 20 min (69.0 ± 12.5%). Nevertheless, 
this maximum coverage obtained following SCW treatment falls short of that obtained 
following trypsin digestion of reduced and alkylated BSA (85.6 ± 11.4%). The protein 
coverage obtained following SCW treatment at 207 °C (20 min) and 253 °C (20 min) 
was 47.0 ± 9.2% and 6.3 ± 2.3%, respectively. No peptides were observed following 
treatment at 300 °C.  
BSA contains 16 disulphide bonds. These PTMs are highlighted in Figure 3.1c. The 
reduced sequence coverage observed for BSA suggests that SCW treatment does not 
result in the cleavage of disulphide bonds. To test that hypothesis, BSA was treated 
with dithiothreitol (DTT) and iodoacetamide (IAM) both pre- and post-SCW treatment. 
When disulphide bonds were reduced post-SCW treatment, a significant increase (p = 
0.007) in sequence coverage was observed for SCW conditions 160 °C for 0 min (80.5 ± 
4.7%). At all other SCW conditions, the levels of sequence coverage were not 
significantly different to those obtained for non-reduced BSA. When disulphide bonds 
were reduced pre-SCW treatment, again, a significant increase (p = 0.016) in sequence 
coverage was observed for SCW conditions 160 °C for 0 min (71.1 ± 6.2%). As seen 
above, the coverages obtained following SCW treatment in all other conditions were 
not significantly different to those for non-reduced BSA.  
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Following SCW hydrolysis of untreated BSA at 160 °C (0 min), five cysteine-containing 
peptides (incorporating 4 cysteine residues) were identified of which the component 
cysteine residues are involved in three disulphide bonds. This observation suggests 
that SCW supports cleavage of disulphide bonds. Nevertheless, the cleavage is limited 
as demonstrated by the results following chemical reduction: reduction of BSA pre-
SCW hydrolysis resulted in identification of 98 cysteine containing peptides 
(incorporating 26 cysteine residues involved in 16 disulphide bonds) and reduction of 
BSA post-SCW hydrolysis revealed 142 cysteine-containing peptides (incorporating 32 
cysteine residues involved in 17 disulphide bonds). For the peptides identified from the 
SCW hydrolysate of untreated BSA at 160 °C for 20 min, 35 cysteine-containing 
peptides were identified. Reduction of BSA pre-SCW treatment revealed 175 cysteine-
containing peptides, and reduction of BSA post-SCW mediated hydrolysis revealed 232 
cysteine containing peptides. The overall protein sequence coverage was similar for 
the three conditions; therefore, the differences in observed cysteine-containing 
peptides suggest that only very limited disulphide bond cleavage occurs under SCW 
conditions of 160 °C for 20 min. These results suggest that proteins containing 
disulphide bonds should be reduced and alkylated either prior to or post-SCW 
treatment in order to maximize sequence coverage. 
3.3.3 Peptides identified from the SCW hydrolysis of β-casein 
Trypsin digestion of β-casein gave an average protein sequence coverage of 40.0 ± 
6.4% (Figure 3.4 C). This low sequence coverage can be explained by the paucity of 
arginine and lysine residues in the protein sequence. In contrast, SCW hydrolysis at 160 
°C, 0 min, gave high sequence coverage (86.0 ± 3.0%). Under SCW conditions of 160 °C 
for 20 min, protein sequence coverage of 100% was achieved in all replicates. A 
reduction in protein coverage was observed following SCW treatment at 207 °C for 20 
min (91.6 ± 9.8%), and this trend continued following SCW treatment at 253 °C for 20 
min (32.4 ± 4.1%). No peptides were identified at 300 °C for 20 min. The results 
obtained for β-casein illustrate the advantages of SCW hydrolysis over trypsin for 
identification of some proteins.  
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On the basis of the results above, the optimum SCW conditions in terms of protein 
sequence coverage were 160 °C for 20 min. Figure 3.4 D summarizes the total 
combined coverage for the three replicates obtained at these conditions for each 
protein. The high protein coverages obtained suggest that these SCW hydrolysis 
conditions may be used as an alternative to trypsin in bottom-up proteomics.  
 
3.3.4 SCW hydrolysis of haemoglobin using a smaller protein: solvent 
ratio 
In the SCW experiments described above, 15 mg/15 mL of protein was used in each 
reaction tube. Twenty μL of hydrolysis product (equivalent to 20 μg of starting protein) 
was desalted using ZipTip C18 pipet tips and loaded onto the LC column. In the tryptic 
digestion experiments, 50 μg of protein was digested and analysed. Although 
comparable amounts of starting protein are ultimately analysed by LC MS/MS in the 
two experiments, the amount of protein in the SCW reaction is much higher. The 
suitability of the SCW setup for lower protein concentration was therefore investigated 
for haemoglobin solutions of concentration 0.1 and 0.01 mg/mL (160 °C for 20 min). 
SCW hydrolysis using 0.1 mg/mL of haemoglobin gave comparable sequence coverage 
to that described above for both α-globin (97.2 ± 2.6%) and β-globin (94.3 ± 1.6%). 
Sequence coverage remained high when using 0.01 mg/mL of haemoglobin (i.e., 150 
μg of starting product) for both α-globin (99.5 ± 0.4%) and β-globin (91.7 ± 3.4%). 
Figure 3.5 shows the summed survey scan mass spectra at each of the three 
concentrations. The base peak in these mass spectra corresponds to 3+ ions of 
[VHLTPEEKSAVTALWGKVNVD-H20]. The signal intensities are 8.5 × 106 , 1.3 × 106 , and 
2.6 × 106 , i.e., within an order of magnitude, across the concentration range. (Note 
that the automatic gain control was used in each experiment to control the number of 
ions entering the orbitrap.) These results suggest that the SCW hydrolysis would be 
suitable as a proteomics sample preparation method. 
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Figure 3. 5 - Summed survey scan mass spectra obtained following LC MS/MS analysis of SCW treated hemoglobin. (a) SCW treatment of 
1 mg/ml Hb; (b) SCW treatment of 0.1 mg/ml Hb; (c) SCW treatment of 0.01 mg/ml Hb. 
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3.4 SCW Mediated Hydrolysis and Phosphorylation  
PTMs are of paramount importance in a protein’s function. Protein phosphorylation is 
a particularly key PTM which plays a crucial role in virtually all cellular signalling 
pathways. Retaining sites of phosphorylation during proteolysis is of paramount 
importance for phosphosite identification or ultimately quantification. 
β-casein is phosphorylated at serine residues at positions 15, 17, 18, 19, and 35 (Figure 
3.1). SCW treated samples of β-casein were analysed by liquid chromatography 
electron transfer dissociation (ETD) tandem mass spectrometry (LC ETD MS/MS). ETD 
retains labile post-translational modifications on peptide backbone fragments, thereby 
enabling localization of sites of modification [200]. The results were compared with 
those obtained following trypsin digestion of β-casein and subsequent LC ETD MS/MS. 
Observed phosphopeptides (and observed unmodified counterparts) are summarized 
in Table 3.1, with annotated mass spectra of the phosphopeptides shown in Figure 3.6. 
No phosphopeptides were identified following SCW treatment at 160 °C for 20 min or 
at temperatures above 160 °C. 
In the trypsin-digested β-casein sample, one phosphosite (Ser35) was identified, 
belonging to the peptide FQsEEQQQTEDELQDK (s is phosphoserine). This 
phosphopeptide was observed in each of three repeats. The remaining phosphosites 
fall within the tryptic peptide ELEELNVPGEIVEsLsssEESITR; however, that peptide was 
not detected in any of the repeats. The peptide comprises a high number of glutamic 
acid residues, in addition to four acidic phosphate groups, and does not favour 
formation of positive ions. 
In contrast, phosphopeptides containing all of the phosphosites (Ser15, Ser17, Ser18, 
Ser19, and Ser35) were identified following SCW treatment at 160 °C for 0 min. Seven 
phosphopeptides were identified across three repeats. Two peptides contained 
pSer35, and a further two contained pSer15. One peptide contained pSer15, pSer17, 
and pSer18. One peptide containing Ser 15 and Ser17 was identified but was observed 
to be modified at Ser17 only.  
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Table 3. 1 - Summary of Phosphopeptides and Unmodified Peptides Containing Known 
Sites of Phosphorylation Observed Following SCW Hydrolysis or Trypsin Digestion of β-
Casein. 
Finally, a doubly phosphorylated peptide was observed which contained four potential 
modification sites (Ser15, Ser17, Ser18, and Ser19). The two phosphosites could be 
localized to Ser17, Ser18, and Ser19 but could not be unambiguously assigned due to 
lack of cleavage between the serine residues. The observation of phosphopeptides 
with under-occupancy of known modification sites, together with the observation of 
unmodified peptides, suggests that SCW treatment can result in removal of 
Peptide sequence Theoretical 
Mass 
Calculated 
Mass 
PPM 
Phosphopeptides identified in SCW hydrolysed β-casein at 160oC for 0 
minutes 
IEKFQsEEQQQTED 1817.7356 1817.7423 3.6474 
KIEKFQsEEQQQTED 1945.8306 1945.8395 4.5379 
RELEELNVPGEIVEs 1791.8292 1791.8347 3.0304 
RELEELNVPGEIVEsL 1904.9132 1904.9211 4.1104 
RELEELNVPGEIVESLs 1991.9452 1991.9551 4.9349 
RELEELNVPGEIVEsLss 2238.9099 2238.9137 1.6660 
RELEELNVPGEIVESLSssEESITRINK 3316.5477 3316.5649 5.1732 
Non-phosphopeptides identified in SCW hydrolysed β-casein 160 oC for 0 
minutes 
RELEELNVPGEIVES 1712.8701 1712.8694 0.4087 
RELEELNVPGEIVESL 1825.9542 1825.9602 3.2859 
RELEELNVPGEIVESLS 1912.9862 1912.9902 2.0910 
Phosphopeptides identified in trypsin digest of β-casein 
FQsEEQQQTEDELQDK 2061.8285 2061.82197 3.1671 
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phosphorylation. This process is exacerbated under harsher SCW conditions: No 
phosphopeptides were identified from samples treated for 20 min at 160, 207, 253, or 
300 °C. Nevertheless, under milder conditions, sufficient phosphorylation is retained to 
identify all modification sites.
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3.5a 
3.5b 
Figure 3. 6 - ETD MS/MS spectra of phosphopeptides produced following SCW hydrolysis or trypsin digestion of β casein. 
79 
 
  
3.5c 
3.5d 
Figure 3. 6 (continued) - ETD MS/MS spectra of phosphopeptides produced following SCW hydrolysis or trypsin digestion of β casein. 
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3.5e 
3.5f 
Figure 3. 6 (continued) - ETD MS/MS spectra of phosphopeptides produced following SCW hydrolysis or trypsin digestion of β casein. 
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3.5g 
3.5h 
Figure 3. 6 (continued) - ETD MS/MS spectra of phosphopeptides produced following SCW hydrolysis or trypsin digestion of β casein. 
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3.5 Analysis of Peptide Spectrum Matches  
In Section 3.2 and 3.3  SCWs effectiveness as a proteolytic agent was demonstrated by 
its ability to provide high sequence coverage of proteins, as well as its capability at 
maintaining post-translational modifications. Despite the high coverages obtained the 
percentage of peptide spectrum matches (PSM) was low. The PSM scoring function 
refers to MS/MS spectra which were confidently assigned to a peptide sequence in the 
protein database search. 
Figure 3.7 shows a plot of the percentage of PSMs versus proteolysis conditions (either 
trypsin digestion or SCW hydrolysis). The percentage of PSM for the samples treated 
with trypsin were consistently greater (23.2 ± 4.7% for haemoglobin, 89.8 ± 10.5% for 
BSA, and 31.9 ± 4.3% β-casein) than for those treated with SCW (<7% in all cases). This 
observation suggests that, in addition to cleavage of the peptide bond, SCW treatment 
results in other hydrolysis products, presumably due to degradation of the amino acid 
side chains.  
 
 
 
 
 
 
 
 
 
83 
 
 
 
 
 
 
 
 
 
 
Figure 3. 7 - Percentage of peptide spectral matches following protein database search 
versus treatment conditions. n=3. Error bars represent one standard deviation. 
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3.6 Conclusion 
The work presented is this chapter investigates the specificity of SCW hydrolysis of 
proteins and the feasibility of SCW as an alternative proteolytic reagent for 
proteomics. SCW was shown to display partial specificity towards aspartic and glutamic 
acid residues. Sequence coverages obtained were comparable to those obtained with 
trypsin. The majority of the experiments described here used 15 mg of starting protein 
(1 mg/mL); however, the results also showed that SCW treatment of 150 μg of protein 
(0.01 mg/mL) gave very high protein sequence coverage (>90%). Moreover, under mild 
SCW conditions, phosphorylation generally remains on the peptide hydrolysis 
products, and all known phosphorylation sites were identified in β-casein; however, 
there was some evidence for dephosphorylation. 
Interestingly, despite the high sequence coverage, the percentage of peptide spectral 
matches, i.e., MS/MS spectra that were confidently assigned to a peptide sequence, 
was low. That suggests that in addition to hydrolysis of the peptide bond cleavage is 
occurring elsewhere in the protein, e.g., in the amino acid side chains. This possibility is 
explored in Chapter 4. 
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Chapter 4: Sub-critical water hydrolysis of peptides: amino acid 
modifications and conjugation 
 
The work presented in this chapter has been published in part as an article in the 
Journal of the American Society for Mass Spectrometry on which I am first author 
[201].  
4.1 Overview 
In Chapter 3 it was shown that SCW has the potential to be used as an alternative 
proteolytic technique during bottom-up proteomics experiments. Hydrolysis of 
proteins under certain conditions was shown to result in protein sequence coverages 
greater than or equal to those obtained following digestion with trypsin; however, the 
percentage of ions selected for fragmentation that were assigned as peptides, or 
peptide spectral matches (PSMs) for the samples treated with trypsin were 
consistently greater than for those treated with subcritical water. This observation 
suggests that in addition to cleavage of the peptide bond, subcritical water treatment 
results in other hydrolysis products, possibly due to modifications of amino acid side 
chains.  
To investigate this further, a model peptide comprising all common amino acid 
residues (VQSIKCADFLHYMENPTWGR) and two further model peptides 
(VCFQYMDRGDR and VQSIKADFLHYENPTWGR) were treated with subcritical water 
with the aim of probing any induced amino acid side-chain modifications. The 
hydrolysis products were analysed by CID and ETD MS/MS and LC CID MS/MS. 
Oxidation of cysteine, methionine and tryptophan residues were identified as the most 
common modifications.  
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4.2 SCW hydrolysis of model peptide VQSIKCADFLHYMENPTWGR 
 
In order to determine the effects of SCW hydrolysis on the side chains of amino acid 
residues, a model peptide that incorporates all 20 natural amino acids was designed 
and synthesized, VQSIKCADFLHYMENPTWGR. An arginine residue was placed at the C-
terminus of the peptide in order to allow efficient generation of a ‘y’ or ‘z’ fragment 
ion series following fragmentation. The acidic glutamate and aspartate residues, which 
were shown to direct backbone cleavage in SCW conditions in Chapter 3, were 
separated by five amino acid residues. The direct infusion electrospray mass spectrum 
of the peptide is shown in Figure 4.1a, with peak assignments detailed in Appendix 
Table 4.1. (Note, there are some low abundance peaks that correspond to impurities 
resulting from incorrect synthesis of the model peptide). In Chapter 3 hydrolysis 
temperatures of 160 ⁰C were shown to be the most effective at generating peptides. In 
this chapter a range of temperatures around 160 ⁰C were employed.  
Samples of the peptide were subjected to SCW hydrolysis at 140 ⁰C for 10 min, 160 ⁰C 
for 10 min, 180 ⁰C for 10 min, and 200 ⁰C for 10 min, and the resulting hydrolysates 
were analysed by direct infusion electrospray mass spectrometry. A summary of the 
peaks observed is given in Table 4.1. Selected peaks were isolated and fragmented by 
both CID and ETD MS/MS, as described below. 
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a 
b 
Figure 4. 1 - Direct infusion electrospray MS of a) untreated peptide VQSIKCADFLHYMENPTWGR, b) peptide VQSIKCADFLHYMENPTWGR 
treated with SCW at 140 °C for 10 min. 
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140oC 10 minutes 
m/z z 
Calculated 
mass (Da) 
Measured 
mass (Da) 
Peptide ΔPPM 
517.5779 3 1549.7136 1549.7119 FLHYMENPTWGR -1.1 
522.9094 3 1565.7085 1565.7064 FLHYMENPTWGR (+O) -1.4 
617.022 4 2464.0701 2464.0589 VQSIKCADFLHYMENPTWGR (+K+2O) -4.5 
621.0207 4 2480.0650 2480.0537 VQSIKCADFLHYMENPTWGR (+K+3O) -4.5 
809.7109 3 2426.1147 2426.1109 VQSIKCADFLHYMENPTWGR (+2O) -1.6 
815.0426 3 2442.1096 2442.1060 VQSIKCADFLHYMENPTWGR (+3O) -1.5 
820.3743 3 2458.1045 2458.1011 VQSIKCADFLHYMENPTWGR (+4O) -1.4 
1214.0621 2 2426.1147 2426.1096 VQSIKCADFLHYMENPTWGR (+2O) -2.1 
1222.0594 2 2442.1096 2442.1042 VQSIKCADFLHYMENPTWGR (+3O) -2.2 
160oC 10 minutes 
m/z z 
Calculated 
mass (Da) 
Measured 
mass (Da) 
Peptide ΔPPM 
522.9093 3 1565.7085 1565.7061 FLHYMENPTWGR (+O)  -1.6 
530.2266 3 1587.6689 1587.658 FLHYMENPTWGR (+ K) -6.9 
645.7868 2 1289.5611 1289.559 HYMENPTWGR -1.6 
775.8629 2 1549.7136 1549.7112 FLHYMENPTWGR -1.5 
809.7106 3 2426.1147 2426.1100 VQSIKCADFLHYMENPTWGR (+2O) -2.0 
815.0424 3 2442.1096 2442.1054 VQSIKCADFLHYMENPTWGR (+3O) -1.7 
180oC 10 minutes 
m/z z 
Calculated 
mass (Da) 
Measured 
mass (Da) 
Peptide  
457.2785 1   Unassigned  
517.5801 3 1549.7136 1549.7185 FLHYMENPTWGR 3.1 
522.9117 3 1565.7085 1565.7133 FLHYMENPTWGR (+O) 3.0 
577.2600 2 1152.5022 1152.5054 YMENPTWGR 2.8 
583.7703 2 1165.5226 1165.526 
FLHYMENPT (C-terminal 
amidation+O) 
3.0 
585.2570 2 1168.4971 1168.4994 YMENPTWGR (+O) 2.0 
616.3218 1 615.3129 615.3145 PTWGR 2.6 
645.7897 2 1289.5611 1289.5648 HYMENPTWGR 2.9 
653.7871 2 1305.556 1305.5596 HYMENPTWGR (+O) 2.8 
727.3919 1   Unassigned  
775.8662 2 1549.7136 1549.7178 FLHYMENPTWGR 2.7 
783.8634 2 1565.7085 1565.7122 FLHYMENPTWGR (+O) 2.4 
867.8906 2 1733.7621 1733.7666   ADFLHYMENPTWGR (-H2O+O)  2.6 
 
Table 4. 1 - Ions identified following SCW hydrolysis of VQSIKCADFLHYMENPTWGR 
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Table 4.1 (continued) - Ions identified following SCW hydrolysis of 
VQSIKCADFLHYMENPTWGR at 140 °C, 160 °C, 180 °C and 200 °C for 10 min. 
 
 
 
 
 
 
 
 
 
 
 
 
 
200oC 10 minutes 
m/z z 
Calculated 
mass (Da) 
Measured 
mass (Da) 
Peptide ΔPPM 
457.2801 1   Unassigned  
517.1089 1   Unassigned  
519.2702 1 518.2601 518.2629 TWGR 5.4 
573.3761 1   Unassigned  
577.2625 2 1152.5022 1152.5104 YMENPTWGR 7.1 
583.7728 2 1165.5226 1165.531 
FLHYMENPT (C- terminal amidation 
+O) 
7.2 
585.2600 2 1168.4971 1168.5054 YMENPTWGR (+O) 7.1 
653.7898 2 1305.556 1305.565 HYMENPTWGR (+O) 6.9 
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Figure 4.1b shows the mass spectrum obtained following SCW hydrolysis of the 
peptide at 140 °C for 10 min. The most intense peak was observed at m/z 809.7109 
and corresponds to triply protonated ions of peptide VQSIKCADFLHYMENPTWGR plus 
two oxygen atoms (m/zcalc 809.7122). Low abundance doubly protonated ions of this 
species were also observed at m/z 1214.0621 (m/zcalc 1214.0646). Figure 4.2a shows 
the ETD MS/MS spectrum of the 3+ ions and the c and z fragments are summarized in 
Appendix Table 4.2. Manual analysis of the mass spectrum revealed that both 
oxidations occur on the cysteine residue (i.e., sulfinic acid is formed). There are a 
number of peaks that correspond to amino acid side-chain losses. These fragments are 
commonly observed in electron-mediated dissociation [202]. Of particular note here is 
the peak corresponding to loss of the sulfinic acid side chain (–SO2H2) observed at m/z 
1181.0746 (m/zcalc 1181.0756), which confirms the double oxidation on cysteine. 
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Figure 4. 2 a) ETD MS/MS spectrum of 3+ ions of [VQSIKCADFLHYMENPTWGR +2O], b) ETD MS/MS fragmentation of 3+ ions of 
[VQSIKCADFLHYMENPTWGR +3O]. Fragments shown in purple can belong to either species; fragments shown in red belong to the spec ies 
with two oxidations on the cysteine and one on the methionine; fragments shown in blue belong to the species with three oxidations on 
the cysteine, c) CID MS/MS fragmentation of the quadruple oxidation product of VQSIKCADFLHYMENPTWGR.*Observed fragments are 
summarized on the peptide sequences, inset. Lower case denotes modified amino acid residues 
a 
b 
c 
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The peak at m/z 815.0426 (Figure 4.1b) corresponds to triply protonated ions of the 
peptide plus three oxygen atoms (m/zcalc 815.0438). This peak was isolated and 
fragmented by use of ETD (Appendix Table 4.. Peaks corresponding to fragments from 
both triply oxidated cysteine (i.e., sulfonic acid) and doubly oxidated cysteine (sulfinic 
acid) together with methionine oxidation, were observed (Figure 4.2b), suggesting two 
species were present. Loss of both the sulfinic acid side chain (m/z 1189.0718) and 
(low abundance) sulfonic acid side chains were observed (m/z 1181.0777) in the +2 
charge state (m/zcalc 1189.0731 and 1181.0756). LC CID MS/MS was performed and 
two species were seen to elute at retention times of ~16 min 45 s and ~19 min (Figure 
4.3). CID MS/MS of the species eluting at RT ~16 min 45 s reveals the addition of two 
oxygen atoms on the cysteine residue (formation of sulfinic acid) and one oxygen atom 
to the methionine residue (Appendix Table 4.4a). CID MS/MS of the species eluting at 
RT 19 min shows that all three oxidations occur on the cysteine residue, forming 
sulfonic acid (Appendix Table 4.4b). The oxidation of methionine is expected as 
numerous studies have shown methionine to be readily oxidized to methionine 
sulfoxide [203]. 
A peak corresponding to 3+ ions of the peptide plus four oxygen atoms was observed 
at m/z 820.3743 (m/zcalc 820.3754) (Figure 4.1b). These ions were isolated and 
fragmented by ETD to reveal a single species comprising three oxidations of the 
cysteine residue and a single oxidation of the methionine residue (Appendix Table 4.5 
and Figure 4.2c). 
The only peak corresponding to a SCW cleavage product was observed 
at m/z 517.5779 (m/zcalc 517.5785) and corresponds to FLHYMENPTWGR (Figure 4.1b). 
This assignment was confirmed by CID (Appendix Figure 4.1). The list of ions used to 
confirm this assignment is shown in Appendix Table 4.6. The peptide product is the 
result of cleavage C-terminal to the aspartic acid residue in the original peptide, 
consistent with the results presented in Chapter 3, which found aspartic acid to be the 
most common site of SCW-induced cleavage. A peak corresponding to this cleavage 
product plus an oxygen atom was also observed at m/z 522.9094 (m/zcalc 522.9105). 
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This ion was isolated and fragmented to reveal methionine oxidation (Appendix Table 
4.7 and Appendix Figure 4.2). 
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Figure 4. 3 - Extracted ion chromatogram (m/z 815.0426, [VQSIKCADFLHYMENPTWGR+3O]) obtained following LC CID MS/MS and the 
two corresponding CID MS/MS spectra at retention times 16 minutes 45 seconds and 19 minutes. Observed fragments are summarised 
on the peptide sequences, inset. Lower case denotes modified amino acid residues. 
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SCW treatment was also performed at 160 °C, 180 °C, and 200 °C (Table 4.1 and 
Figures 4.4). In each case, the residency time was 10 min. A greater amount of 
peptide bond hydrolysis was observed as the temperature increased, as expected 
from the results in the prior chapter. Following treatment at 160 °C, the cleavage 
product FLHYMENPTWGR represents the base peak in the mass spectrum. At SCW 
conditions of 180 °C, water loss could also be detected as a modification. In the 
previous chapter, it was shown that inclusion of water loss as a dynamic modification 
in the automated protein database search of LC MS/MS data obtained from SCW 
hydrolysates resulted in a 9% increase in peptide identifications for α-globin, β-
globin, BSA, and β-casein at SCW conditions of 160 °C (0 min), 160 °C (20 min), and 
207 °C (20 min). In addition Basil et al. showed that in the thermal decomposition of 
peptides at comparable temperatures to those used here, dehydration products 
could be detected [204]. The identity of the specific sites of water loss could not be 
ascertained reliably: CID is not a reliable indicator as the CID process itself can result 
in water loss and no fragment ions were observed following ETD MS/MS. 
Interestingly, Basil et al. further identify C-terminal amidation as a modification 
through thermal denaturation. A small amount of this modification under the two 
harshest SCW conditions (180 °C and 200 °C) was observed: CID MS/MS was used to 
confirm that the amidation occurred on the C-terminus (Figure 4.5 and Appendix 
Table 4.8). 
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Figure 4. 4 - Direct infusion electrospray MS of peptide VQSIKCADFLHYMENPTWGR treated with SCW at a)160oC for 10 minutes; b) 180oC 
for 10 minutes and c) 200oC for 10 minutes. 
a 
b 
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Figure 4.4 (continued) - Direct infusion electrospray MS of peptide VQSIKCADFLHYMENPTWGR treated with SCW at a)160oC for 10 
minutes; b) 180oC for 10 minutes and c) 200oC for 10 minutes. 
 
 
 
 
Figure 4. 5 - Direct infusion electrospray MS of 3+ ions of CID MS/MS spectrum of 2+ ions of [FLHYMENPT + O + C-term amidation 
 
c 
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4.3 SCW hydrolysis of model peptide VCFQYMDRGDR 
 
SCW hydrolysis was next performed under 140 oC for 10 minutes on a second 
peptide, which also contained cysteine and methionine, VCFQYMDRGDR. The data 
here was used to confirm the results from the first peptide. 
The direct infusion electrospray mass spectrum of the peptide prior to subcritical 
treatment is shown in Figure 4.6a, with peak assignments detailed in Appendix Table 
4.9. Peaks at m/z 469.2041 and 703.3028 correspond to singly oxidized species 
(m/zcalc 469.2044 and 703.3030), which CID MS/MS confirmed as methionine 
oxidation (Appendix Figure 4.3 and Appendix Table 4.10). Figure 4.6b shows the 
direct infusion electrospray mass spectrum of the SCW hydrolysate (see also Table 
4.2). As observed for VQSIKCADFLHYMENPTWGR, the most intense peaks correspond 
to oxidized forms of the peptide. Peaks observed at m/z 474.5359 (+3) and m/z 
711.3004 (+2) correspond to the peptide plus the addition of two oxygen atoms 
(m/zcalc 474.5360 and 711.3000). CID MS/MS analysis of the 3+ ions confirmed that 
the oxidation occurs solely on the cysteine residue (Figure 4.13 and Appendix Table 
4.11). 
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Figure 4. 6 - a) Direct infusion electrospray MS of a) untreated peptide VCFQYMDRGDR and b) peptide VCFQYMDRGDR treated with 
SCW at 140 °C for 10 min. 
 
a 
b 
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140oC 10 minutes 
m/z z 
Calculated 
mass (Da) 
Measured 
mass (Da) 
Peptide ΔPPM 
463.873 3 1388.5965 1388.5972 VCFQYMDRGDR 0.5 
468.5323 3 1402.5758 1402.5751 VCFQYMDRGDR (-H2O+2O) -0.5 
473.8640 3 1418.5707 1418.5702 VCFQYMDRGDR (-H2O+3O) -0.4 
474.5359 3 1420.5863 1420.5859 VCFQYMDRGDR (+2O) -0.3 
479.8675 3 1436.5812 1436.5807 VCFQYMDRGDR (+3O) -0.4 
624.2444 2 1246.4747 1246.4742 VCFQYMDRGD (-H2O+2O) -0.3 
632.2418 2 1262.4696 1262.4690 VCFQYMDRGD  (-H2O+3O) -0.4 
633.2498 2 1264.4852 1264.4850 VCFQYMDRGD (+2O) -0.1 
635.2353 2 1268.4561 1268.4560 VCFQYMDRGD (-H2O+2O+Na) 0.0 
641.2472 2 1280.4811 1280.4798 VCFQYMDRGD (+3O) -1.0 
643.2327 2 1284.4510 1284.4508 VCFQYMDRGD  (-H2O+3O+Na) -0.1 
652.2381 2 1302.4625 1302.4616 VCFQYMDRGD  (+3O+Na) -0.7 
702.2950 2 1402.5758 1402.5754 VCFQYMDRGDR (-H2O+2O) -0.2 
710.2924 2 1418.5707 1418.5702 VCFQYMDRGDR (-H2O+3O) -0.3 
711.3004 2 1420.5863 1420.5862 VCFQYMDRGDR (+ 2O) -0.1 
718.2898 2 1434.5656 1434.5650 VCFQYMDRGDR (-H2O+4O) -0.4 
719.2999 2 1436.5812 1436.5852 VCFQYMDRGDR (+3O) 2.8 
727.2950 2 1452.5761 1452.5754 VCFQYMDRGDR (+4O) -0.5 
1229.4707 1 1228.4641 1228.4634 VCFQYMDRGD (-2H2O+2O) -0.6 
1247.4811 1 1246.4747 1246.4738 VCFQYMDRGD (-H2O+2O) -0.7 
1263.4760 1 1262.4696 1262.4687 VCFQYMDRGD (-H2O+3O) -0.7 
1265.4926 1 1264.4852 1264.4853 VCFQYMDRGD (+2O) 0.1 
1281.4868 1 1280.4811 1280.4795 VCFQYMDRGD (+3O) -1.2 
1285.4578 1 1284.4510 1284.4505 VCFQYMDRGD (-H2O+3O+Na) -0.3 
Table 4. 2 - Ions identified following SCW hydrolysis of VCFQYMDRGDR at 140 °C 
for 10 min. 
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Figure 4. 7 - a) CID MS/MS spectrum of 3+ ions of [VCFQYMDRGDR +2O]; b)ETD MS/MS fragmentation of 3+ ions of [VCFQYMDRGDR 
+3O]. Fragments shown in purple belong to either species; fragments shown in red belong to the species with two oxidations on  the 
cysteine and one on the methionine; fragments shown in blue belong to the species with three oxidations on the cysteine and c) ETD 
MS/MS spectrum of 2+ ions of [VCFQYMDRGDR +3O]. Observed fragments are summarized on the peptide sequences, inset. Lower 
case denotes modified amino acid residues. 
a 
b 
c 
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Peaks observed at m/z 479.8675 (+3) and m/z 719.2999 (+2) (m/zcalc 479.8677 and 
719.2979) (Figure 4.6b) correspond to the peptide plus the addition of three oxygen 
atoms. Subsequent MS/MS analysis proved ambiguous, i.e., fragments from both 
Vc(3O)FQYMDRGDR and Vc(2O)FQYm(O)DRGDR were identified (Figure 4.7b). 
Furthermore, peaks corresponding to the loss of sulfinic acid (m/z 1371.6102), 
sulfonic acid (m/z 1355.6148), and methionine sulfoxide (m/z 1374.5942) side chains 
were observed (m/zcalc 1371.6099, 1355.6150, and 1374.5969). LC ETD MS/MS was 
performed and two species were seen to elute at retention times of ~11.5 min and 
~13.5 min. ETD MS/MS of the species eluting at ~11.5 min revealed the presence of 
Vc(2O)FQYm(O)DRGDR and ETD MS/MS of the species eluting at ~13.5 min revealed 
the presence of Vc(3O)FQYMDRGDR (Figure 4.8 and Appendix Table 4.12). 
Furthermore, the loss of the sulfinic acid side chain 
(m/zmeas 1371.6091, m/zcalc 1371.6099) was only observed in the ETD mass spectrum 
obtained at RT 11.5 min, and the loss of the sulfonic acid side chain 
(m/zmeas 1355.6128, m/zcalc 1355.6150) was only observed in the ETD mass spectrum 
obtained at RT 13.5 min. 
 
The peak at m/z 727.2950 (Figure 4.6b), corresponding to the addition of four 
oxygen atoms (m/zcalc 727.2953), was isolated and fragmented by ETD MS/MS to 
reveal the addition of three oxygen atoms on the cysteine residue and the addition 
of one oxygen atom on the methionine residue (Figure 4.7c and Appendix Table 
4.13). 
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Figure 4. 8 - a) - Extracted ion chromatogram (m/z 719.2973, [VCFQYMDRGDR +3O]) obtained following LC ETD MS/MS and the 
two corresponding ETD MS/MS spectra at retention times 11 min 30 s and 13 min 30 s. Observed fragments are summarized on 
the peptide sequences, inset. Lower case denotes modified amino acid residues. 
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In addition to oxidation, extensive dehydration was observed for this peptide. This 
was attributed to the presence of two aspartic acid residues in the peptide sequence. 
Dehydration of the doubly oxidized species was observed (m/zmeas 468.5323 (+3) and 
702.2950 (+2), m/zcalc 468.5322 and 702.2496), as was dehydration of the triply 
oxidized species (m/zmeas 473.8640 (+3) and 710.2924 (+2), m/zcalc 473.8638 and 
710.2921). ETD MS/MS was performed; however, the site of water loss was 
ambiguous in all cases. The fragment ions observed for the species at m/z 468.5323 
and 710.2924 is listed in Appendix Tables 4.14 - 4.15. 
As with the previous peptide, cleavage at the C-terminal of the aspartic acid was also 
observed. Following cleavage at the Asp C-terminus peaks were observed 
corresponding to the addition of two oxygen atoms with (m/z 624.2444) and without 
water loss (m/z 633.2498) (m/zcalc 624.2446 and 633.2499), and addition of three 
oxygen atoms with (m/z 632.2418) and without water loss (m/z 641.2472) (m/zcalc 
632.2421 and 641.2471). 
The results above show that the most commonly occurring amino acid side-chain 
modifications following treatment with SCW are oxidation of cysteine and 
methionine residues. In order to determine whether other modifications might occur 
in the absence of those residues, SCW treatment was performed on (1) a model 
peptide VQSIKADFLHYENPTWGR that did not contain either cysteine or methionine 
and (2) the peptide VQSIKCADFLHYMENPTWGR following capping of the cysteine 
residue. 
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4.4 SCW hydrolysis of model peptide VQSIKADFLHYENPTWGR 
 
To further probe the effects of SCW hydrolysis on residues that were not cysteine or 
methionine, a synthetic peptide was designed, VQSIKADFLHYENPTWGR. The direct 
infusion ESI mass spectrum is show in Figure 4.9a (Appendix Table 4.16). The 
peptide was treated with SCW at 140 °C for 10 min. Direct infusion MS of the SCW-
treated peptide revealed that the most abundant species was the unmodified 
peptide in the +3 charge state (Figure 4.9b and Table 4.3), in contrast to SCW-
treated VQSIKCADFLHYMENPTWGR, in which the major product was an oxidized 
form of the peptide. 
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Figure 4. 9 a - Direct infusion electrospray MS of a) untreated peptide VQSIKADFLHYENPTWGR; b) of peptide VQSIKADFLHYENPTWGR 
treated with SCW at 140 °C for 10 min. 
 
 
a 
b 
m/z 
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m/z z 
Calculated 
mass (Da) 
Measured 
mass (Da) 
Peptide ΔPPM 
473.9003 3 1418.6731 1418.6791 FLHYENPTWGR 4.2 
536.5265 4 2142.0647 2142.0769 VQSIKADFLHYENPTWGR (-H2O) 5.7 
541.0280 4 2160.0752 2160.0829 VQSIKADFLHYENPTWGR 3.6 
545.0272 4 2176.0701 2176.0797 VQSIKADFLHYENPTWGR (+O) 4.4 
549.0260 4 2192.0650 2192.0749 VQSIKADFLHYENPTWGR (+2O) 4.5 
710.3466 2 1418.6731 1418.6786 FLHYENPTWGR 3.9 
715.0316 3 2142.0647 2142.0730 VQSIKADFLHYENPTWGR (-H2O) 3.9 
721.0348 3 2160.0752 2160.0826 VQSIKADFLHYENPTWGR 3.4 
726.3670 3 2176.0701 2176.0792 VQSIKADFLHYENPTWGR (+O) 4.2 
731.6989 3 2192.0650 2192.0749 VQSIKADFLHYENPTWGR (+2O) 4.5 
1081.0483 2 2160.0752 2160.0820 VQSIKADFLHYENPTWGR 3.2 
 
 
Peaks observed at m/z 545.0272 (+4) and m/z 726.3670 (+3) correspond to the 
peptide plus addition of a single oxygen atom (m/zcalc 545.0248 and 726.3640). ETD 
MS/MS of the ions with m/z 545.0272 confirmed that oxidation of the tryptophan 
residue had occurred (Figure 4.10 and Appendix Table 4.17). The oxidation of 
tryptophan has previously been reported in proteomic studies [205, 206]. Peaks 
corresponding to the addition of two oxygen atoms to the peptide were also 
observed in the +4 and +3 charge states at m/z 549.0260 and m/z 731.6989 
(m/zcalc 549.0235 and 731.6956). Analysis of the double oxidation product using CID 
MS/MS revealed that both oxidations occur on the tryptophan (Figure 4.11 and 
Appendix Table 4.18). This is consistent with work by Taylor et al., which shows 
tryptophan is able to adopt a second oxidation state in mitochondrial proteins [207]. 
A peak corresponding to the dehydrated peptide is observed under these conditions 
at m/z 715.0316 (m/zcalc 715.0288). Isolation of the ions and ETD MS/MS showed 
water loss to occur at the aspartic acid residue (Figure 4.12 and Appendix 
Table 4.19). The loss of water from amino acid residues has previously been 
investigated by Sun et al., who demonstrated that aspartic acid is a likely candidate 
[208]. Finally, for this peptide, an SCW hydrolysis cleavage product was observed 
at m/z 710.3466, corresponding to the peptide, FLHYENPTWGR (m/zcalc710.3438). 
 
Table 4. 3 - Ions identified following SCW hydrolysis of VQSIKADFLHYENPTWGR at 
140 °C for 10 min. 
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Figure 4. 10 -ETD MS/MS spectrum of 4+ ions of [VQSIKADFLHYENPTWGR+O]. 
 
Figure 4. 11 - CID MS/MS spectrum of 4+ ions of [VQSIKADFLHYENPTWGR+2O]. 
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Figure 4. 12 - ETD MS/MS spectrum of 3+ ions of [VQSIKADFLHYENPTWGR- H2O]. 
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4.5 SCW hydrolysis of model peptide VQSIKCADFLHYMENPTWGR pre-
treated with IAM 
 
To further probe the effects of SCW hydrolysis on amino acids, the original peptide 
VQSIKCADFLHYMENPTWGR, was pre-treated with iodoacetamide prior to hydrolysis. 
This should ensure alkylation of cysteine residues and prevent its oxidation. 
Furthermore, it was discussed in Chapter 3 that alkylating BSA prior to SCW hydrolysis 
offered increased sequence coverage under certain conditions. Understanding SCW 
modifications on proteins that have already been treated with IAM is therefore of 
interest. 
Figure 4.13a shows the direct infusion electrospray mass spectrum of the 
iodoactamide-treated peptide VQSIKCADFLHYMENPTWGR prior to SCW treatment (see 
also Appendix Table 4.20). CID MS/MS confirms carbamidomethylation of the cysteine 
residue (Figure 4.14 and Appendix Table 4.21). 
Figure 4.13b shows the direct infusion electrospray mass spectrum of the resulting 
mixture when the peptide VQSIKCADFLHYMENPTWGR pre-treated with iodoacetamide 
was subjected to SCW treatment at 140 °C for 10 min (see also Table 4.4). The most 
abundant multiply charged ions are the carbamidomethylated peptide ions in the 3+ 
charge state, observed at m/z 818.0517 (m/zcalc 818.0561). These species were also 
observed in the 4+ charge state (m/zmeas 613.7906; m/zcalc 613.7939). In addition, a 
single oxidation was seen to occur at m/z 617.7893 (+4) and 823.3833 (+3) (m/zcalc 
617.7926 and 823.3877). The triply protonated species was fragmented by ETD, 
revealing that oxidation occurred on the methionine residue (Figure 4.15 and 
Appendix Table 4.22).  
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a 
b 
Figure 4. 13 a) Direct infusion electrospray MS of a) peptide VQSIKCADFLHYMENPTWGR treated with iodoacetamide; b) 
VQSIKCADFLHYMENPTWGR following iodoacetamide treatment treated with SCW at 140 °C for 10 min  
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Figure 4. 14 - CID MS/MS spectrum of 3+ ions of [VQSIKCADFLHYENPTWGR+C2H5ON]. 
Figure 4. 15 - ETD MS/MS spectrum of 3+ ions of [VQSIKCADFLHYENPTWGR+C2H5ON+O]. 
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m/z z 
Calculated 
mass (Da) 
Measured 
mass (Da) 
Peptide ΔPPM 
454.8248 1   Singly charged (unassigned)  
613.7906 4 2451.1464 2451.1333 
VQSIKCADFLHYMENPTWGR (+ 
C2H3ON) 
-5.3 
617.7893 4 2467.1413 2467.1281 
VQSIKCADFLHYMENPTWGR (+ C2H3ON 
+ O) 
-5.3 
628.0459 4 2508.1678 2508.1545 
VQSIKCADFLHYMENPTWGR 
(+2(C2H3ON)) 
-5.3 
642.3011 4 2565.1893 2565.1753 
VQSIKCADFLHYMENPTWGR 
(+3(C2H3ON)) 
-5.5 
721.6640 1   Singly charged (unassigned)  
818.0517 3 2451.1464 2451.1333 
VQSIKCADFLHYMENPTWGR (+ 
C2H3ON) 
-5.3 
823.3833 3 2467.1413 2467.1281 
VQSIKCADFLHYMENPTWGR (+ C2H3ON 
+ O) 
-5.4 
837.0587 3 2508.1678 2508.1543 
VQSIKCADFLHYMENPTWGR 
(+2(C2H3ON)) 
-5.4 
856.0685 3 2565.1893 2565.1837 
VQSIKCADFLHYMENPTWGR 
(+3(C2H3ON)) 
-2.2 
1226.5742 2 2451.1464 2451.1338 
VQSIKCADFLHYMENPTWGR (+ 
C2H3ON) 
-5.1 
1255.0846 2 2508.1678 2508.1546 
VQSIKCADFLHYMENPTWGR 
(+2(C2H3ON)) 
-5.3 
1283.5925 2 2565.1893 2565.1704 
VQSIKCADFLHYMENPTWGR 
(+3(C2H3ON)) 
-7.4 
 
Table 4. 4 - Ions observed following SCW hydrolysis of iodoacetamide pre-treated 
VQSIKCADFLHYMENPTWGR at 140 °C for 10 min. 
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Interestingly, the addition of a further carbamidomethyl group to the peptide, 
observed at m/z 628.0459 (+4), 837.0587 (+3), 1255.0846 (+2) (m/zcalc 628.0492, 
837.0632, and 1255.0912), as well as species with three carbamidomethyl groups 
at m/z 642.3011 (+4), 856.0685 (+3), and 1283.5925 (+2) (m/zcalc 642.3046, 837.0704, 
and 1283.6019) was observed. That is, the excess iodoacetamide present in the 
sample further alkylates the peptide under SCW conditions. Alkylation of cysteine by 
iodoacetamide occurs via nucleophilic substitution (SN2) at basic pH. It is also known 
that under certain conditions (pH, concentration, length of incubation), alkylation of 
other amino acid residues (methionine, histidine, lysine, tyrosine, glutamic acid, and 
aspartic acid) and the N-terminus or C-terminus by iodoacetamide can occur [209-
213]. The data suggests that SCW promotes substitution by other nucleophiles. It 
was not possible to determine the sites of modification due to the composite MS/MS 
spectra obtained, even when coupled with liquid chromatography. Appendix Table 
4.23 summarises the CID MS/MS for the ions observed at m/z 837.0587 
demonstrating the multiple species observed. 
The presence of nonspecific carbamidomethylation could be detrimental for 
proteomics analysis and therefore the effect of quenching excess iodoacetamide 
with dithiothreitol [211] prior to SCW treatment was investigated. 
Figure 4.16a shows the direct infusion electrospray mass spectrum of the 
iodoacetamide and DTT-treated peptide VQSIKCADFLHYMENPTWGR before and after 
SCW treatment at 140 °C for 10 min. Both spectra are dominated by singly charged 
ions, likely due to the excess of both iodoacetamide and dithiothreitol. The singly 
carbamidomethylated peptide is observed at m/z 818.0562 (+3) and 1226.5809 (+2), 
and there is no evidence for multiple carbamidomethylation. Peaks corresponding to 
addition of hydrogen and iodine to carbamidomethylated peptides are observed in 
both the non-SCW treated sample at m/z 1290.5372 and m/z 1354.4932, and the 
SCW treated sample at m/z 1290.5365 and m/z 1354.4926 (m/zcalc 1290.5366 and 
1354.4928). These modifications were not observed in the non-DTT treated sample. 
Furthermore, methionine oxidation was not observed under these conditions. 
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Figure 4. 16 - Direct infusion electrospray MS of peptide VQSICKADFLHYENPTWGR treated with iodoacetamide and DTT a) prior to SCW 
hydrolysis and b) hydrolysed at 140oC for 10 minutes. 
 
b 
a 
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4.6 Conjugation reactions using SCW  
 
These results presented in section 4.4 suggest SCW could be effective in catalysing 
nucleophilic interactions. Whilst SCW is effective in catalysing various organic reactions 
[214], using this technology to promote SN2 reactions has not been well studied.  
In Section 1.5 the various benefits of dietary antioxidants are discussed. Aydemir and 
Yemenicioglu recently investigated the antioxidant activity of lentils, which are rich in 
phenolic content [215]. The authors hypothesise that phenolic compounds are initially 
bound to proteins, but are subsequently released in their free form during digestion. 
They speculate this is the major contributing factor behind the health benefits 
associated with phenolic rich pulses and other legume seeds. If an effective method of 
conjugating phenolic compounds to proteins could be realised, it may prove beneficial 
in the production of artificial antioxidants.  
Having already demonstrated iodine as a leaving group in a SCW catalysed SN2 
reaction, investigating whether an element with similar chemical properties behaves in 
the same way is of interest. Secondly, it is important to investigate whether cyclic 
compounds would conjugate in the same way as IAM.  Here the conjugation of the 
cyclic compound, benzyl bromide, to the peptide VQSIKCADFLHYMENPTWGR was 
investigated. 
The peptide was incubated with an equimolar amount of benzyl bromide (15µM) and 
hydrolysed at 140 oC for 10, 30 and 60 minute time points.  Figure 4.17 shows the 
direct infusion electrospray mass spectrum of the peptide incubated with benzyl 
bromide for 10 minutes at room temperature (see also Table 4.5). The most intense 
peak in the mass spectrum at m/z 799.0440 corresponds to the triply protonated ions 
of the peptide with no modifications (m/zcalc 799.0489). This species was also observed 
in the +2 and +4 charge states at m/z 599.5349 and m/z 1198.0612 (m/zcalc 599.8385 
and 1198.0697). The peak at m/z 829.0589 corresponds to the peptide with a benzyl 
group conjugated (m/zcalc 829.4003). This species was also observed in the +2 and +4 
charge states, albeit at low abundance at m/z 1243.0843 and 622.0462 (m/zcalc 
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1243.0362 and 622.0502). It was not possible to determine the sites of conjugation 
due to the composite MS/MS spectra obtained, even when coupled with liquid 
chromatography. The fragment ions observed from the CID MS/MS of the ion at m/z 
622.0462 are listed in Appendix Table 4.24. 
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Figure 4. 17 - Direct infusion electrospray MS of peptide VQSIKCADFLHYENPTWGR incubated with benzyl bromide for a) 10 minutes at 
room temperature and b) 60 minutes at room temperature. 
a 
b 
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Room temperature 10 minutes 
m/z z 
Calculated 
mass (Da) 
Measured 
mass (Da) 
Peptide ΔPPM 
595.0323 4 2376.1144 2376.1001 VQSIKCADFLHYMENPTWGR (-H2O) -6.0 
599.5349 4 2394.1249 2394.1105 VQSIKCADFLHYMENPTWGR -6.0 
622.0462 4 2484.1719 2484.1557 VQSIKCADFLHYMENPTWGR (+C7H6) -6.5 
799.0440 3 2394.1249 2394.1102 VQSIKCADFLHYMENPTWGR -6.2 
829.0589 3 2484.1719 2484.1549 VQSIKCADFLHYMENPTWGR (+C7H6) -6.9 
1198.0612 2 2394.1249 2394.1078 VQSIKCADFLHYMENPTWGR -7.1 
1243.0843 2 2484.1719 2484.1540 VQSIKCADFLHYMENPTWGR (+C7H6) -7.2 
Room temperature 60 minutes 
m/z z 
Calculated 
mass (Da) 
Measured 
mass (Da) 
Peptide ΔPPM 
595.0320 4 2376.1144 2376.0989 VQSIKCADFLHYMENPTWGR (-H2O) -6.5 
599.5349 4 2394.1249 2394.1105 VQSIKCADFLHYMENPTWGR -6.0 
622.0463 4 2484.1719 2484.1561 VQSIKCADFLHYMENPTWGR (+C7H6) -6.4 
799.0440 3 2394.1249 2394.1102 VQSIKCADFLHYMENPTWGR -6.2 
829.0589 3 2484.1719 2484.1549 VQSIKCADFLHYMENPTWGR (+C7H6) -6.9 
1198.0613 2 2394.1249 2394.1080 VQSIKCADFLHYMENPTWGR -7.0 
1243.0844 2 2484.1719 2484.1542 VQSIKCADFLHYMENPTWGR (+C7H6) -7.1 
140oC 10 minutes 
m/z z 
Calculated 
mass (Da) 
Measured 
mass (Da) 
Peptide ΔPPM 
595.0324 4 2376.1144 2376.1005 VQSIKCADFLHYMENPTWGR (-H2O) -5.8 
599.5348 4 2394.1249 2394.1101 VQSIKCADFLHYMENPTWGR -6.2 
622.0462 4 2484.1719 2484.1557 VQSIKCADFLHYMENPTWGR (+C7H6) -6.5 
799.0441 3 2394.1249 2394.1105 VQSIKCADFLHYMENPTWGR -6.0 
829.0587 3 2484.1719 2484.1543 VQSIKCADFLHYMENPTWGR (+C7H6) -7.1 
1198.0613 2 2394.1249 2394.1080 VQSIKCADFLHYMENPTWGR -7.1 
140oC 30 minutes 
m/z z 
Calculated 
mass (Da) 
Measured 
mass (Da) 
Peptide ΔPPM 
517.5785 3 1549.7136 1549.7137 FLHYMENPTWGR 0.0 
547.5942 3 1639.7606 1639.7608 FLHYMENPTWGR (+C7H6) 0.1 
595.0352 4 2376.1144 2376.1117 VQSIKCADFLHYMENPTWGR (-H2O) -1.1 
599.5385 4 2394.1249 2394.1249 VQSIKCADFLHYMENPTWGR 0.0 
622.0502 4 2484.1719 2484.1717 VQSIKCADFLHYMENPTWGR (+C7H6) -0.1 
775.8644 2 1549.7136 1549.7142 FLHYMENPTWGR 0.4 
799.0489 3 2394.1249 2394.1249 VQSIKCADFLHYMENPTWGR 0.0 
829.0647 3 2484.1719 2484.1723 VQSIKCADFLHYMENPTWGR (+C7H6) 0.1 
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859.0805 3 2574.2188 2574.2197 VQSIKCADFLHYMENPTWGR (+2C7H6) 0.3 
1001.4988 2  2000.9830 Unassigned  
1066.0212 2  2130.0278 Unassigned  
1198.0693 2 2394.1249 2394.1240 VQSIKCADFLHYMENPTWGR -0.4 
1238.0331 2 2474.0516 2474.0516 VQSIKCADFLHYMENPTWGR (+HBr) 0.0 
1243.0918 2 2484.1719 2484.1690 VQSIKCADFLHYMENPTWGR (+C7H6) -1.1 
1277.9962 2 2553.9783 2553.9778 VQSIKCADFLHYMENPTWGR (+2HBr) -0.2 
1283.0563 2 2564.0986 2564.0980 
VQSIKCADFLHYMENPTWGR (+C7H6 + 
HBr) 
-0.2 
140oC 60 minutes 
m/z z 
Calculated 
mass (Da) 
Measured 
mass (Da) 
Peptide ΔPPM 
502.9179 3  1505.7319 unassigned  
517.5778 3 1549.7136 1549.7116 FLHYMENPTWGR -1.3 
547.5934 3 1639.7606 1639.7584 FLHYMENPTWGR (+C7H6) -1.4 
577.6093 3 1729.8076 1729.8061 FLHYMENPTWGR (+2C7H6) -0.9 
595.0341 4 2376.1144 2376.1073 VQSIKCADFLHYMENPTWGR (-H2O) -3.0 
599.5377 4 2394.1249 2394.1217 VQSIKCADFLHYMENPTWGR -1.3 
616.3193 1 615.3124 615.3120 PTWGR -0.6 
622.0494 4 2484.1719 2484.1685 VQSIKCADFLHYMENPTWGR (+C7H6) -1.4 
644.5610 4 2574.2189 2574.2149 VQSIKCADFLHYMENPTWGR (+2 C7H6) -1.5 
667.0732 4 2664.2658 2664.2637 VQSIKCADFLHYMENPTWGR (+3 C7H6) -0.8 
753.8731 2  1505.7316 unassigned  
775.8630 2 1549.7136 1549.7114 FLHYMENPTWGR -1.4 
799.0481 3 2394.1249 2394.1225 VQSIKCADFLHYMENPTWGR -1.0 
820.8863 2 1639.7606 1639.7580 FLHYMENPTWGR (+C7H6) -1.6 
829.0634 3 2484.1719 2484.1684 VQSIKCADFLHYMENPTWGR (+C7H6) -1.4 
859.0791 3 2574.2189 2574.2155 VQSIKCADFLHYMENPTWGR (+2 C7H6) -1.3 
865.9097 2 1729.8076 1729.8048 FLHYMENPTWGR (+2 C7H6) -1.6 
889.0944 3 2664.2658 2664.2614 VQSIKCADFLHYMENPTWGR (+3 C7H6) -1.7 
1198.0662 2 2394.1249 2394.1178 VQSIKCADFLHYMENPTWGR -2.9 
1238.0319 2 2474.0516 2474.0492 VQSIKCADFLHYMENPTWGR (+HBr) -1.0 
1243.0912 2 2484.1719 2484.1678 VQSIKCADFLHYMENPTWGR (+C7H6) -1.6 
1277.9942 2 2553.9783 2553.9738 VQSIKCADFLHYMENPTWGR (+2HBr) -1.7 
1283.0563 2 2564.0986 2564.0908 
VQSIKCADFLHYMENPTWGR (+C7H6 + 
HBr) 
-0.2 
1323.0165 2 
2644.0253 
2644.0184 
VQSIKCADFLHYMENPTWGR (+C7H6 + 
2 HBr) 
-2.6 
Table 4. 5 - Ions Observed Following SCW hydrolysis of benzyl bromide pre-treated 
VQSIKCADFLHYMENPTWGR at room temperature for 0 and 60 minutes and 140oC for 
10, 30 and 60 minutes. 
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Figure 4.17b shows the direct infusion electrospray mass spectrum of the peptide 
incubated with benzyl bromide for 60 minutes at room temperature. There is no 
significant difference in the mass spectra obtained when compared to that obtained 
when the incubation period was 10 minutes.  
The peptide-benzyl bromide mixture was hydrolysed at 140 oC for 10 minutes (Figure 
4.18a). No additional peaks were observed under these conditions. This is in contrast 
to the results observed when the peptide was incubated with IAA at 140 oC for 10 
minutes, where a limited amount of cleavage product was observed as well as 
increased conjugation. Furthermore, no additional oxidation was observed. It is 
unclear why these results were observed. 
Figure 4.18b shows the direct infusion electrospray mass spectrum of the resulting 
mixture when the peptide pre-treated with benzyl bromide was hydrolysed at 140 °C 
for 30 min. The most abundant species observed was the peptide with no 
modifications at m/z 599.5385 (+4), 799.0489 (+3) and 1198.0693 (+2). I also observe a 
dehydration product at m/z 595.0352 as well as addition of a benzyl group at m/z 
622.0502.  
Increased conjugation was observed following the longer residency time. The addition 
of two benzyl groups to the peptide was observed at m/z 859.0805 (m/zcalc 859.0802). 
Interestingly, the addition of one (m/z 1238.0331) and two (m/z 1277.9962) hydrogen 
bromide (HBr) molecules to the peptide were also identified (m/zcalc 1238.0331 and 
1277.9964). In Section 4.5 additions of hydrogen iodide were observed when the 
peptide was hydrolysed with IAA in the presence of DTT. This observation confirms 
SCW may help catalyse reactions other than nucleophilic substitution. The addition of 
HBr and a benzyl group to the same peptide at m/z 1283.0563 was also noted (m/zcalc 
1283.0566). 
Moreover, a cleavage product was detected at m/z 517.5785 (m/zcalc 517.5785). This is 
a result of cleavage next to the C-terminal of aspartic acid, which is consistent with the 
results obtained thus far. The conjugation of a benzyl group to this product was 
observed at m/z 547.5942 (m/zcalc 547.5941). 
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Figure 4. 18 - Direct infusion electrospray MS of peptide VQSIKCADFLHYENPTWGR incubated with benzyl bromide hydrolysed at a) 
140oC for 10 minutes; b) 140oC for 30 minutes and c) 140oC for 60 minutes. 
a 
b 
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Figure 4. 18 (continued) - Direct infusion electrospray MS of peptide VQSIKCADFLHYENPTWGR incubated with benzyl bromide 
hydrolysed at a) 140oC for 10 minutes; b) 140oC for 30 minutes and c) 140oC for 60 minutes. 
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The peptide-benzyl bromide mixture was also hydrolysed at 140 °C for 60 min. The 
direct infusion electrospray mass spectrum is shown in Figure 4.18c. Conjugation of 
benzyl bromide to the peptide noticeably increased under these conditions. The base 
peak in this mass spectrum corresponds to the addition of a benzyl group to the 
peptide in the +3 charge state (m/z 829.0634). This species was also observed in the 
+4 (m/z 622.0494) and +2 charge states (m/z 1243.0492). This observation is in 
contrast to the previous time points where the unmodified peptide was the base 
peak, observed here at m/z 599.5377 (+4), 799.0481 (+3) and 1198.0662 (+2). 
Furthermore, an increased abundance of the peptide which has two benzyl groups 
conjugated at m/z 644.5610, 859.0791 and 1277.9942 (m/zcalc 644.5620, 859.0802, 
1277.9964) was noted. Moreover, the peptide with three benzyl groups attached was 
observed at m/z 667.0732 and 889.0944 (m/zcalc 667.0737 and 889.0959). The 
observation of peptide with the addition of: HBr (m/z 1238.0319), 2HBr (m/z 
1277.9943), HBr and C7H6 (m/z 1283.0563), and 2HBr and C7H6 (m/z 1323.0165) were 
also noted (m/zcalc 1238.0331, 1277.9964, 1283.0566 and 1323.0199). Note the 
additions of multiple benzyl groups or HBr was not observed when incubated at 
room temperature for 60 minutes (Figure 1.7b).  
A species resulting from cleavage at the C-terminal of aspartic acid was also observed 
(m/z 517.5778). Conjugation of a benzyl group to this species was observed at m/z 
547.5934 (+3) and 820.8863 (+2) (m/zcalc 547.5941 and 820.8876). The addition of a 
second benzyl group to this peptide was also noted at m/z 577.6093 (m/zcalc 
577.6098). Furthermore, under this time point the cleavage product PTWGR at m/z 
616.3193 (m/zcalc 616.3197) resulting from non-specific cleavage was observed. 
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4.6 Re-analysis of Chapter 3 data 
In light of the above results, the data obtained from the SCW treatment of 
proteins in Chapter 3 were re-analyzed. The data were searched against the 
relevant protein sequence as obtained from UniProt using the SEQUEST 
algorithm in Proteome Discoverer ver. 1.4.1.14 (Thermo Fisher Scientific). Data 
were searched using “nonspecific enzyme.” Precursor tolerance was 10 ppm 
and MS/MS tolerance was 0.5 Da. The following were allowed as dynamic 
modifications: addition of two and three oxygen atoms on cysteine, addition of 
one and two oxygen atoms on tryptophan, water loss from aspartic acid 
residues, C-terminal amidation and methionine oxidation. (Note that 
methionine oxidation was also allowed as dynamic modification in the previous 
analysis) The database search resulted in an increase in the number of 
identified peptides. An additional 108 (that is, an increase of 63.1%), 121 
(38.7%), and 64 (34.2%) peptides were identified for α-globin hydrolysed at 160 
°C for 0 min, 160 °C for 20 min, and 207 °C for 20 min. A further 69 (increase of 
24.3%), 96 (31.1%), and 74 (48.7%) peptides were identified in β-globin 
hydrolysed at 160 °C for 0 min, 160 °C for 20 min, and 207 °C for 20 min. 
Twenty-eight (28.3%), 91 (37.0%), and 58 (25.3%) further peptides were 
identified for BSA hydrolysed at 160 °C for 0 min, 160 °C for 20 min, and 207 °C 
for 20 min. Thirteen (9%), 163 (25.2%), and 168 (23.5%) additional peptides 
were identified for β-casein hydrolysed at 160 °C for 0 min, 160 °C for 20 min, 
and 207 °C for 20 min. No significant increase in overall sequence coverage was 
observed, however these were already very high under these conditions. 
Understanding additional reactions that occur under sub critical conditions may 
be of further use when analysing more complex mixtures of proteins. 
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4.7 Conclusion 
 
The work presented in this chapter shows that SCW hydrolysis of peptides results in 
efficient oxidation of the hydrolysates. SCW treatment under mild conditions (140 °C 
for 10 min) resulted in oxidation of cysteine and methionine residues. Oxidation of 
cysteine to sulfinic and sulfonic acid was observed. SCW treatment of a peptide that 
did not contain cysteine or methionine resulted in oxidation of tryptophan. Under 
harsher SCW conditions (160 °C- 200 °C), dehydration and amidation of the peptides 
were detected. Water loss occurs at aspartic acid. In addition, the C-terminal of 
aspartic acid is consistently shown to be a site of preferential cleavage for SCW. 
Furthermore, these results suggest that SCW hydrolysis can catalyse nucleophilic 
substitution reactions. Amino acid side chains are more likely to participate in SN2 
reactions with both benzyl bromide and iodoacetamide under sub-critical conditions, 
when compared to incubation at room temperature. The ability of SCW to catalyse 
conjugation reactions could be explored in future work, potentially in the binding of 
antioxidant compounds to proteins.  
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Chapter 5: Sub-critical antioxidant extraction from protein  
5.1 Overview 
The brewing industry generates large amounts of by-products and wastes, the most 
common being brewer’s spent grain (BSG). A sample of BSG was supplied by Phytatec 
UK. A sample of barley grain that is typically used as a brewing starting reactant was 
also supplied as a comparison. Extraction details are described in Section 2.1. 
Prior to this work, sub-critical water has been used in the extraction of antioxidant 
compounds from a variety of sources. This capability has been discussed in detail in 
Chapter 1.5.  Antioxidants are substances which inhibit oxidation and can remove 
damaging reactive oxygen species (ROS) during oxidative stress. Oxidative stress has 
been linked to many diseases including cancer; Parkinson’s disease and atherosclerosis 
[216-218].  
The aim of the work presented in this chapter was to determine whether SCW 
treatment of BSG would result in production of peptides with antioxidant properties. 
The antioxidant capacity of each substance was assessed using the ORAC assay [139], a 
valuable tool in assessing ex-vivo antioxidant potential. To provide confirmation of the 
results obtained from the ORAC assay, the antioxidant potential of the generated 
compounds was further assessed using reducing power [134] and comet assays [136].  
The results suggest that it is not in fact the peptides, but small molecule products that 
show antioxidant properties. The structure of these antioxidant components was 
identified using HCD MS/MS and potential mechanisms of formation are discussed.  
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5.2 Characterisation of hordein extract 
Two protein extracts were supplied by Phytatec UK. The first was extract from the 
barley blend ‘Golden Promise’. In this thesis, the protein extract is termed non-treated 
grain (NTG). The second extract was from the same blend which had undergone 
malting and mashing, i.e. ‘brewer’s spent grain’ (BSG). Protein extraction was 
performed using methods described in Section 2.1. These conditions are specific for 
the extraction of the hordein family of proteins. 
The protein extracts were analysed by SDS-PAGE, see Figure 5.1. Protein bands were 
assigned based on classifications of hordein from published work [219, 220].  
 
 
 
 
 
 
 
 
Figure 5. 1- SDS-PAGE analysis of the hordein fraction from the NTG and BSG extracts. 
The subgroups of hordeins (D-, C-, B-,γ- and A-hordein) are indicated. Lane 1 = NTG, 
lanes 2 = BSG. Markers with their molecular masses are shown in lane 3. 
 
The band at ~100 kDa was assigned as D-hordiens, the bands between ~50 – 70 kDa 
were assigned as C-hordeins, the bands ~35-50kDa were assigned as a mixture of B 
and ƴ-hordeins and the low molecular weight bands were assigned as A-hordeins. In 
order to confirm the protein assignments, individual bands were excised and the 
proteins were digested with Proteinase K and subsequently analysed by LC MS/MS 
(described in Section 2.4). Unfortunately, this analysis failed to provide confirmation as 
multiple hordein classes were identified following the protein database search for each 
band. This results is perhaps unsurprising given the sequence homology between the 
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hordeins (i.e. proteolysis will result in peptides from multiple proteins with identical 
sequences).  
The results following SDS PAGE suggest that malting and mashing have a marked effect 
on the hordein protein content. Previous work by Baxter et al. has shown that during 
malting, barley proteins begin to decompose into peptides and amino acid by 
enzymatic digestion [221]. Here, the larger D hordeins are not detected in the BSG 
sample, suggesting they have been degraded. The patterns are similar for the other 
hordein classes between the two samples. Previous work has shown that B and D 
hordeins are more liable for degradation [222, 223]. During malting, disulfide bonds 
are reduced and B and D hordeins are in part subjected to proteolysis. 
 
5.3 Preparation of hydrolysates 
NTG and BSG were hydrolysed at 160 oC for 0 minutes, 160 oC for 20 minutes, 207 oC 
for 20 minutes, 253 oC for 20 minutes and 300 oC for 20 minutes. Figure 5.2 shows the 
number of peptides that could be identified using LC MS/MS from each of the 
hydrolysates. A full list of the peptides identified is listed in Appendix Tables 5.1- 5.14. 
Few peptides could be identified from these hydrolysates. This is consistent with the 
results to be discussed in Chapter 6 where few peptides were identified from SCW 
hydrolysates of a complex mixture using LC MS/MS via the Orbitrap Elite. 
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Figure 5. 2 - Number of Peptide identifications for LC MS/MS analyses from SCW hydrolysates and enzymatic digests for a) 
NTG and b) BSG. n=3. Error bars represent 1 S.D.  
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The results observed here are in agreement with this observed in Chapter 6. Here it is 
hypothesised the low peptide identifications was due to mixture complexity, this is 
investigated further in Chapter 6. Figure 5.3 shows an example screenshot of the HPLC 
chromatogram, illustrating the large amounts of peptides that are eluted.  
To confirm the presence of hordeins in the NTG and BSG provided, proteins were 
tryptically digested in solution and analysed using LC MS/MS, again using the Orbitrap 
Elite (Figure 5.2). As with the SCW hydrolysates, this mixture resulted in few peptide 
identifications. This is likely due to the lack of arginine and lysine residues in the amino 
acid sequences of the hordeins. Proteins were next digested using proteinase K, a non-
specific enzyme. A large increase in protein IDs was observed, where ~50% peptides 
assigned were a result of digestion from B-hordeins.
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Figure 5. 3 - Example LC ion chromatogram for BSG hydrolysate. 
 
133 
 
5.4 Antioxidant Potential of SCW hydrolysates 
ORAC, comet and reducing power assays have been used extensively to assess both 
the direct and indirect antioxidant activity of a range of mixtures [146, 224-229]. These 
are described in more detail in Chapter 1.5.4. 
 
5.4.1 ORAC assay 
The total antioxidant capacity (TAC) of a substance can be crudely described using the 
ORAC assay, through estimation of the antioxidant components of a sample in a global 
manner.  The ORAC assay measures the ability of a substance to quench free radicals 
by hydrogen donation. A detailed overview of the method is discussed in Chapter 
1.5.4.1. The ORAC assay was used to assess the TAC of the NTG and BSG hydrolysates 
as well as those from the standard protein BSA under the same hydrolysis conditions. 
Here, Trolox (6-hydroxy-2,5,7,8-tetrametmethylchroman-2-carboxylic acid), a water 
soluble vitamin E analog, is used as the calibration standard and ORAC results are 
expressed as μM Trolox equivalents. 
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Figure 5.4 shows the effect of SCW reaction time and temperature on total antioxidant 
capacity of NTG and BSG. Values are reported as the concentration of Trolox standard 
that was required to achieve the same antioxidant capacity (Trolox Equivalence (TE) 
Value). SCW conditions were 160 °C for 0 min, 160 °C for 20 min, 207 °C for 20 min, 
253 °C for 20 min and 300 °C for 20 min. 
 
 
 
 
 
 
 
 
 
Figure 5. 4 - ORAC assay of NTG, BSG and BSA hydrolysates compared to commercial 
antioxidants at 0.05mg/ml. Absorbance was recorded at 700 nm. Data represent mean 
± SD of three replicates.  
 
TE values of 6.3 ± 1.0 and 6.7 ± 0.8 µM were reported for SCW hydrolysis of BSG at 160 
°C for 0 and 20 minutes.  When the hydrolysis temperature was increased from 160 °C 
to 207 °C, a significant increase in TE was observed (16.0 ± 3.2 µM) (p < 0.05). A similar 
level of antioxidant capacity was obtained at 253 °C (17.5 ± 2.5 µM). A sharp increase 
in TE value was observed following SCW hydrolysis at 300 °C (36.3 ± 5.2 µM) (p < 0.05).  
A positive correlation between hydrolysis temperature and antioxidant capacity was 
observed for NTG. SCW hydrolysis at 160 °C for 0 min gave a TE value of 4.2 ± 2.8 µM. 
Extension of the reaction time to 20 min resulted in a similar level of antioxidant 
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capacity (7.6 ± 2.1 µM). A significant increase in antioxidant capacity was observed at 
207 °C (23.8 ± 1.6 µM) (p < 0.05). Comparable levels of antioxidant activity were 
observed at 253 °C and 300 °C (28.5 ± 6.6 µM and 23.4 ± 3.1 µM). 
To compare the TAC of hordein hydrolysates against those of a standard protein, BSA 
was hydrolysed under the same conditions. The TE values for BSA hydrolysates from 
160 °C for 0 and 20 min treatments were 7.3 ± 1.9 µM and 7.3 ± 2.7 µM. An increase in 
TAC was again observed at 207 °C (14.5 ± 4.4 µM). High TE values were also obtained 
at 253 °C and 300 °C (22.5 µM ± 3.5 and 21.9 ± 5.7 µM).   
Two antioxidants that are routinely used as supplements within the food and 
pharmaceutical industries are Butylated hydroxytoluene (BHT) and ascorbic acid. The 
TACs observed following hydrolysis at the higher temperature points of all three 
reactants compared favourably against the same w/v of BHT (24.8 ± 0.6µM) and 
ascorbic acid (41.7 ± 6.1 µM).  
These results suggest that SCW hydrolysis of protein results in the efficient formation 
of a powerful antioxidant mixture under increasing temperatures points, regardless of 
the starting protein. A general correlation between temperature and TAC was 
observed. Significant increases in TAC were observed between hydrolysates obtained 
at 160 ⁰C and 207 ⁰C for BSG and NTG. Whilst the realisation of a process to produce a 
valuable product from BSG has economic potential for the brewing industry, providing 
a standard methodology for the transformation of any protein-based waste into a 
powerful antioxidant has increased commercial applications.  
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5.4.2 Reducing Power assay 
Reducing power serves as a reflection of antioxidant activity. This assay is based on the 
reduction of Fe3+ to Fe2+ and subsequently monitoring the increase in absorbance at 
700nm. As with the ORAC assay, the biological relevance of this assay is uncertain, 
particularly given the electron transfer mechanism of action. This is described in more 
detail in Chapter 1.5.4.2. 
Figure 5.5 shows the Abs700nm against each hydrolysis condition. A substance exhibiting 
reducing power will cause the complex to be reduced to the ferrous (Fe2+) form, 
resulting in an increased absorbance recorded at 700nm. 
The reducing power consistently increased with the harshness of the hydrolysis 
conditions. Under hydrolysis conditions of 160 oC for 0 minutes, no Abs700nm was 
recorded for BSG or NTG (both 0.00 ± 0.00) whilst a limited amount was recorded for 
BSA (0.06 ± 0.03). Under hydrolysis conditions of 160 oC for 20 minutes little Abs700nm 
was again recorded for NTG or BSG (again both 0.00 ± 0.00), whilst a moderate 
increase in BSA was observed (0.11 ± 0.02). Hydrolysates from 207 oC for 20 minutes 
showed significant increases in Abs700nm for all three mixtures: 0.04 ± 0.01 for BSG, 
0.08 ± 0.02 for NTG and 0.20 ± 0.01 for BSA (p < 0.005 in all cases). Significant increases 
in Abs700nm were also increased between 207 and 253 ⁰C for 20 minutes: 0.16 ± 0.02 
(p<0.001) for BSG, 0.18 ± 0.02 for NTG and 0.26 ± 0.03 for BSA (both p < 0.05).The 
highest levels of Abs700nm were recorded for hydrolysates from 300 oC for 20 minutes 
for NTG (0.29 ± 0.04), BSG (0.26 ± 0.04) and BSA (0.31 ± 0.03). These represented 
significant increases in Abs700nm for BSG and NTG compared to the values obtained at 
253 ⁰C for 20 minutes (p < 0.05). Here, the reducing power of the hydrolysates was not 
as high as that observed in the commercial antioxidants BHT (0.65 ± 0.02) and ascorbic 
acid (0.64 ± 0.02). 
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Figure 5. 5 - Reducing power assay of NTG, BSG and BSA hydrolysates and commercial 
antioxidants at 0.05mg/ml. Absorbance was recorded at 700 nm. n=3. Data represent 
mean ± SD of three replicates.  
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5.4.3 Comet assay  
To confirm the results described above, the more rigorous comet assay was applied, in 
which the antioxidant potential is assessed on live cells. The comet assay offers a 
sensitive method for measuring DNA strand breaks in individual cells. A comprehensive 
explanation of the assay is detailed in Chapter 1.5.4.3.  
Prior to performing the comet assay, HaCaT cells were incubated in NTG, BSG and BSA 
hydrolysates from 160 °C for 0 min, 160 °C for 20 min, 207 °C for 20 min, 253 °C for 20 
min and 300 °C for 20 min. The incubation period was 24 hours and the cell viability 
was assessed using trypan blue exclusion. This assay is discussed in Chapter 1.5.4.3. 
The % cell viability was recorded to ensure each hydrolysate mixture did not produce 
any unwanted cytotoxic effects.  
Figure 5.6 shows the results of trypan blue staining of HaCaT cells after 24 h of 
incubation with different concentration of the test compounds. Cell viability following 
the various treatments was >90 % and no floating cells were noticed in the medium. 
This is comparable to untreated cells. The presence of 50 µM H2O2 for the final 30 
minutes of incubation caused a slight decrease in viability to ~90%.  
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Figure 5. 6- Viability of HaCaT cells incubated in SCW hydrolysates and commercial 
antioxidants for 24h. n=3. Data represent mean values. 
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DNA damage was analysed by the comet assay. Following single-cell electrophoresis, 
the relative tail length was measured, with longer tails representing increased DNA 
damage. Cells were pre-incubated with protein hydrolysates (specific experimental 
details described in Chapter 2.9) and exposed to 50 µM H2O2 for the last 30 minutes of 
treatment.  
Figure 5.7 shows the mean amount of DNA in comet tails for each experimental 
condition. Figure 5.8 shows an example screenshot of comets visualised from the 
comet assay. The bright circles represent a comets ‘head’. In this example the DNA has 
migrated a large distance away from the head to generate a characteristic ‘tail’. The % 
of DNA that is in the comet’s tail is proportional to the amount of DNA damage 
induced by H2O2 treatment.  
Following incubation of HaCaT cells with 50 µM H2O2 for 30 minutes a large amount of 
DNA in comet tails (55.2 ± 3.0 %) was observed (the positive control). When pre-
incubated in protein hydrolysates from 160 oC for 0 min treatment a reduction in tail 
length was observed for BSG (45.5 ± 2.0), NTG (47.5 ± 0.7 %) and BSA (43.5 ± 1.0 %, 
statistically significant p < 0.05). Pre-incubation in hydrolysates from 160 oC for 20 min 
treatment yielded a similar level of % tail DNA for all three proteins (50.7 ± 2.8 % for 
NTG, 50.6 ± 0.11 % for BSG and 39.0 ± 6.3 % for BSA). A steady reduction in % tail DNA 
with respect to hydrolysis temperature was observed over the remaining pre-
incubation conditions. After treatment with hydrolysates from 207 oC for 20 min a 
decrease in DNA migration in the comet tails was noted and for BSG, NTG and BSA (43. 
5 ± 2.1 % ,42.0 ± 2.1 % and 37.7 ± 1.9 %). A further decrease in % tail DNA was 
observed in incubation solutions from 253 oC for 20 min for BSG (36.8 ± 2.1 %) and BSA 
(30.3 ± 1.9 %) whilst similar results were obtained for NTG (42.9 ± 1.6 %). The % tail 
DNA further decreased when pre-incubated in solutions from 300 oC for 20 min 
treatment for BSG (39.5 ± 0.3 %), NTG (26.1 ± 3.3 %) and BSA (29.8 ± 2.5 %). 
In contrast to the results obtained from the ORAC assay, SCW hydrolysates were not 
shown to convey a comparable level of antioxidant activity compared to either of the 
commercial antioxidants. % tail DNA was reported as 17.3 ± 3.5 % for BHT and 14.9 ± 
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1.1 % for ascorbic acid. These results suggest a disparity between the ex vivo and in 
vivo antioxidant activity of the hydrolysates, thereby underlying the limitations of the 
ORAC assay. However, a large decrease in DNA damage observed when incubating in 
hydrolysates under certain conditions remains encouraging. Furthermore, the general 
positive correlation between antioxidant power and hydrolysis temperature is 
consistent with the ORAC assay results.  
 
1 6
0  
o C  
0  
m
in
1 6
0  
o C  
2 0
 m
in
2 0
7  
o C  
2 0
 m
in
2 5
3  
o C  
2 0
 m
in
3 0
0  
o C  
2 0
 m
in
C o
n
tr
o
l
0
2 0
4 0
6 0
8 0
%
 t
a
il
 D
N
A
 
Figure 5. 7 - DNA strand breakage detected by the comet assay using a HaCaTs. Values 
represent the mean tail movement, where n = 2. Data represent mean ± SD of two 
replicates.   
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Figure 5. 8 - Example screenshot of comets visualised in the comet assay. 
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5.3.4 Identification of the molecular origin of the antioxidant activity 
The results presented in Chapter 3 indicate that hydrolysis conditions of 160 oC for 20 
mins results in production of peptides, and that the peptides are gradually 
decomposed into smaller molecules at temperatures above this. Given the results of 
the antioxidant assays above, it is hypothesised that the small molecules produced 
under hydrolysis conditions of 207 oC and greater are responsible for the antioxidant 
capacity, rather than the peptides.  
Enzymatic digests of hordeins have previously shown evidence of antioxidant 
activity[230]. Bamdad et al. showed the digestion of hordein extract using alcalase, 
flavorzyme and pepsin can produce extracts with strong radical scavenging, metal 
chelating and oxidative reducing power. Whilst some antioxidant power from the 
protein had been converted to peptides (hydrolysis conditions of 160 oC for 0 and 20 
minutes) was observed, it is at temperatures ≥ 207 oC that we observe the strongest 
antioxidant capacity. 
Figure 5.9 shows the TE values obtained from an ORAC assay of a tryptic and 
proteinase K digests BSG, NTG and BSA. Whilst modest antioxidant activity could be 
obtained from both the tryptic (8.8 ± 1.5 μM for BSG; 4.9 ± 0.9 μM for NTG and 3.7 ± 
1.1 μM for BSA) and proteinase K digests (6.6 ± 1.7 μM for BSG; 10.9 ± 3.0 μM for NTG 
and 5.2 ± 1.8 μM for BSA), they do not substantially differ to those obtained for 
corresponding samples which had not been digested (6.3 ± 0.9 μM for NTG; 5.2 ± 2.4 
for BSG and 4.9 ± 2.4 μM for BSA).  
Previous work has shown that amino acid side chains either in their free form or within 
protein and peptide structures can provide strong antioxidant activity [231, 232]. To 
assess whether free amino acids directly contribute to increased antioxidant activity, 
the TAC of an equimolar solution of all 20 natural amino acids was also assessed via 
the ORAC assay. The TE value obtained was comparable to those obtained under the 
enzymatic digests (9.4 ± 2.5 μM). It is hypothesised that under hydrolysis conditions of 
207 oC and above, rather than release the component amino acids, their lysis from the 
peptide chain would involve modification of the molecules and that these would be  
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directly responsible for the very high levels of antioxidant activity observed under the 
most harsh hydrolysis conditions. 
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Figure 5. 9 - TE values obtained for enzymatic digests of NTG, BSG and BSA and 
equimolar amino acid mixture using the ORAC assay. n=3. Data represent mean ± SD of 
three replicates. 
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5.5 Small molecule analysis 
To better understand the bioactive behaviour of the decomposition products of 
proteins in sub critical conditions, it is necessary to characterise the compounds 
formed. Although decomposition pathways of proteins and amino acids in SCW have 
been previously studied, these studies focus on the identification of pre-selected 
compounds using a HLPC system, with post column electro conductivity detection 
[185, 233].  The aim here was to identify unknown components in a SCW mixture and 
to propose mechanisms for their formation. 
To identify the decomposition products from the SCW hydrolysis of proteins, 
hydrolysates were analysed by direct infusion electrospray mass spectrometry. Ions of 
relative abundance >5% were isolated and fragmented using higher energy collisional 
dissociation (HCD) MS/MS. A list of all ions isolated and fragmented using HCD are 
listed in Appendix Figures 5.1-5.60 in order of mass-to-charge ratio. Figures are 
annotated with predicted structures of precursor and fragment ions. 
The mass spectra obtained for the hydrolysates in the mass range of 50 - 210 m/z for 
the 160 oC for 0 min and 20 min hydrolysates can be viewed in Appendix Figures 5.61-
5.69 (See also Appendix Tables 5.15-5.22). The most abundant peaks in each spectrum 
correspond to solvent and very few molecules were identified in this range. 
 
 
 
 
 
 
 
145 
 
5.5.1 BSA hydrolysate analysis 
Figure 5.10a shows the mass spectrum obtained following SCW hydrolysis of BSA at 
207 oC for 20 minutes. A summary of the peaks observed is listed in Table 5.1.  
The most intense peak was observed at m/z 130.0503. This corresponds to a molecular 
formula of C5H8NO3. HCD MS/MS suggests that this peak corresponded to singly-
charged pyroglutamic acid (Appendix Figure 5.27). It has previously been shown in the 
SCW hydrolysis of BSA that pyroglutamic acid is a major reactant product under 
comparable conditions [233]. This study differed from this experiment, not only in the 
hydrolysis conditions, but also that pre-selected products were quantitated, rather 
than providing a qualitative analysis. In a separate study Abdelmoez. et al. studied the 
decomposition of 17 of the 20 natural amino acids [185]. Pyroglutamate was identified 
as the sole decomposition product from the SCW hydrolysis of glutamate, resulting 
from its dehydration. The mechanism of pyroglutamate formation is shown in Scheme 
5.1 a. However, the decomposition of glutamine was not discussed in their study. In 
Chapter 4 deamination was identified as a SCW induced modification. Deamination of 
glutamine can also result in the formation of pyroglutamate (Scheme 5.1a) [234]. 
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Figure 5. 10 - Direct infusion ESI MS of BSA hydrolysed at a) 207oC for 20 min, b) 253 oC for 20 min and c) 300 oC for 20 min. 
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m/z 
Calculated 
mass (Da) 
Measured 
mass (Da) 
Formula Proposed Structure HCD MS/MS ΔPPM 
Relative 
abundance 
84.0446 83.0371 83.0373 C4H5ON 
 
No 2.7 7.65 
84.0809 83.0735 83.0736 C5H9N 
 
No 1.5 8.24 
86.0966 85.0892 85.0893 C5H11N 
 
No 1.5 10.89 
98.9756 n/a n/a solvent n/a n/a n/a 6.86 
100.0759 n/a n/a solvent n/a n/a n/a 9.12 
115.0870 114.0793 114.0797 C5H10ON2 
 
Appendix 
Figure 5.13 
3.7 17.22 
116.0709 115.0633 115.0636 C5H9O2N 
 
Appendix 
Figure 5.14 
2.8 83.26 
118.0866 117.0790 117.0793 C5H11O2N 
 
Appendix 
Figure 5.16 
2.8 8.72 
120.0812 119.0735 119.0739 C8H9N 
 Appendix 
Figure 5.18 
3.6 12.35 
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129.1027 128.0950 128.0954 C6H12N2O 
 
Appendix 
Figure 5.26 
3.3 75.26 
130.0503 129.0426 129.0430 C5H7O3N 
 
Appendix 
Figure 5.27 
3.3 100.00 
130.0867 129.0790 129.0794 C6H11O2N 
 
Appendix 
Figure 5.28 
3.3 9.07 
131.1183 130.1106 130.1110    C6H14ON2 Unassigned No 3.3 17.70 
132.1023 131.0946 131.0950 C6H13ON2 
 
Appendix 
Figure 5.29 
3.2 23.61 
144.0660 143.0582 143.0587 C6H9O3N 
 
No 3.7 6.10 
147.1133 146.1055 146.1060 C6H14O2N2 
 
Appendix 
Figure 5.38 
3.6 17.74 
150 
 
155.0821 154.0742 154.0748 C7H10O2N2 
 
Appendix 
Figure 5.43 
4.0 15.81 
156.0773 155.0695 155.0700 C6H9O2N3 
 
Appendix 
Figure 5.44 
3.4 23.43 
157.1089 156.1011 156.1016 C6H12ON4 
 
Appendix 
Figure 5.46 
3.4 10.89 
158.0929 157.0851 157.0856 C6H11O2N3 
 
Appendix 
Figure 5.48 
3.3 22.77 
166.0868 165.0790 165.0795 C9H11O2N 
 
Appendix 
Figure 5.51 
3.2 24.52 
171.1134 170.1055 170.1061 C8H14O2N2 
 
Appendix 
Figure 5.53 
3.7 8.66 
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175.1195 174.1117 174.1122 C6H14O4N2 
 
Appendix 
Figure 5.55 
3.0 28.64 
181.0978 180.0899 180.0905 C9H12O2N2 
 
Appendix 
Figure 5.57 
3.5 10.24 
182.0818 181.0739 181.0745 C9H11O3N 
 
Appendix 
Figure 5.58 
3.4 7.34 
185.0927 184.0847 184.0854 C8H12O3N2 Unassigned No 3.9 5.88 
185.1291 184.1212 184.1218 C9H16O2N2 Unassigned No 3.4 9.63 
186.1243 185.1164 185.1170 C8H15O2N3 Unassigned No 3.4 5.51 
 
 
Table 5. 1 - Ions Observed Following SCW Hydrolysis of BSA at 207 °C for 20 min. 
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a b 
c 
d 
Scheme 5. 1 - Proposed mechanism for a) Deamination of glutamine and dehydration of glutamic acid, b) deamination of arginine, c) 
deamination of lysine and d) dehydration of aspartic acid.  
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A peak was observed at m/z 144.0660 corresponding to singly protonated ions of 
C6H9O3N. This ion may correspond to methylation of pyroglutamic acid, although no 
HCD MS/MS data was collected to support this, due to difficulties in peak isolation. In 
addition a peak was observed at m/z 84.0446. The mass difference suggests this could 
be the result of decarboxylation of pyro glutamic acid (-CO2). No fragments could be 
observed from the HCD of this ion due to the limited sensitivity of the instrument at 
the lower mass range and the relatively high energies that are needed to fragment 
cyclic structures. Decarboxylation has been identified as a major reaction pathway in 
SCW hydrolysis [185]. Abdelmoez. et al. were able to show in the SCW hydrolysis of 17 
of the natural amino acids that 13 of them produced formic acid, the leaving group 
from decarboxylation. 
Ions were also detected at m/z 120.0812 and 157.1089. The mass differences observed 
between these ions and the masses of the natural amino acids suggest that these 
could be products of phenylalanine decarboxylation and arginine dehydration. The 
structure of these compounds was confirmed using HCD MS/MS (Appendix Figures 
5.18 and 5.46).  
As well as the data collected from the SCW hydrolysis of peptides in Chapter 4, 
dehydration and deamination reactions have been identified as reaction pathways in 
other SCW treated molecules. Decarboxylation of indole-2-carboxylic acid to 
unsubstituted indole has been shown under conditions of 255 oC for 20 minutes [235], 
as has the decarboxylation of an ester to produce a styrene[236]. Additionally, in 
previous work by Kuhlmann et al. cyclohexanol was shown to be dehydrated under 
sub-critical conditions of 250-300 oC, although this was in deuterium oxide rather than 
water [237].  
The peak at m/z 116.0709 corresponds to singly protonated C5H9O2N, the elemental 
composition of proline (+1). This assignment was confirmed using HCD MS/MS 
(Appendix Figure 5.13). The transformation of arginine to proline is a common 
biological reaction. This reaction has previously been demonstrated in sub-critical 
conditions [185]. 
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Other peaks corresponding to the m/z of amino acids were observed. HCD MS/MS was 
used to confirm their assignment. Amino acids liberated from BSA under these 
conditions including valine (m/z 118.0866) (HCD MS/MS analysis in Appendix Figure 
5.16), leucine and isoleucine (m/z 132.1023) (HCD MS/MS analysis in Appendix Figure 
5.29), lysine (m/z 147.1123) (HCD MS/MS analysis in Appendix Figure 5.39), histidine 
(m/z 156.0773) (HCD MS/MS analysis in Appendix Figure 5.44), phenylalanine (m/z 
166.0868) (HCD MS/MS analysis in Appendix Figure 5.51), arginine (m/z 175.1195) 
(HCD MS/MS analysis in Appendix Figure 5.55) and tyrosine (m/z 182.0818) (HCD 
MS/MS analysis in Appendix Figure 5.58).  
The peak at m/z 115.0870 corresponds to singly protonated C5H10ON2. HCD MS/MS 
analysis suggests that this peak corresponds to proline that has undergone amidation – 
a SCW induced modification established in Chapter 4 (HCD MS/MS analysis in 
Appendix Figure 5.13). The results suggest a further pyrollidine-based structure 
observed at m/z 158.0929. The mass difference suggests that this ion could be a result 
of arginine deamination. Deamination was established as a modification induced under 
certain SCW conditions in Chapter 4. A mechanism for arginine deamination has been 
previously been proposed (Scheme 5.1b) [238]. HCD MS/MS produced fragment ions 
that are consistent with this structure (Appendix Figure 5.48). 
The ion observed at m/z 130.0837 may be the result of lysine deamination. This 
reaction has previously been predicted to form pipecolic acid (Scheme 5.1c)  [238]. The 
fragment ions observed in the HCD MS/MS spectra of this species were consistent with 
this structure (Appendix Figure 5.28). A peak corresponding to the subsequent 
amidation of this species was observed at m/z 129.1027, and confirmed by HCD 
MS/MS (Appendix Figure 5.26). These structures share a common piperidine ring, 
which may correspond to the peak observed at m/z 86.0966, although this was not 
confirmed by HCD MS/MS due to the limited mass range of the instrument. Similarly, 
decarboxylation of pipecolic acid may be responsible for the ion observed at m/z 
84.0809, although the structure was not confirmed. It is hypothesised that the 
piperidine-based structure forms the basis for ions observed at m/z 155.0821 (HCD 
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MS/MS analysis in Appendix Figure 5.43), 171.1134 (HCD MS/MS analysis in Appendix 
Figure 5.53), 181.0978 (HCD MS/MS analysis in Appendix Figure 5.57).  
MS analysis was next performed on hydrolysates from the SCW treatment of BSA at 
253oC for 20 minutes (Figure 5.10b and Table 5.2). Peaks observed in the mass spectra 
that had not been detected following SCW treatment at 207 oC were selected for 
fragmentation and are highlighted in Table 5.2.  
The most abundant peak in the mass spectrum was observed at m/z 129.1024. In the 
analysis of the data observed when BSA was hydrolysed at 207 oC for 20 minutes it was 
suggested that this ion corresponds to amidation of the species observed at m/z 
130.0865. Under hydrolysis conditions of 253 oC for 20 minutes, a greater abundance 
of amidated species are observed relative to their non-amidated counterparts. The 
species at m/z 129.1024 has a relative abundance of 100% compared to the non-
amidated species at m/z 130.0865 which has a relative abundance of 6.14%. In 
contrast, under conditions of 207 oC for 20 minutes the ion at m/z 130.0865 was 
observed in greater abundance. Additionally, an ion of m/z 115.0867 is observed. It is 
hypothesised that this ion is prolinimide (a proline residue that has undergone 
amidation). The ion observed at m/z 116.0708 was assigned as proline. Prolinamide 
has a relative abundance ~ 4x greater than that of proline. This observation is in 
contrast to the results obtained following hydrolysis at 207 oC for 20 min where the 
opposite was true.  
An ion was observed at m/z 122.0966. The mass suggests the ion could be a result of 
Phe-CO2. Two possible structures were assigned using HCD MS/MS (Appendix Figure 
5.21). Coupling liquid chromatography to HCD MS/MS could be an effective method of 
separating the possible isomers and confirming their assignment. Furthermore an ion 
was observed at m/z 105.0700, which could be a result of NH3 loss from the ion at m/z 
122.0966. Its structure was hypothesised (HCD MS/MS analysis in Appendix Figure 
5.5). In addition, an ion was observed at m/z 158.0927 which was previously attributed 
to Arg-NH3 (HCD MS/MS analysis in Appendix Figure 5.48). 
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m/z 
Calculated 
mass (Da) 
Measured 
mass (Da) 
Formula Proposed Structure HCD MS/MS PPM 
Relative 
abundance 
84.0808 83.0735 83.0735 C5H9N 
 
No 0.3 8.84 
86.0965 85.0892 85.0892 C5H11N 
 
No 0.3 22.36 
100.0758 n/a n/a solvent n/a No n/a 8.86 
100.1122 99.1048 99.1049 C6H13N 
 
Appendix 
Figure 5.4 
1.3 9.37 
105.0700 104.0626 104.0627 C8H8 
 
Appendix 
Figure 5.5 
1.2 11.01 
114.0915 n/a n/a solvent n/a n/a n/a 11.00 
115.0867 114.0793 114.0794 C5H10ON2 
 
Appendix 
Figure 5.13 
1.1 44.49 
116.0708 115.0633 115.0635 C5H9O2N 
 
Appendix 
5.14 
1.9 14.47 
120.0810 119.0735 119.0737 C8H9N 
 
Appendix 
5.18 
1.9 7.31 
121.0650 120.0575 120.0577 C8H10O 
 
Appendix 
5.20 
1.9 6.09 
157 
 
122.0966 121.0891 121.0893 C8H11N 
 
Appendix 
5.21 
1.8 6.66 
129.1024 128.0950 128.0951 C6H12ON2 
 
Appendix 
5.26 
1.0 100 
130.0865 129.0790 129.0792 C6H11O2N 
 
Appendix 
5.27 
1.7 6.14 
130.1058 Unassigned 129.0985 Unassigned Unassigned n/a n/a 6.43 
132.1021 131.0946 131.0948 C6H13O2N 
 
Appendix 
5.29 
1.7 8.18 
147.1131 146.1055 146.1058 C6H14O2N2 
 
Appendix 
5.39 
2.2 8.45 
156.0770 155.0695 155.0697 C6H9O2N2 
 
Appendix 
5.44 
1.4 5.38 
158 
 
158.0927 157.0851 157.0854 C6H11O2N3 
 
Appendix 
5.48 
2.1 10.77 
159.0919 158.0844 158.0846 C10H11N2 Unassigned n/a 8.4 9.69 
166.0865 165.0790 165.0792 C9H11O2N 
 
Appendix 
5.51 
1.4 16.98 
186.1240 185.1164 185.1167 C8H15O2N3 Unassigned n/a 1.8 7.04 
 
 
Table 5. 2 - Ions Observed Following SCW Hydrolysis of BSA at 253 °C for 20 min. 
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Furthermore, the ion observed at m/z 121.0650 has a mass difference corresponding 
to CO2 and NH2 loss from tyrosine. The assignment and structure were confirmed using 
HCD MS/MS (Appendix Figure 5.20). The further loss of the hydroxyl group from this 
structure was observed at m/z 105.0700 (HCD MS/MS analysis in Appendix Figure 
5.21). Moreover, decarboxylation of phenylalanine was observed at m/z 120.0810 
(HCD MS/MS analysis in Appendix Figure 5.18). 
Free amino acids were also observed under these conditions, although fewer and at 
lower relative abundances compared to those at 207 oC. This observation suggests that 
amino acids are initially liberated under lower temperature points and then further 
modified as temperatures increase. Peaks corresponding to proline (m/z 116.0708), 
leucine and isoleucine (m/z 132.1021), lysine (m/z 147.1131), histidine (m/z 156.0770) 
and phenylalanine (m/z 166.0865) were observed.  
Peaks that were speculated to correspond to tetrahydropyridine and piperidine were 
again observed at m/z 84.0808 and m/z 86.0965. As with the previous temperature 
point, further modifications on tetrahydropyridine and piperidine molecules are 
apparent (m/z 100.1131 and m/z 122.0966). Structures for these ions are proposed in 
Appendix Figures 5.4 and 5.21. Work in Chapter 4 suggested the propensity of sub-
critical water to catalyse organic reactions. Moreover, sub-critical water has also been 
shown to catalyse alkylation reactions specifically. Aria et al. demonstrated the 
alkylation of phenol with propionaldehyde in the absence of a catalyst under sub-
critical water conditions[239]. Additionally, Eckart et al. showed increased alkylation of 
phenol and p-cresol with tert-butanol shown at a temperature of 250 - 300 oC. [240] 
MS analysis was also performed on hydrolysates obtained from BSA hydrolysed at 300 
oC for 20 minutes (Figure 5.10c and Table 5.3). Peaks not observed under 207oC or 
253oC for 20 minutes are highlighted in Table 5.3. The main reaction products that 
were detected under these conditions were additions of hydrocarbon chains to cyclic 
structures formed in the more moderate conditions.  
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m/z 
Calculated 
mass (Da) 
Measured 
mass (Da) 
Formula Proposed Structure HCD MS/MS PPM 
Relative 
abundance 
86.0600 85.0528 85.0527 C4H7NO 
 
No -0.4 5.77 
86.0963 85.0892 85.0890 C5H11N 
 
No -2.1 96.88 
88.1120 87.1048 87.1047 C5H13N 
 
No -0.9 10.77 
95.0603 94.0531 94.0530 C5H6N2 
 
No -0.8 6.70 
100.0757 99.0684 99.0684 C5H9ON 
 
No 0.2 22.27 
100.1120 99.1048 99.1047 C6H13N 
 
Appendix 
Figure 5.4 
-0.8 98.56 
105.0698 106.0783 106.0782 C8H10 
 
Appendix 
Figure 5.5 
-1.2 6.42 
111.0917 110.0844 110.0844 C6H10N2 
 
Appendix 
Figure 5.9 
0.2 5.58 
114.0914 n/a n/a solvent n/a n/a n/a 41.40 
114.1277 113.1204 113.1204 C7H15N 
 
Appendix 
Figure 5.12 
0.2 100.00 
161 
 
115.0866 114.0793 114.0793 C5H10ON2 
 
Appendix 
Figure 5.13 
0.2 15.84 
116.1070 115.0997 115.0997 C6H13ON 
 
Appendix 
Figure 5.15 
0.2 14.47 
121.0648 120.0575 120.0575 C8H9O 
 
 
Appendix 
Figure 5.20 
0.2 22.89 
122.0965 121.0891 121.0892 C8H12N 
 
Appendix 
Figure 5.21 
1.0 22.11 
125.1074 124.1000 
 
124.1001 
C7H12N2 
 
Appendix 
Figure 5.24 
1.0 5.41 
128.1434 127.1361 127.1361 C8H17N 
 
Appendix 
Figure 5.25 
0.2 10.23 
129.1023 128.0950 128.0950 C6H12ON2 
 
Appendix 
Figure 5.26 
0.2 23.79 
130.0503 129.0426 129.0430 C5H7O3N 
 
Appendix 
Figure 5.27 
3.3 31.56 
138.0913 137.0841 137.0840 C8H11ON 
 
Appendix 
Figure 5.33 
-0.6 9.27 
162 
 
138.1027 137.0953 137.0954 C7H11N3 
 
Appendix 
Figure 5.34 
0.9 7.16 
139.1231 138.1157 138.1158 C8H14N2 
 
Appendix 
Figure 5.35 
0.9 6.06 
142.1591 
 
141.1518 141.1518 C9H19N 
 
Appendix 
Figure 5.36 
 0.2 16.10 
144.1020 143.0946 143.0947 C7H13NO2 
 
No 0.9 6.29 
156.1748 155.1674 155.1675 C10H21N 
 
Appendix 
Figure 5.45 
0.8 10.33 
157.1336 156.1263 156.1263  C8H16N2O  
 
Appendix 
Figure 5.47 
 0.2 7.24 
158.1176 157.1103 157.1103  C8H15NO2 
 
Appendix 
Figure 5.49 
0.2  7.65 
159.0917 158.0844 158.0844 C10H10N2 
 
Appendix 
Figure 5.50 
0.2 16.7 
163 
 
166.1228 165.1154 165.1155 C10H16ON 
 
Appendix 
Figure 5.52 
0.8 6.1 
173.1074 172.1001 172.1001 C11H13N2 
 
Appendix 
Figure 5.54 
0.1 9.4 
185.1286  184.1212 184.1213 C9H17O2N2 Unassigned No 0.7 8.4 
Table 5. 3 - Ions Observed Following SCW Hydrolysis of BSA at 300 °C for 20 min. 
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The base peak in the spectrum was observed at m/z 114.1277, corresponding to singly 
protonated C7H15N. This ion could represent piperidine with the addition of a C2H4 
group. Fragment ions consistent with this structure were identified following HCD 
MS/MS (Appendix Figure 5.12). Moreover, the peak hypothesised to correspond to 
piperidine was observed at m/z 86.0963. Additional peaks with mass differences 
corresponding to piperidine plus : CH2 at m/z 100.1120 (HCD MS/MS analysis in 
Appendix Figure 5.3), C3H at m/z 122.0965 (HCD MS/MS analysis in Appendix Figure 
5.21b), C3H6 at m/z 128.1434 (HCD MS/MS analysis in Appendix Figure 5.25), C5H10 at 
m/z 156.1748 (HCD MS/MS analysis in Appendix Figure 5.45), CH2O at m/z 116.1070 
(HCD MS/MS analysis in Appendix Figure 5.15),C3H4O2  (HCD MS/MS analysis in 
Appendix Figure 5.49), C5H5O at m/z 166.1228 (HCD MS/MS analysis in Appendix 
Figure 5.52) were also noted.   
 
The results also suggest that an imidazole ring can be observed with various additions. 
These included C2H2 at m/z 95.0603 (proposed structure is listed in Table 5.3 despite 
no HCD MS/MS data being collected for this ion), C3H6 at m/z 111.0917 (HCD MS/MS 
analysis in Appendix Figure 5.9), C4H8 at m/z 125.1074 (HCD MS/MS analysis in 
Appendix Figure 5.24), C4N2 at m/z 138.1027 (HCD MS/MS analysis in Appendix Figure 
5.34) and C5H10 at m/z 139.1231 (HCD MS/MS analysis in Appendix Figure 5.35). 
Additions to benzene were also identified: additions of C2H4 at m/z 105.0698 (HCD 
MS/MS analysis in Appendix Figure 5.5), C4H4N2 at m/z 159.0917 (HCD MS/MS analysis 
in Appendix Figure 5.50). 
Interestingly,an ion is observed at m/z 157.1336. HCD MS/MS analysis confirmed the 
structure to involve the conjugation of piperidine to azetidine (Appendix Figure 5.47). 
Azetidine has previously been shown to be a deamination product of asparagine 
(Scheme 5.1d) [238]. Parsons et al. have performed similar coupling reactions on 
arenes with various alkenes at temperatures of 260 oC - 400oC. However, these 
reactions were performed with a Pd catalyst and its removal was shown to be 
detrimental to the yield [241].  
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Unlike the analyses of BSA hydrolysates obtained from hydrolysis at 207 and 253 oC for 
20 minutes, a peak corresponding to pipecolic acid was not observed. Possible 
methylation and ethylation products of this species were observed at m/z 144.1020 
and 158.1176). HCD MS/MS analysis was only performed on the ion at m/z 158.1176 
due to difficulties in isolation, however fragment ions consistent with this assignment 
were observed (Appendix Figure 5.49). Furthermore, the ion at m/z 129.1023 
corresponds to amidation of pipecolic acid (Appendix Figure 5.26). 
A peak corresponding to pyroglutamate was observed during these conditions at m/z 
130.0503. The neutral loss of carbon dioxide was observed at m/z 86.0600 to form 
pyrollidone. The additions of CH2 at m/z 100.0757 (no HCD MS/MS data collected due 
to difficulties in isolation) and C5H10 at m/z 142.1591 (HCD MS/MS analysis in Appendix 
Figure 5.45) were observed.  
Additional ions identified under these conditions included peaks at m/z 138.091, which 
was attributed to Tyr-CO2, m/z 121.0698 which was attributed to Tyr-CO2- NH3, m/z 
88.1120, which was attributed to Ile/Leu-CO2. The structure of the ions at m/z 138.09 
and 121.0698 was solved using HCD MS/MS analysis (Appendix Figure 5.33 and 5.20). 
No fragment ions were observed when this peak was isolated and subjected to HCD 
due to the limited sensitivity of the instrument at this mass range. 
Furthermore, when BSA was hydrolysed at 253 oC for 20 mins an increase in amidated 
species (compared to hydrolysis conditions 207 oC for 20 minutes) was noted. The 
amidated form of proline (prolinamide) being observed at higher abundance than 
proline itself. Under hydrolysis conditions of 300 oC for 20 minutes, prolinamide was 
observed at m/z 115.0866, whilst no ion corresponding to proline was detected. This 
suggests amidation continues to become a more favourable reaction as temperature 
increases. 
A further ion was observed at m/z 173.1074 which was unique to these conditions. The 
structure was determined using HCD MS/MS analysis (Appendix Figure 5.54).  
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The results above are consistent with the prior findings from the SCW hydrolysis of 
peptides in Chapter 4. Commonly occurring amino acid modifications following 
treatment with SCW are dehydration, deamination and amidation. Furthermore 
decarboxylation was identified as a major modification which is consistent with 
previous studies on the SCW of amino acids.  
  
5.5.2 NTG hydrolysate analysis 
Figure 5.11a shows the direct infusion electrospray mass spectrum of the NTG 
hydrolysed at 207 oC for 20 minutes (see also Table 5.4). As with the hydrolysis of BSA, 
amino acids were liberated from the protein under these conditions. Peaks 
hypothesised to corresponding to the alanine at m/z 90.0550, proline at m/z 116.0708 
(Appendix Figure 5.14) , valine at m/z 118.0865 (Appendix Figure 5.16), lysine and 
isoleucine at m/z 132.1022 (Appendix Figure 5.29), aspartic acid at m/z 134.0451 
(Appendix Figure 5.32), histidine at m/z 156.0771 (Appendix Figure 5.44), 
phenylalanine at m/z 166.867 (Appendix Figure 5.51) and arginine at m/z 175.1194 
(Appendix Figure 5.55)  were observed. HCD analysis of the ion observed at m/z 90.05 
failed to provide confirmation of alanine, due to the limited sensitivity of the Orbitrap 
mass analyser under these conditions. A solution of pure alanine was analysed using 
the same electrospray and HCD conditions and no fragment ions could be detected.  
The base peak in the spectrum was observed at m/z 130.0501. This peak was observed 
in the SCW hydrolysis of BSA and attributed to pyroglutamate. Ions observed at m/z 
84.0445 and 86.0601 correspond to decomposition products of pyroglutamate, as well 
as a peak corresponding to piperidine at m/z 86.0965.  
Two hydrolysis products that are observed specifically in NTG are ions at m/z 96.0445 
and m/z 102.1279. These species are hypothesised aspyridinol and hexylamine, 
although these structures are inconsistent with the reactions already identified and 
the HCD data acquired were not of good quality.
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Figure 5. 11 - Direct infusion ESI MS of BSA hydrolysed at a) 207oC for 20 min, b) 253 oC for 20 min and c) 300 oC for 20 min. 
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m/z 
Calculated 
mass (Da) 
Measured 
mass (Da) 
Formula Proposed Structure 
HCD 
MS/MS 
PPM 
Relative 
abundance 
84.0445 83.0371 83.0372 C4H5ON 
 
No 1.5 6.11 
86.0601 85.0528 85.0528 C4H7ON 
 
No 0.3 8.58 
86.0965 85.0892 85.0892 C5H12N 
 
No 0.3 11.71 
90.0550 89.0477 89.0477 C3H8O2N 
 
No 0.3 6.46 
96.0445 95.0371 95.0372 C5H5ON 
 
No 1.3 8.81 
97.0761 96.0688 96.0689 C5H8N2 
 
Appendix 
Figure 5.2 
0.8 5.49 
102.1279 101.1205 101.1206 C6H15N 
 
No 1.2 41.02 
106.0500 n/a n/a Solvent n/a n/a n/a 5.55 
114.0916 n/a n/a Solvent n/a n/a n/a 17.4 
115.0868 114.0793 114.0795 C5H10ON2 
 
Appendix 
Figure 5.12 
2.0 15.04 
170 
 
116.0708 115.0633 115.0635 C5H9O2N 
 
Appendix 
Figure 5.13 
1.9 100 
118.0865 117.0790 117.0792 C5H11O2N 
 
Appendix 
Figure 5.15 
1.9 24.28 
130.0501 129.0426 129.0428 C5H7O3N 
 
Appendix 
Figure 5.26 
1.7 89.63 
130.0978 129.0902 129.0905 C5H12ON3 Unassinged n/a 2.5 10.49 
132.1022 131.0946 131.0949 C6H13O2N 
 
Appendix 
Figure 5.28 
2.5 49.88 
134.0451 133.0375 133.0378 C4H7O4N 
 
Appendix 
Figure 5.31 
2.4 8.57 
156.0771 155.0695 155.0698 C6H9O2N3 
 
Appendix 
Figure 5.43 
2.1 6.88 
166.0867 165.0790 165.0794 C9H11O2N 
 
 
Appendix 
Figure 5.50 
2.6 8.36 
171 
 
175.1194 174.1117 174.1121 C6H14O2N4 
 
Appendix 
Figure 5.54 
2.4 7.54 
 
Table 5. 4  - Ions Observed Following SCW Hydrolysis of NTG at 207 °C for 20 min. 
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In addition ions were observed at m/z 84.0445, 86.0601. 86.0965 and 97.0761. These 
were attributed to neutral losses from the structures previously established under 
these conditions.  
Hydrolysates obtained from SCW treatment of NTG at 253 oC for 20 minutes were next 
analysed (Figure 5.11b and Table 5.5). Peaks not observed at 207 oC for 20 minutes are 
highlighted in Table 5.5. Fewer peaks corresponding to amino acids could be detected 
at this increased temperature. Ions were observed m/z 116.0708, 118.0865, 132.1022, 
166.0867, corresponding to proline, valine, leucine and/or isoleucine and 
phenylalanine. 
Ions were also observed that were previously identified in hydrolysates as pyroll-2-one 
(m/z 86.0601), ethylimidazole (m/z 97.0762), piperidine (m/z 86.0965), pipecoline (m/z 
100.1122), prolinamide (m/z 115.0868), pyroglutumate (m/z 130.0502) and pipecolic 
acid (m/z 130.0865). Additional ions, not previously detected, were observed at m/z 
110.0602 and 116.1072. The structures of the two ions were determined using HCD 
MS/MS (Appendix Figure 5.7 and 5.15). 
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m/z 
Calculated 
mass (Da) 
Measured 
mass (Da) 
Formula Proposed Structure HCD MS/MS PPM 
Relative 
abundance 
86.0601 85.0528 85.0528 C4H7ON 
 
No 0.3 5.21 
86.0965 85.0892 85.0892 C5H11N 
 
No 0.3 30.17 
97.0762 96.0688 96.0689 C5H8N2 
 
Appendix 
Figure 5.2 
1.8 5.49 
100.1122 99.1048 99.1049 C6H13N 
 
Appendix 
Figure 5.3 
1.3 12.28 
102.1279 101.1205 101.1206 C6H15N 
 
No 1.2 9.87 
104.1071 103.0997 103.0998 C5H13ON Unassigned No 1.2 13.44 
110.0602 109.0528 109.0529 C6H7ON 
 
Appendix 
Figure 5.7 
1.1 9.57 
114.0916 n/a n/a Solvent n/a n/a n/a 6.54 
115.0868 114.0793 114.0795 C5H10ON2 
 
Appendix 
Figure 5.13 
2.0 10.45 
116.0708 115.0633 115.0635 C5H9O2N 
 
Appendix 
Figure 5.14 
1.9 100.00 
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116.1072 115.0997 115.0999 C6H13ON 
 
Appendix 
Figure 5.15 
1.9 10.17 
117.0742 n/a n/a Solvent n/a n/a n/a 6.76 
118.0865 117.0790 117.0792 C5H11O2N 
 
Appendix 
Figure 5.16 
1.9 11.05 
130.0502 129.0426 129.0429 C5H7O3N 
 
Appendix 
Figure 5.27 
2.5 56.13 
130.0865 129.0790 129.0792 C6H11O2N 
 
Appendix 
Figure 5.28 
1.7 6.25 
132.1022 131.0946 131.0949 C6H13O2N 
 
Appendix 
Figure 5.29 
2.5 22.22 
166.0867 165.0790 165.0794 C9H11O2N 
 
Appendix 
Figure 5.51 
2.6 7.85 
 
Table 5. 5 - Ions Observed Following SCW Hydrolysis of NTG at 253 °C for 20 min. 
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Figure 5.11c shows the direct infusion electrospray mass spectrum of NTG hydrolysed 
at 300 oC for 20 minutes (see also Table 5.6). Peaks not observed under 207oC or 253 
oC for 20 minutes are highlighted in Table 5.6. Only one unmodified amino acid was 
observed under these conditions, and that was proline (m/z 116.0706). The base peak 
in the mass spectrum was at m/z 130.0498, which was again attributed to 
pyroglutamate. 
Furthermore, the deamination of lysine to pipecolic acid (m/z 130.0862) and its 
subsequent amidation to piperidine-4-carboxamide (m/z 129.1023) were again noted. 
Species corresponding to the amidation of proline (m/z 115.0865) as well as a 
decarboxylation of phenylalanine (m/z 120.0805) were also noted. As with the BSA 
hydrolysates, an increased amount of addition reactions occurred under these 
conditions. The conjugation of piperidine to CH2 (m/z 100.1120) (HCD MS/MS analysis 
in Appendix Figure 5.3), CH3O (m/z 116.1069) (HCD MS/MS analysis in Appendix 
Figure 5.15) and C3 (m/z 122.0964) (HCD MS/MS analysis in Appendix Figure 5.21) 
were apparent. The conjugation of piperidine to a bezene ring (m/z 176.1433) was also 
identified (HCD MS/MS analysis in Appendix Figure 5.56). The benzene ring, which is 
formed from the decomposition of phenylalanine or tyrosine, was itself speculated to 
have additions of C2H4, C2H4O, C2H5N, and C6H12ON (m/z 105.0698, 121.0648, 122.0964 
and 192.1383) (HCD MS/MS analysis in Appendix Figure 5.5, 5.20, 5.21, 5.59). 
Additions of C2H2 to an imidazole ring and C5H10 to pyrollidine were also speculated 
(m/z 95.0603 and m/z 142.1590). No HCD MS/MS data were collected for the ion at 
95.0603, although the structure of the ion at m/z 142.1590 was speculated in 
Appendix Figure 5.36. 
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m/z 
Calculated 
mass (Da) 
Measured 
mass (Da) 
Formula Proposed Structure HCD MS/MS PPM 
Relative 
abundance 
84.0443 83.0371 83.0370 C4H5ON 
 
No -0.9 6.10 
86.0963 85.0892 85.0890 C5H11N 
 
No -2.1 30.70 
95.0603 94.0531 94.0530 C5H6N2 
 
No -0.8 5.76 
100.1120 99.1048 99.1047 C6H13N 
 
Appendix 
Figure 5.3 
-0.8 26.85 
105.0698 106.0783 106.0782 C8H10 
 Appendix 
Figure 5.5 
-1.2 27.37 
115.0865 114.0793 114.0792 C5H10ON2 
 
Appendix 
Figure 5.13 
-0.7 19.97 
116.0706 115.0633 115.0633 C5H9O2N 
 
Appendix 
Figure 5.14 
0.2 18.17 
116.1069 115.0997 115.0996 C6H14ON 
 
Appendix 
Figure 5.15 
-0.7 12.14 
177 
 
121.0648 122.0732 122.0732 C8H10O 
 
Appendix 
Figure 5.20 
14.70 121.0648 
122.0964 121.0892 121.0891 C8H11N 
 
Appendix 
Figure 5.21 
-0.6 19.96 
129.1023 128.0950 128.0950 C6H12ON2 
 
Appendix 
Figure 5.26 
0.2 5.29 
130.0498 129.0426 129.0425 C5H7O3N 
 
Appendix 
Figure 5.27 
-0.6 100.00 
130.0862 129.0790 129.0789 C6H11O2N 
 
Appendix 
Figure 5.28 
-0.6 8.81 
138.0914 137.0841 137.0841 C8H11ON 
 
Appendix 
Figure 5.33 
0.5 5.97 
142.1590 141.1518 141.1517 C9H19N 
 
Appendix 
Figure 5.36 
-0.5 8.20 
178 
 
152.0318 n/a 151.0245 n/a Unassigned n/a n/a 11.81 
176.1433 175.1361 175.1360 C12H17N 
 
Appendix 
Figure 5.56 
-0.4 9.99 
 
Table 5. 6- Ions Observed Following SCW Hydrolysis of NTG at 300 °C for 20 min. 
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5.5.3 BSG hydrolysate analysis 
Figure 5.12a shows the direct infusion electrospray mass spectrum of the BSG 
hydrolysed at 207oC for 20 minutes. A list of predicted structures for all ions is shown 
in Table 5.7. Under hydrolysis conditions of 207oC for 20 minutes, amino acids were 
efficiently generated under these conditions and ions corresponding to proline (m/z 
116.0700), valine (m/z 118.0856), leucine and/or isoleucine (m/z 132.1013), glutamine 
(m/z 147.0757), lysine (m/z 147.1121), glutamate (m/z 148.0597), histidine (m/z 
156.0760), phenylalanine (m/z 166.0854), arginine (m/z 175.1181) and tyrosine (m/z 
182.0803) were observed. Additional ions at m/z 86.0959, 97.0755, 120.0802 and 
130.0492 were observed. These were detected in previous hydrolysates and structures 
were determined using HCD MS/MS.   
Figure 5.12b shows the direct infusion electrospray mass spectrum of the BSG 
hydrolysed at 253oC for 20 minutes (see also Table 5.8).Peaks not observed under 
207oC are highlighted in Table 5.8. Under these conditions the base peak in the mass 
spectrum remains m/z 116.0700, which was attributed to proline. Under these 
conditions, an increased amount of proline amidation is observed (m/z 115.0860). The 
amino acids valine (m/z 118.0856), leucine and/or isoleucine (m/z 132.1012) and 
phenylalanine (m/z 166.0854) were also detected. Pyroglutamate was also observed at 
an increased abundance (m/z 130.0492). Piperidine (m/z 86.0659) and its methylated 
product (m/z 100.1115) were also observed. 
Figure 5.12b shows the direct infusion electrospray mass spectrum of the BSG 
hydrolysed at 300oC for 20 minutes (see also Table 5.9). Peaks not observed under 207 
oC or 253 oC are highlighted in Table 5.9. Very few ions representing unmodified amino 
acids were observed under these conditions. This was consistent with BSA and NTG 
hydrolysates from the same hydrolysis conditions. Only ions corresponding to proline 
(m/z 116.0700) and leucine and/or isoleucine (m/z 132.1013) were observed. 
Piperidine was observed in high abundance (m/z 86.0959), with speculated additions 
of CH2 (m/z 100.1115), C2H2 (m/z 112.1115), C2H4 (m/z 114.1271), CH2O (m/z 86.0959) 
and C2H2O2 (m/z 144.1012) as well as a species at m/z 110.0595.  
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Similar additions were speculated on the imidazole ring of histidine of CH2 (m/z 
97.0755), C3H6 (m/z 111.0911), C4H6 (m/z 123.0911), C4H8 (m/z 125.1067), C5H10 (m/z 
139.1223) and C6H12 (m/z 153.1378). The addition of C3H to piperidine and the 
decarboxylation of phenylalanine were again observed as hydrolysis of BSA under 
these conditions (both m/z 122.0962). Prolinamide and pyroglutamate were again 
detected at m/z 115.0860 and m/z 130.0492.  
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Figure 5. 12- Direct infusion ESI MS of BSG hydrolysed at a) 207 oC for 20 min, b) 253 oC for 20 min and c) 300 oC for 20 min. 
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Figure 5. 12 (continued) - Direct infusion ESI MS of BSG hydrolysed at a) 207 oC for 20 min, b) 253 oC for 20 min and c) 300 oC for 
20 min. 
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m/z 
Calculated 
mass (Da) 
Measured 
mass (Da) 
Formula Proposed Structure HCD MS/MS PPM 
Relative 
abundance 
84.9592 n/a n/a Solvent n/a No n/a 12.79 
86.0959 85.0892 85.0886 C5H11N 
 
No -6.8 12.69 
97.0755 96.0688 96.0682 C5H8N2 
 Appendix 
Figure 5.2 -5.5 
6.84 
102.9697 n/a n/a Solvent n/a No n/a 8.79 
104.1064 103.0997 103.0991 CH13ON Unassigned No -5.7 18.62 
114.0907 n/a n/a Solvent n/a No n/a 12.87 
116.0700 115.0633 115.0627 C5H9O2N 
 Appendix 
Figure 5.14 
-5.0 100 
118.0856 117.0790 117.0783 C5H11O2N 
 
Appendix 
Figure 5.16 
-5.8 20.18 
120.0802 119.0735 119.0729 C8H9N 
 Appendix 
Figure 5.18 
-4.8 11.75 
130.0492 129.0426 129.0419 C5H7O3N 
 
Appendix 
Figure 5.27 
-5.2 24.76 
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132.1013 131.0946 131.0940 C6H13O2N 
 
Appendix 
Figure 5.29 
-4.4 68.32 
147.0757 146.0691 146.0684 C5H10O3N2 
 
Appendix 
Figure 5.38 
-4.8 28.24 
147.1121 146.1055 146.1048 C6H14O2N2 
 
Appendix 
Figure 5.39 
-4.6 6.78 
148.0597 147.0532 147.0524 C5H9O4N 
 
Appendix 
Figure 5.40 
-5.3 52.91 
156.0760 155.0695 155.0687 C6H9O2N3 
 
Appendix 
Figure 5.44 
-5.0 10.27 
185 
 
166.0854 165.0790 165.0781 C9H11O2N 
 
Appendix 
Figure 5.51 
-5.3 47.07 
175.1181 174.1118 174.1108 C6H14O4N2 
 
Appendix 
Figure 5.55 
-5.6 28.23 
182.0803 181.0739 181.0730 C9H11O3N 
 
Appendix 
Figure 5.58 
-4.8 12.96 
 
Table 5. 7 - Ions Observed Following SCW Hydrolysis of BSG at 207 °C for 20 min. 
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m/z 
Calculated 
mass (Da) 
Measured 
mass (Da) 
Formula Structure HCD MS/MS PPM 
Relative 
abundance 
86.0959 85.0892 85.0886 C5H11N 
 
No -6.8 28.34 
100.1115 99.1048 99.1042 C6H13N 
 
Appendix 
Figure 5.3 
-5.8 13.45 
115.0860 114.0793 114.0787 C5H10ON2 
 
Appendix 
Figure 5.13 
-5.0 10.65 
116.0700 115.0633 115.0627 C5H9O2N 
 Appendix 
Figure 5.14 
-5.0 100 
118.0856 117.0790 117.0783 C5H11O2N 
 
Appendix 
Figure 5.16 
-5.8 10.11 
130.0492 129.0426 129.0419 C5H7O3N 
 
Appendix 
Figure 5.27 
-5.2 49.95 
187 
 
132.1012 131.0946 131.0939 C6H13O2N 
 
Appendix 
Figure 5.29 
-5.2 24.41 
166.0854 165.0790 165.0781 C9H11O2N 
 
Appendix 
Figure 5.50 
-5.3 6.51 
 
Table 5. 8 - Ions Observed Following SCW Hydrolysis of BSG at 253 °C for 20 min. 
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 6.10 
Calculated 
mass (Da) 
Measured 
mass (Da) 
Formula Proposed Structure HCD MS/MS PPM 
Relative 
abundance 
86.0959 85.0892 85.0886 C5H11N 
 
No -6.8 91.94 
97.0755 96.0688 96.0682 C5H8N2 
 
Appendix 
Figure 5.2 
-5.5 38.51 
100.0751 n/a n/a solvent n/a n/a n/a 17.35 
100.1115 99.1048 99.1042 C6H13N 
 
Appendix 
Figure 5.3 
-5.8 58.1 
105.0693 104.0626 104.0620 C8H8 
 Appendix 
Figure 5.5 
-5.5 11.49 
110.0595 109.0528 109.0522 C6H7ON 
 Appendix 
Figure 5.7 
-5.3 12.04 
111.0911 110.0844 110.0838 C6H10N2  
Appendix 
Figure 5.9 
-5.2 63.15 
112.1115 111.1048 111.1042 C7H13N 
 
Appendix 
Figure 5.11 
-5.2 10.8 
114.0908 n/a n/a Solvent n/a n/a n/a 6.47 
114.1271 113.1204 113.1198 C7H15N 
 Appendix 
Figure 5.12 
-5.1 13.61 
189 
 
115.086 114.0793 114.0787 C5H10ON2 
 Appendix 
Figure 5.13 
-5.0 7.98 
116.0700 115.0633 115.0627 C5H9O2N 
 Appendix 
Figure 5.14 
-5.0 15.38 
116.1064 115.0997 115.0991 C6H13ON 
 Appendix 
Figure 5.15 
-5.0 16.21 
122.0958 121.0891 121.0885 C8H12N 
 
Appendix 
Figure 5.21 
-4.8 14.18 
123.0911 122.0844 122.0838 C7H10N2 
 
Appendix 
Figure 5.22 
-4.7 11.28 
125.1067 124.1000 124.0994 C7H12N2 
 
Appendix 
Figure 5.24 
-4.6 43.89 
130.0492 129.0426 129.0419 C5H7O3N 
 
Appendix 
Figure 5.27 
-5.2 100 
139.1223 138.1157 138.1150 C8H14N2 
 
Appendix 
Figure 5.35 
-4.9 45.91 
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144.1012 143.0946 143.0939 C7H13NO2 
 
No -4.7 5.56 
152.0311 n/a 151.0245 n/a Unassigned n/a n/a 7.43 
153.1378 152.1314 152.1305 C9H16N2 
 
Appendix 
Figure 5.42 
-5.8 15.52 
 
Table 5. 9 - Ions Observed Following SCW Hydrolysis of BSG at 300 °C for 20 min. 
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5.5.4 Amino acid hydrolysate analysis 
To further probe the pathway of protein degradation in SCW, an equimolar mixture of 
all 20 natural amino acids was hydrolysed. The direct infusion electrospray mass 
spectrum of this mixture prior to SCW treatment is shown in Appendix Figure 5.67 
(see also Appendix Table 5.8). Peaks were observed corresponding to 19 of the 20 
amino acids and the structures were confirmed using HCD MS/MS. Ions corresponding 
the amino acids were observed: alanine at 90.0550 (HCD MS/MS analysis did not result 
in the observation of fragment ions)  serine at m/z 106.0500 (HCD MS/MS analysis in 
Appendix Figure 5.5), proline at m/z 116.0708 (HCD MS/MS analysis in Appendix 
Figure 5.14), valine at m/z 118.0864 (HCD MS/MS analysis in Appendix Figure 5.16), 
threonine at m/z 120.0657 (HCD MS/MS analysis in Appendix Figure 5.17), leucine and 
isoleucine at m/z 132.1021 (HCD MS/MS analysis in Appendix Figure 5.29), asparagine 
at m/z 133.0605 (HCD MS/MS analysis in Appendix Figure 5.30), aspartic acid at m/z 
134.0445 (HCD MS/MS analysis in Appendix Figure 5.32), glutamine at m/z 147.0767 
(HCD MS/MS analysis in Appendix Figure 5.38), lysine at m/z 147.1131 (HCD MS/MS 
analysis in Appendix Figure 5.39) glutamate at m/z 148.0607 (HCD MS/MS analysis in 
Appendix Figure 5.40), methionine at m/z 150.0586 (HCD MS/MS analysis in Appendix 
Figure 5.41), histidine at m/z 156.0770 (HCD MS/MS analysis in Appendix Figure 5.43), 
phenylalanine at m/z 166.0866 (HCD MS/MS analysis in Appendix Figure 5.51) and 
arginine at m/z 175.1193 HCD MS/MS analysis in (Appendix Figure 5.55), tyrosine at 
m/z 182.0816 (HCD MS/MS analysis in Appendix Figure 5.58) and tryptophan tyrosine 
at m/z 205.0967 (HCD MS/MS analysis in Appendix Figure 5.60).Glycine could not be 
detected in the mass spectrum due to the limited sensitivity of the orbitrap in this 
mass range. A solution of pure glycine was analysed by direct infusion ESI and could 
not be detected in the orbitrap.  
A peak hypothesised to correspond to piperidine, at m/z 86.0962, was observed. It is 
unclear whether these ions are a result of incorrect amino acid synthesis or the 
ionisation procedure. 
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Figure 5.13 shows the direct infusion electrospray mass spectrum of the 20 amino acid 
mixture hydrolysed at 207 oC for 20 minutes (see Table 5.10). Under these conditions 
the majority of observed ions were assigned as unmodified amino acids. Here, the 
mass spectra obtained are not dissimilar to that observed when not treated with SCW. 
Ions were observed at m/z 90.0547 (alanine) m/z 106.0496 (serine), m/z 116.0704 
(proline), m/z 118.0860 (valine), m/z 120.0653 (threonine), m/z 132.1017 (leucine 
and/or isoleucine), m/z 134.0446 (aspartic acid), m/z 147.1127 (lysine), m/z 150.0581 
(methionine), m/z 156.0765 (histidine), m/z 166.0859 (phenylalanine) and m/z 
175.1186 (arginine). 
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Figure 5. 13 - Direct infusion ESI MS of 20 aa mixture at a) 207 oC for 20 min, b) 253 oC for 20 min and c) 300 oC for 20 min. 
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m/z 
Calculated 
mass (Da) 
Measured 
mass (Da) 
Formula Proposed Structure HCD MS/MS PPM 
Relative 
abundance 
72.0806 71.0735 71.0733 C4H9N 
 
No -2.5 6.70 
84.9595 n/a n/a Solvent n/a No n/a 5.20 
86.0962 85.0892 85.0889 C5H11N 
 
No -2.7 22.66 
90.0547 89.0477 89.0474 C3H7NO2 
 
No -3.1 6.63 
102.9700 n/a n/a Solvent n/a No n/a 5.41 
106.0496 105.0426 105.0423 C3H7NO3 
 
Appendix 
Figure 5.6 
-2.6 29.40 
114.0912 n/a n/a Solvent n/a n/a n/a 17.00 
115.0864 114.0793 114.0791 C5H10ON2 
 
Appendix 
Figure 5.13 
-1.5 7.51 
116.0704 115.0633 115.0631 C5H9O2N 
 
Appendix 
Figure 5.14 
-1.5 67.38 
196 
 
118.0860 117.0790 117.0787 C5H11O2N 
 
Appendix 
Figure 5.16 
-2.4 37.86 
120.0653 119.0582 119.0580 C4H9O3N 
 
Appendix 
Figure 5.17 
-1.5 24.63 
120.0805 119.0735 119.0732 C8H9N 
 Appendix 
Figure 5.18 
-2.3 7.31 
129.1021 128.0950 128.0948 C6H12ON2 
 
Appendix 
Figure 5.26 
-1.4 5.64 
130.0497 129.0426 129.0424 C5H7O3N 
 
Appendix 
Figure 5.27 
-1.4 12.95 
130.0861 129.0790 129.0788 C6H11O2N 
 
Appendix 
Figure 5.28 
-1.4 10.12 
132.1017 131.0946 131.0944 C6H14ON2 
 
Appendix 
Figure 5.29 
-1.3 100.00 
197 
 
133.1050 n/a n/a Solvent 
 
Appendix 
Figure 5.31 
n/a 6.00 
134.0446 133.0375 133.0373 C7H7O4N 
 
Appendix 
Figure 5.32 
-1.3 9.54 
147.1126 146.1055 146.1053 C6H14O2N2 
 
Appendix 
Figure 5.39 
-1.2 47.52 
150.0581 149.0511 149.0508 C5H11O2NS 
 
Appendix 
Figure 5.41 
-1.9 18.09 
156.0765 155.0695 155.0692 C6H9O2N3 
 
Appendix 
Figure 5.44 
-1.9 38.79 
158.0921 157.0851 157.0848 C6H11O2N3 
 
Appendix 
Figure 5.48 
-1.8 5.27 
198 
 
166.0859 165.0790 165.0786 C9H11O2N 
 
Appendix 
Figure 5.51 
-2.3 33.31 
175.1186 174.1118 174.1113 C6H14O4N2 
 
Appendix 
Figure 5.55 
-2.7 37.99 
 
Table 5. 10 - Ions Observed Following SCW Hydrolysis of AA at 207 °C for 20 min. 
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Ions were also observed at m/z 115.0864, 129.1021 and 158.0921. The ion at m/z 
115.0864 has previously been assigned as  prolinamide (HCD MS/MS analysis in 
Appendix Figure 5.13) and the ion at m/z 129.1021 to be piperidine-4-carboxamide 
(HCD MS/MS analysis in Appendix Figure 5.26). These were attributed to be a result of 
proline and pipecolic acid amidation. Furthermore, the species observed at m/z 
158.0921, was previously speculated to be the result of arginine deamination. The HCD 
MS/MS spectrum of this ion is shown in Appendix Figure 5.48.  
MS analysis was next performed on the hydrolysates of the equimolar amino acid 
mixture from 253 oC for 20 minutes SCW treatment (Figure 5.13b and Table 5.11). 
Peaks not observed under 207 oC for 20 minutes are highlighted in Table 5.11. As with 
hydrolysis on protein mixtures, fewer unmodified amino acids could be observed 
under these harsher conditions. Only ions corresponding to alanine (m/z 90.0548), 
proline (m/z 116.0705), valine (m/z 118.0861), leucine and isoleucine (m/z 132.1018), 
lysine (m/z 147.1127) and phenylalanine (m/z 166.0861) were noted. It has previously 
been shown that decomposition products under SCW conditions of serine and cysteine 
include alanine. Serine or cysteine were not observed at this temperature. 
Furthermore valine has previously been shown to be a decomposition product of 
lysine [185]. 
At this temperature point, arginine is no longer detected however its deamination 
product, 1-carbamimidoylproline (m/z 158.0923) is observed. Furthermore a marked 
increase in the relative abundance of ions speculated to correspond to pyroglutamate 
were noted (at m/z 130.0498) as well as the subsequent decarboxylation to 
pyrrolidone (m/z 86.0599). Under these conditions an increased amount of amidation 
on pipecolic acid to piperidine-4-carboxamide (m/z 129.1022) as well as its 
deamination product piperidine (m/z 86.0963) was noted.  
Species corresponding  to valeric acid (m/z 101.0596) (HCD MS/MS analysis in 
Appendix Figure 5.4), as well a benzene based structure at m/z 146.0600 (HCD MS/MS 
analysis in Appendix Figure 5.37), were observed although the mechanism 
offormation process remains elusive. 
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m/z 
Calculated 
mass (Da) 
Measured 
mass (Da) 
Formula Proposed Structure HCD MS/MS PPM 
Relative 
abundance 
72.0806 71.0735 71.0733 C4H9N 
 
No -2.5 7.88 
84.9596 n/a n/a Solvent n/a n/a n/a 13.13 
86.0599 85.0528 85.0526 C4H7ON 
 
No -2.1 8.32 
86.0963 85.0892 85.0890 C5H11N 
 
No -1.5 29.27 
90.0548 89.0477 89.0475 C4H7NO2 
 
No -1.8 20.49 
100.0756 99.0684 99.0683 C5H9NO 
 
 
 
 
 
No -0.9 10.09 
101.0596 102.0681 102.0680 C5H10O2 
 
 
Appendix 
Figure 5.4 
-1.0 11.00 
102.9701 n/a n/a Solvent n/a n/a n/a 12.99 
114.0913 n/a n/a solvent n/a n/a n/a 21.57 
201 
 
115.0865 114.0793 114.0792 C5H10ON2 
 
Appendix 
Figure 5.13 
-0.7 51.04 
116.0705 115.0633 115.0632 C5H9O2N 
 
 
 
 
Appendix 
Figure 5.13 
-0.7 100.00 
118.0861 115.0633 115.0632 C5H9O2N 
 
 
Appendix 
Figure 5.16 
-1.5 42.71 
120.0807 119.0735 119.0734 C8H9N 
 
 
 
 
Appendix 
Figure 5.18 
-0.6 5.31 
129.1022 128.0950 128.0949 C6H12N2O 
 
Appendix 
Figure 5.26 
-0.6 43.44 
130.0498 129.0426 129.0425 C5H7O3N 
 
Appendix 
Figure 5.27 
-0.6 58.12 
202 
 
130.0862 129.0790 129.0789 C6H11O2N 
 
Appendix 
Figure 5.28 
-0.6 11.04 
132.0767 131.0695 131.0694 C4H9O2N3 
 
Unassigned 
 
No -0.6 8.80 
132.1018 131.0946 131.0945 C6H14ON2 
 
Appendix 
Figure 5.29 
-0.6 74.65 
146.0600 145.0528 145.0527 C9H7ON 
 
 
Appendix 
Figure 5.37 
-0.5 7.39 
147.1127 146.1055 146.1054 C6H14O2N2 
 
 
Appendix 
Figure 5.39 
-0.5 5.30 
203 
 
158.0923 157.0851 157.0850 C6H11O2N3 
 
Appendix 
Figure 5.48 
-0.5 10.88 
166.0861 165.0790 165.0788 C9H11O2N 
 
 
Appendix 
Figure 5.51 
-1.1 9.98 
 
Table 5. 11 - Ions Observed Following SCW Hydrolysis of AA at 253 °C for 20 min. 
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Figure 5.13c shows the direct infusion electrospray mass spectrum of the 20 amino 
acid mixture hydrolysed at 300 oC for 20 minutes (see also Table 5.12). Peaks not 
observe under 207 oC or 253 oC are highlighted in Table 5.12. In contrast to the 
degradation of BSA, unmodified amino acids were still observed at this temperature 
point. Unmodified alanine (m/z 90.0547), proline (m/z 116.0703), valine (m/z 
118.0860), leucine and isoleucine (m/z 132.1016), lysine (m/z 147.1125), proline (m/z 
116.0703), methionine (m/z 150.0581), histidine (m/z 156.0765) and phenylalanine 
(m/z 166.0859) were observed. The two most abundant peaks in the mass spectrum 
correspond to prolinamide (m/z 115.0765) and piperidine-4-carboxamide (m/z 
129.1020) form through amidation. The ratio of prolinamide:proline increases with 
temperature. This pattern is consistent in all of the results, reflecting a correlation 
between temperature and amidation levels. 
Various modifications on histidine including decarboxylation (m/z 112.0867) (HCD 
MS/MS analysis in Appendix Figure 5.10) as well as the addition of C2H2O and C3H4O 
the imidoazole ring (m/z 111.0551 and 125.0707) (HCD MS/MS analysis in Appendix 
Figure 5.8 and 5.23) were observed. The addition of C3H to piperidine and the 
decarboxylation of phenylalanine were again observed as hydrolysis of BSA under 
these conditions (both m/z 122.0962). Deamination of arginine was also observed (m/z 
158.0921). 
The results above confirm that in the SCW temperature range of 207 oC - 253 oC, the 
most commonly occurring reactions are amidation, deamination, dehydration, and 
decarboxylation of amino acid side chains. Interestingly as the temperature is raised to 
300 oC further addition reactions on amino acid side chains were identified.  
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m/z 
Calculated 
mass (Da) 
Measured 
mass (Da) 
Formula Proposed Structure HCD MS/MS PPM 
Relative 
abundance 
70.0649 69.0579 69.0576 C4H7N 
 
No -4.0 5.1200 
72.0805 71.0735 71.0732 C4H9N 
 
No -3.9 6.4100 
86.0962 85.0892 85.0889 C5H11N 
 
No -3.24 31.7300 
90.0547 89.0477 89.0474 C5H11N 
 
No -3.1 13.8300 
111.0551 110.0480 110.0478 C5H6ON2 
 
Appendix 
Figure 5.8 
-1.6 16.0100 
112.0867 111.0797 111.0794 C5H6ON3 
 
Appendix 
Figure 5.10 
-2.5 8.5600 
114.0912 n/a n/a Solvent n/a n/a n/a 9.7900 
115.0863 114.0793 114.0790 C5H10ON2 
 
Appendix 
Figure 5.13 
-2.4 100.0000 
116.0703 115.0633 115.0630 C5H9O2N 
 
Appendix 
Figure 5.14 
-2.4 53.1000 
206 
 
118.0860 117.0790 117.0787 C5H11O2N 
 
Appendix 
Figure 5.16 
-2.4 35.0100 
120.0805 119.0735 119.0732 C8H9N 
 Appendix 
Figure 5.18 
-2.3 5.9500 
122.0962 121.0892 121.0889 C8H11N 
 
Appendix 
Figure 5.21 
-2.3 5.3500 
125.0707 124.0637 124.0634 C6H8N2O 
 
Appendix 
Figure 5.23 
-2.2 8.9900 
129.1020 128.0950 128.0947 C6H12N2O 
 
Appendix 
Figure 5.26 
-2.2 68.2600 
130.0497 129.0426 129.0424 C5H7O3N 
 
Appendix 
Figure 5.27 
-1.4 12.3800 
130.0860 129.0790 129.0787 C6H11O2N 
 
Appendix 
Figure 5.28 
-2.1 16.9600 
207 
 
132.1016 131.0946 131.0943 C6H14ON2 
 
Appendix 
Figure 5.29 
-2.1 87.1700 
147.1125 146.1055 146.1052 C6H14O2N2 
 
Appendix 
Figure 5.39 
-1.9 11.1700 
150.0581 149.0511 149.0508 C5H11O2NS 
 
Appendix 
Figure 5.41 
-1.9 10.5900 
156.0765 155.0695 155.0692 C6H9O2N3 
 
Appendix 
Figure 5.44 
-1.8 25.0700 
158.0921 157.0851 157.0848 C6H11O2N3 
 
Appendix 
Figure 5.48 
-1.8 19.6000 
208 
 
166.0859 165.0790 165.0786 C9H11O2N 
 
Appendix 
Figure 5.52 
-2.3 23.2600 
 
Table 5. 12 - Ions Observed Following SCW Hydrolysis of AA at 300 °C for 20 min. 
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5.6 Conclusion 
The work described in this chapter shows the transformation of protein into mixtures 
with antioxidant properties using SCW as a reagent. A strong correlation between 
reaction temperature and the antioxidant capacity of the resulting hydrolysates was 
observed in ORAC, comet and reducing power assays.  
To better understand the bioactive behaviour of the decomposition products of 
proteins in sub critical conditions, the compounds formed were analysed. Although 
decomposition pathways of proteins have been previously studied, there is a lack of 
structural data on the compounds that are formed from the SCW hydrolysis of 
proteins.  Here, compounds obtained following the SCW hydrolysis of NTG, BSG and 
BSA was identified. The products of SCW hydrolysis were analysed by mass 
spectrometry. Structural characterisation of the resulting compounds was obtained by 
higher energy collision dissociation (HCD). The influence of SCW on proteins was 
shown to be release of amino acids followed by amidation, decarboxylation and 
deamination. The results also support previous work which states the transformation 
of more complex amino acids into simpler ones (Ala, Val and Pro). To further probe the 
pathway of thermal decomposition SCW treatment was applied to an equimolar 
mixture of all 20 natural amino acids and the chemical reactions were consistent with 
those obtained for the protein.  
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Chapter 6: Sub-critical water applications in proteomics 
6.1 Overview  
The work presented in Chapters 3 and 4 suggested that SCW may find a role as a 
proteolytic reagent within in the context of a standard bottom-up proteomics 
workflow. For individual proteins, the sequence coverages obtained following SCW 
hydrolysis were comparable to those obtained when using trypsin. In this Chapter, the 
results observed following SCW hydrolysis of a more complex protein mixture are 
presented. Whilst the eventual aim of this technology would be to provide efficient 
proteolysis of an extremely complex sample, e.g., a cell lysate, here the focus is on a 
mixture of six proteins.  
The Pierce 6 protein digest is a protein digest mixture used as a quality control 
standard for LC MS/MS of proteomic samples. It contains the tryptic digest of the 
following proteins: BSA, bovine cytochrome C, chicken lysozyme, E-coli β-
galactosidase, bovine apo-transferrin and S.cerevisiae alcohol dehydrogenase. The 
sequence coverage for each of the proteins offered by Pierce 6 protein mixture is 
typically high (reported as >70% on average) [242].  
In the work presented in this Chapter the same six proteins were tryptically digested in 
house and the sequence coverages observed were compared to those of a 
corresponding SCW hydrolysate of the same mixture. During the work completed in 
this Chapter it became apparent that optimisation of MS, HPLC and database search 
parameters would be required for SCW hydrolysates to offer sequence coverages 
comparable to those of the tryptic digests. These included comparing the data 
collected from different mass spectrometers (the Orbitrap Elite and the Q Exactive HF), 
gradient and column lengths as well as dynamic modifications included in search 
parameters. 
   
  
211 
 
6.2 Preparation of six protein mixture  
Lyophilized samples of Bovine Serum Albumin (BSA) (Uniprot accession P02769), 
Bovine Cytochrome C (Uniprot accession P62894), Chicken Lysozyme (Uniprot 
accession P00698), E-coli β-galactosidase (Uniprot accession P00722), Bovine Apo-
transferrin (Uniprot accession Q29443) and S.cerevisiae Alcohol Dehydrogenase 
(Uniprot accession P00330) were acquired individually. Three 15 ml solution containing 
0.01mg/ml of each protein was hydrolysed at 160 oC for 20 minutes - conditions shown 
to obtain high sequence coverage in Chapter 3. Hydrolysates were desalted and 
analysed via LC - CID MS/MS using parameters described in Section 2.7. Peptides were 
identified using Proteome discoverer using methods described in Section 2.8. 
Parameters included dynamic modifications of N/Q and single oxidation of C/M. Data 
were searched using “nonspecific enzyme”. 
 
6.3 LC MS/MS analysis using Orbitrap Elite 
Figure 6.1 shows the sequence coverage that was acquired for each protein in the six 
protein mixture following SCW hydrolysis. The values are calculated from the 
Proteome Discoverer searches, with errors representing the standard deviation across 
three replicates.  The data obtained shows that SCW hydrolysis of a mixture of proteins 
provides less sequence coverage per protein compared to when proteins were 
hydrolysed individually under the same conditions (97.4 ± 3.9% for α-globin and 96.2 ± 
0.8% for β-globin, 69.0 ± 12.5% for BSA and 100.0 ± 0.0 % for β-casein from the data 
analysed in Chapter 3). The raw peptides identified are listed in Appendix Table 6.1. 
The sequence coverage obtained for each proteins were as follows: 9.3 ± 2.7 % for 
BSA, 11.1 ± 0.5 % for cytochrome C, 32.7 ± 1.2 % for lysozyme, 3.7 ± 1.0 % for β-
galactosidase, 21.1 ± 1.6 % for apo-transferrin and 45.4 ± 3.8 % for alcohol 
dehydrogenase. For comparison, the six protein mixture was tryptically digested and 
analysed using LC MS/MS (see Figure 6.1). The data obtained demonstrates that 
tryptic digestion of this mixture results in greater sequence coverage than SCW 
hydrolysis. This was proven for each protein. BSA presented sequence coverage of 51.6 
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± 4.9, cytochrome C, coverage of 72.4 ± 9.1 %, lysozyme, coverage of 68.7 ± 3.0 %, β-
galactosidase, coverage of 52.0 ± 5.9 %, apo-transferrin, coverage of 62.3 ± 3.8 % and 
alcohol dehydrogenase, coverage of 59.9 ± 4.3 %. The raw peptides identified are 
listed in Appendix Table 6.2. 
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Figure 6. 1 - Mean sequence coverage obtained for trypsin digests and SCW hydrolysis 
at 160 °C for 20 min for six protein mixture. n = 3. Error bars represent one standard 
deviation.  
 
 
 
 
SCW Hydrolysate, 1 hr gradient, 150 mm column, Orbitrap Elite 
Tryptic digest, 1 hr gradient, 150 mm column, Orbitrap Elite 
SCW hydrolysate, 1 hr gradient, 150 mm column, Q-Exactive 
Tryptic digest, 1 hr gradient, 150 mm column, Q-Exactive 
213 
 
6.4 Optimisation of HPLC parameters 
Figure 6.2 shows example screenshots of fragmentation spectra that were observed 
for tryptic digests and Figure 6.3 shows example screenshots of fragmentation spectra 
that were observed for SCW hydrolysates in the Orbitrap Elite. The quality of the 
MS/MS data collected for the tryptic digests was far superior to that observed for the 
corresponding SCW hydrolysates.  
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Figure 6. 2 - Representative CID MS/MS spectrum from six protein mixture tryptic digest. 
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Figure 6. 3 - Representative CID MS/MS spectrum from six protein mixture hydrolysate. 
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I hypothesise that the reduced sequence coverage observed for the proteins was due 
to the vast numbers of peptides that are generated during SCW hydrolysis. Whilst 
trypsin is a fully specific enzyme and is only liable to cleave at R and K residues, SCW 
(as shown in Chapter 3) displays only partial specificity towards D and E residues. This 
results in the production of an increased number of peptides, and therefore an 
amplified number being eluted during the same time period during HPLC separation. 
The co-elution of peptides results in poor MS/MS data observed, for the SCW 
hydrolysates, and therefore fewer peptide matches.  
 
6.4.1 LC MS/MS analysis using Q-Exactive 
To increase peptide identifications the analysis was repeated using the Q-Exactive 
mass spectrometer, using HCD as a fragmentation method. The Q-Exactive makes use 
of a quadrupole mass filter coupled to a orbitrap, rather than an ion trap coupled to a 
orbitrap used the LTQ Orbitrap Elite. The Q-Exactive has been compared favourably to 
the LTQ Orbitrap Elite in both peptide and protein identifications from complex 
mixtures [243]. The quadrupole mass filter achieves peptide separation nearly 
instantaneously. In contrast, the linear ion trap applies external RF-DC fields that allow 
only a certain ion population to stably remain in the trap. The scan rate for the Q-
exactive is therefore much higher. Moreover, the fragmentation data collected using 
HCD in the Q-Exactive is of higher resolution than the CID data collected in the LTQ 
Orbitrap Elite. In the Q-Exactive the fragment ions are analysed using the Orbitrap, 
rather than the lower resolution ion-trap which was used to monitor the CID fragment 
ions in the LTQ Orbitrap Elite. Higher resolution results in a lower mass error of 
product ions, leading to smaller number of peptides matched to the reversed database 
and therefore a lower score threshold. 
A large increase in sequence coverage for BSA (34.8 ± 4.7 %), cytochrome C (56.2 ± 5.8 
%), lysozyme (65.3 ± 4.4 %) and alcohol dehydrogenase (82.8 ± 6.6 %) was observed 
when re-analysing the SCW hydrolysates analysing using HCD MS/MS via the Q-
Exactive (Figure 6.1). No improvement in sequence coverage was observed for β-
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galactosidase (5.6 ± 2.6 %). Figure 6.4 shows an example of the MS/MS data obtained 
from the Q-E analysis of the six protein mixture hydrolysate. This is of much better 
quality than that observed in the Orbitrap Elite (Figure 6.3). Note the increased mass 
range to facilitate lower mass fragment ions also. The raw peptides identified are listed 
in Appendix Table 6.3. 
Q-Exactive analysis of the tryptic digests also increased in comparison to data collected 
in the Orbitrap Elite (see Figure 6.1). However, the increased coverage for the SCW 
hydrolysates was much more marked. Sequence coverages observed were 62.8 ± 5.0% 
for BSA, 75.6 ± 10.2% for cytochrome C, 77.9 ± 4.1% for lysozyme, 64.2 ± 6.2% for β-
galactosidase, 73.4 ± 3% for apo-transferrin and 61.1 ± 4.2% for alcohol 
dehydrogenase. The raw peptides identified are listed in Appendix Table 6.4. 
To investigate the low sequence coverage observed for β-galactosidase, the protein 
was hydrolysed individually under the same hydrolysis conditions and analysed using 
the Q-Exactive. The coverage garnered was 42.8 ± 3.7, ~tenfold higher than that 
observed when hydrolysing within the mixture. Furthermore the coverage observed 
for BSA was 69.0 ± 12.5% when hydrolysed individually in (see Chapter 3), significantly 
higher than that observed from the six protein mixture analysis (although it should be 
noted that starting material concentrations were higher in the earlier experiments). 
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Figure 6. 4 - Representative CID MS/MS spectrum from Six Protein Mixture SCW hydrolysate using the Q Exactive. 
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6.4.2 Optimisation of search parameters  
The data observed thus far in Chapter 6 was searched using the same dynamic 
modifications that were used in Chapter 3, i.e. deamidation of asparagine/ glutamine 
residues and oxidation on cysteine/methionine residues. However, from data observed 
in Chapters 4 and 5 the results suggests that modifications induced by SCW are 
primarily single oxidation of methionine or tryptophan, double or triple oxidation of 
cysteine, C-terminal amidation, water loss and deamination. Table 6.1 shows the 
sequence coverages that were obtained by sequentially searching the data acquired 
using Q-Exactive HF these modifications. A column listing the coverages observed 
when no dynamic modifications were included is shown as a comparison.
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Dynamic modification 
No 
Mods 
Deam 
Oxidation 
(1,2) 
Oxidation 
(1) 
Oxidation 
(2,3) 
Oxidation 
(1,2,3) 
Amidation - H2O - NH3 All Oxidation 
Residues affected 
 N/Q/C/M M/W C C/M/W C-terminal D N 
C/M/D/E/C
-term 
M/W + 
AspC 
Aldehyde 
Dehydrogenase 
78.4 ± 2.6 82.8 ± 2.6 85.9 ± 2.7 83.4 ± 1.8 80.8 ± 3.9 78.7 ± 4.4 80.5 ± 4.2 78.9 ± 3.0 55.8 ± 4.1 36.1 ± 2.1 
Lysozyme 57.1 ± 4.4 65.3 ± 4.4 68.0 ± 3.3 67.8 ± 4.0 66.7 ± 4.8 63.4 ± 4.0 71.4 ± 4.7 62.8 ± 3.3 69.8 ± 4.2 71.4 ± 7.3 
Apo Transferrin 28.8.± 2.5 30.8.± 2.3 33.7.± 4.7 33.5.± 2.9 32.5 ± 4.9 34.5 ± 5.4 25.0 ± 2.6 24.3 ± 4.5 20.5 ± 5.1 25.0 ± 4.8 
BSA 29.8.± 2.3 34.8.± 4.7 35.3.± 3.6 33.3.± 3.1 33.1 ± 5.9 41.0 ± 5.9 19.7 ± 5.1 26.4 ± 6.2 17.5 ± 4.3 19.7 ± 6.5 
Cytochrome C 43.9.± 6.7 56.2.± 5.8 57.3 ± 5.0 55.1 ± 4.9 52.2 ± 4.6 60.0 ± 5.3 55.2 ± 6.6 52.9 ± 3.5 39.1 ± 4.0 55.2 ± 5.2 
β-galactosidase 4.9 ± 2.4 5.6 ± 2.6 4.6 ± 1.9 4.1± 1.4 4.7 ± 1.7 2.8 ± 1.5 2.8 ± 1.5 1.9 ± 1.0 2.8 ± 1.3 2.8 ± 1.3 
 
Table 6. 1 - Percentage sequence coverage obtained for six protein mixture using different search parameters. 
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Interestingly, the overall highest sequence coverages were observed when dynamic 
modifications listed included single oxidation of methionine and tryptophan only. The 
raw peptides identified are listed in Appendix Table 6.5. These parameters were 
subsequently used for all further analyses described in this chapter. This data is not 
consistent with the data obtained in Chapter 4 which suggest that double and triple 
oxidation of cysteine are the most common modifications. A reduction in sequence 
coverage was noted when the search parameters included double and triple oxidation 
of cysteine.  
In Chapter 3 and 4, I also observe semi-specific cleavage towards aspartic acid 
residues. When the enzyme specificity was changed from ‘non-specific’ to ‘semi-
specificity at Asp C-terminal’ a reduction in sequence coverage was observed for 5/6 
proteins. Whilst identifying the cleavage mechanism of SCW was not helpful in peptide 
identifications, it will be of further use in the field for understanding the sub-critical 
reactions on proteins and peptides. 
Introducing a variable modification allows the chosen PTM to occur in any instance on 
the selected amino acid residue, in all theoretical peptides within the chosen data. This 
approach offers an effective method at identifying peptides with known PTM sites. 
However, the introduction of PTMs also substantially increases the database size 
required for the search [244].The increased database size leads to an increase in 
spectra being assigned to peptides incorrectly (false positive) [245, 246]. Maintaining 
the FDR at 1% means that peptides now typically require a higher score to be listed as 
‘high confidence’ peptides [247]. There is now an increased chance of spectra not 
being assigned (false negatives). 
The introduction of each modification lists peptides that are unique to that search. 
Furthermore, each search gives consistently higher sequence coverage for all proteins 
compared to when no dynamic modifications were listed in the search parameters. 
This data suggests all of these modifications are induced during SCW hydrolysis. When 
all dynamic modifications were included in the same search a large reduction in 
sequence coverage was observed for all proteins, with the exception of lysozyme. This 
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reduction is likely due to rise of false positives and subsequently false negatives as a 
result of many dynamic modifications in the same search.  
 
6.4.2 LC MS/MS analysis using longer column 
Next, the effect of column length on protein identification was examined (Figure 6.4). 
Here, the column length was increased from 150 mm to 500 mm. Increasing the 
column length will allow greater separation of peptides and improve the resolution of 
the chromatograph. Increasing the column length is an important parameter to 
optimise for SCW hydrolysates where co-elution of peptides using the shorter column 
was predicted. Modest increases in sequence coverages were observed for BSA (44.7 ± 
9.4), cytochrome C (69.8 ± 4.0 %), β-galactosidase (8.9 ± 6.9 %) and apo-transferrin 
(40.2 ± 6.1 %). Comparable data was observed for alcohol dehydrogenase (83.0 ± 6.7 
%) and lysozyme (72.0 ± 5.9 %). The raw peptides identified are listed in Appendix 
Table 6.6. 
 
6.4.3 LC MS/MS analysis using longer gradient 
 
The effect of gradient length on the sequence coverage observed for the SCW 
hydrolysates was also examined. Here, the gradient was increased from 1 hour to 4.5 
hours. Further increases in sequence coverages for BSA (49.1 ± 5.5 %), lysozyme (82.1 
± 5.4 %), β-galactosidase (9.4 ± 3.5 %) and apotransferrin (43.5 ± 7.9 %) were noted. 
Comparable data was observed for aldehyde dehydrogenase (81.1 ± 8.0 %) and a 
decrease was observed for cytochrome C (60.0 ± 16.2 %).  The raw peptides identified 
are listed in Appendix Table 6.7. 
MacCoss et al. investigated the effects of using both a longer column and longer 
gradient lengths on Peptide IDs in proteomic samples [177]. Longer gradients were 
effective at increasing peptide IDs. The use of longer columns also showed increased 
peptide IDs, but only when longer gradients were also used. This is in contrast to our 
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data which suggest using a longer column is effective in improving peptide IDs in its 
own right.  
Whilst these latter two parameters show limited improvement in the sequence 
coverage observed for all 6 proteins, they are likely to be of more use when more 
complex samples are used. 
 
 
Figure 6. 5 - Mean sequence coverage obtained for SCW hydrolysis at 160 °C for 20 
min for six protein mixture using Q-exactive. n = 3. Error bars represent one standard 
deviation.  
 
 
 
 
 
SCW hydrolysate, 1 hr gradient, 150 mm column 
SCW hydrolysate, 1 hr gradient, 500 mm column 
SCW hydrolysate, 4.5 hr gradient, 500 mm column 
B
SA
C y
to
ch
ro
m
e  
C
L y
so
zy
m
e

-g
a l
a c
to
s i
d
a s
e
A
p
o
-t
ra
n
s f
e r
r i
n
A
lc
o
h
o
l d
e h
y d
ro
g e
n
a s
e
0
2 0
4 0
6 0
8 0
1 0 0
S
e
q
u
e
n
c
e
 c
o
v
e
ra
g
e
  
(%
)
224 
 
6.5 Conclusion 
 
The work presented in this chapter builds on data obtained in Chapters 3 and 4. Here, I 
continue the development of SCW as an alternative proteolysis reagent. I have 
optimised the parameters required to reliably identify the components of a mixture of 
BSA, cytochrome C, lysozyme, β-galactosidase, apo-transferrin and alcohol 
dehydrogenase.  
Using SCW as a reagent on this mixture did not garner the same sequence coverages 
that were observed when performing SCW hydrolysis on mixtures of single proteins, 
therefore a thorough optimisation of several areas of the proteomics protocol needed 
to be assessed. Firstly, the use of the Q-Exactive mass spectrometer offered increased 
peptide IDs compared to the Orbitrap Elite, which was used for prior analysis. The use 
of the Q-Exaciive was more advantageous for SCW generated peptides than tryptic 
peptides.  Furthermore the search parameters were optimised, and the dynamic 
modifications included in the Proteome Discoverer search were altered. The use of a 
longer LC column and gradient showed modest increases in protein identification. 
Changing these parameters allowed the identification of 5 of the 6 proteins to 
excellent certainty (sequence coverage 40-80%). The data observed for β-galactosidase 
was consistently of poor quality (sequence coverage <10 %), although unique peptides 
to this protein were observed in each of the replicates. 
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Chapter 7: Conclusion and Future Work 
SCW hydrolysis is an emerging technology in antioxidant extraction from industrial 
waste, in particular waste which is rich in protein. The brewing industry generates 
huge volumes of residues and by products. The most common is brewers spent grain 
(BSG) which is extremely rich in protein. In the work presented in this thesis I aim to 
demonstrate antioxidant extraction from BSG using SCW.  
To address the aim, the behaviour of protein during SCW hydrolysis was investigated 
(Chapter 3). The results obtained within this chapter led to the possibility of using SCW 
as an alternative proteolytic reagent for proteomics experiments. Investigating the 
modifications that SCW induces on amino acid side chains to assist in peptide 
identification was completed in Chapter 4. The work presented in Chapter 5 focused 
on assessing the antioxidant activity of the small molecule products of SCW hydrolysis.  
Chapter 6 further explored the potential of utilising SCW within a proteomic workflow. 
HPLC MS/MS conditions, including column and gradient length, as well as search 
parameters were optimised.   
7.1 Sub-critical water hydrolysis of proteins: specificity and post 
translational modifications 
In order to better understand the mechanisms of SCW hydrolysis, three model 
proteins (haemoglobin, BSA, β-casein) were hydrolysed using SCW at a wide range of 
temperatures (160 ⁰C - 300 ⁰C) at different time points (0 min and 20 min). The 
resulting hydrolysates were analysed using LC MS/MS as a method of peptide 
identification. The peptide products generated resulted in high protein sequence 
coverages, indeed the sequence coverages obtained were comparable to those 
obtained with trypsin, the choice method for proteomic studies. In addition SCW was 
effective at maintaining PTMs under certain conditions and displayed partial specificity 
towards negatively charged residues. 
The percentage of PSMs for the samples treated with trypsin was consistently greater 
than for those treated with SCW. This observation suggests that in addition to 
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hydrolysis of the peptide bond, SCW treatment results in other chemical reactions, 
potentially including modification of amino acid side chains. This was explored further 
in Chapter 4. 
 
7.2 Sub-critical water hydrolysis of peptides: amino acid modifications 
and conjugation  
In Chapter 4 the effect of SCW on amino acid side chains was determined using a 
model peptide approach. The synthetic peptide VQSIKCADFLHYMENPTWGR, which 
contains all 20 commonly-occurring amino acid residues, was synthesized and treated 
with SCW at one of four temperature points (140, 160, 180, 200 °C) for 10 min. SCW 
hydrolysis of peptides resulted in efficient oxidation of the hydrolysates. SCW 
treatment under mild conditions (140 °C for 10 min) resulted in oxidation of cysteine 
and methionine residues. Oxidation of cysteine to sulfinic and sulfonic acid was also 
observed. SCW treatment of a peptide that did not contain cysteine or methionine 
resulted in oxidation of tryptophan. Under harsher SCW conditions (160 °C - 180 °C), 
dehydration, amidation and deamination of the peptides was detected. Water loss 
occurs at aspartic acid. In addition, the C-terminal of aspartic acid is consistently shown 
to be a site of preferential cleavage for SCW.  
Additionally, when the peptide was incubated with a nucleophile, SCW was shown to 
promote SN2 reactions. Using SCW to promote nucleophilic interactions could present 
an interesting alternative to traditional catalysts. To investigate this more rigorous 
testing is required. I propose a study involving incubating a variety of nucleophiles with 
the 20 aa synthetic peptide under a wide range of temperature and time points. 
 
 
 
 
227 
 
7.3 Sub-critical antioxidant extraction from protein  
Chapter 5 was aimed at exploring the antioxidant capacity of SCW hydrolysates using 
ORAC, reducing power and comet assays. SCW hydrolysis was performed on a blend of 
barley that had not undergone brewing (Non-treated grain (NTG)), brewers spent grain 
(BSG) and BSA. Antioxidant capacity was identified in all hydrolysates and comparable 
antioxidant activity to commercial antioxidants was obtained under certain hydrolysis 
conditions. The results inferred that it is not in fact the peptides, but small molecule 
products that show antioxidant properties. The structure of these antioxidant 
components was speculated using HCD MS/MS. In the work presented in this thesis 
ions of the same m/z were assumed to have the same chemical structure despite 
originating from different starting reactants and/or hydrolysis conditions. A more 
complete analysis would have involved collecting HCD MS/MS of each selected ion for 
each hydrolysate. 
In future work, the propensity of SCW to produce mixtures with antioxidant properties 
from any protein will be explored.  A general procedure for antioxidant extraction from 
any protein mixture has huge economic potential. I would aim to hydrolyse standard 
proteins at time and temperature points shown to be most efficient at generating 
strong antioxidant power (300 oC and 20 minutes). As well as assessing antioxidant 
activity via the assays already discussed, I would also complete other assays such as 
the FRAP assay which assess other aspects of antioxidant mechanisms. 
Furthermore, a more thorough analysis of the small compounds produced during SCW 
hydrolysis is needed. I propose a study where hydrolysates are fractionated using HPLC 
and the antioxidant activity of each fraction is assessed.  The compounds present in 
each fraction would be assessed using a mass spectrometer with a lower mass range 
than that used in this study to facilitate the assignment of compounds which showed 
no fragmentation data in the results presented in this thesis. This would provide data 
on which of the specific compounds provides the most antioxidant power. 
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7.4 Sub-critical water applications in proteomics 
The idea of pursuing SCW hydrolysis as an alternative proteolytic reagent was further 
explored in Chapter 6 by completing SCW hydrolysis on a mixture of 6 proteins. SCW 
hydrolysis initially failed to provide comparable sequence coverage to tryptic digests 
using the same mass spectrometry and chromatography conditions. An enhancement 
in protein IDs was offered using a Q-Exactive HF mass spectrometer compared to the 
Orbitrap Elite that was used in previous experiments. Further improvements in protein 
sequence coverage were offered by increasing column and gradient length.  
If further time was provided future experiments would be completed to validate some 
of the data I presented in this Chapter. In the work presented in this thesis I do not 
complete HCD analysis using the Orbitrap Elite, and therefore have no direct 
comparison between fragmentation methods on the same instrument. Moreover, I do 
not complete an experiment to directly measure effect of gradient length against 
peptide IDs whilst using the 150 mm column. 
The ultimate aim of the SCW technology would be to supply a faster, cheaper 
alternative to trypsin in a proteomic experiment. These typically involve the analysis of 
a complex mixture of many proteins e.g. from a cell lysate. A future study may involve 
cell lysates being digested using trypsin and equivalent volumes of extracted protein 
also hydrolysed using SCW hydrolysis. The number and type of proteins identified at 
each hydrolysis condition will be compared against the corresponding tryptic digest. 
Peptides would be fractionated by both gel-free and/or gel-based approaches prior to 
analysis. 
Furthermore, I hypothesise using SCW may be able remove the need for the lysis 
cocktail in lysate extraction. I propose an experiment where cells will be directly 
introduced into the SCW reaction vessels. I hypothesise the harsh conditions involved 
in SCW hydrolysis will prove sufficient to lyse the cell walls and subsequently hydrolyse 
the proteins into peptides. This will remove the need for many of the expensive and 
time consuming chemical processes necessary during the preparation of samples prior 
to LC MS/MS and will represent a significant contribution to the proteomics filed. 
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Appendix Figure 3. 1 - Summary of peptides identified following SCW hydrolysis of a) α-globin, b) β- globin, c)BSA and d) β-casein under 
conditions 160 oC for 0 minutes, 160 oC for 20 minutes, 207 oC for 20 minutes, 253 oC for 20 minutes and 300 oC for 20 minutes. 
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Appendix Figure 3.1 a) SCW hydrolysis of α- globin at 160
0
C for 0 minutes. 
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Appendix Figure 3.1 a) SCW hydrolysis of α- globin at 160
0
C for 20 minutes. 
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VLSPADKTNVKAAWGKVGAHAGEYGAEALERMFLSFPTTKTYFPHFDLSHGSAQVKGHGKKVADALTNAVAHVDDMPNALSALSDLHAHKLRVDPVNFKLLSHCLLVTLAAHLPAEFTPAVHASLDKFLASVSTVLTSKYR 
Appendix Figure 3.1 a) SCW hydrolysis of α- globin at 207
0
C for 20 minutes. 
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Appendix Figure 3.1 a) SCW hydrolysis of α- globin at 253
0
C for 20 minutes. 
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VLSPADKTNVKAAWGKVGAHAGEYGAEALERMFLSFPTTKTYFPHFDLSHGSAQVKGHGKKVADALTNAVAHVDDMPNALSALSDLHAHKLRVDPVNFKLLSHCLLVTLAAHLPAEFTPAVHASLDKFLASVSTVLTSKYR 
Appendix Figure 3.1 a) SCW hydrolysis of α- globin at 300
0
C for 20 minutes. 
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G V V V AHHFG V A Y KVVAGVANALAHKYH 
Appendix Figure 3.1 b) SCW hydrolysis of β- globin at 160
0
C for 0 minutes. 
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G V V V AHHFG V A Y KVVAGVANALAHKYH 
Appendix Figure 3.1 b) SCW hydrolysis of β- globin at 160 
0
C for 20 minutes. 
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P K TFATLSELHCDKLHVDPENFRLLGNVLVCVLAHHFGKEFTPPVQAAYQKVVAGVANALAHKYH 
Appendix Figure 3.1 b) SCW hydrolysis of β- globin at 207
0
C for 20 minutes. 
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Appendix Figure 3.1 b) SCW hydrolysis of β- globin at 253
0
C for 20 minutes. 
Q F ESFGDLSTPDAVMGNPK F TLSELHCDKLHVDPENFRLLGNVLVCVLAHHFG V A YQKVVAGVANALAHKYH 
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VHLTPEEKSAVTALWGKVNVDEVGGEALGRLLVVYPWTQRFFESFGDLSTPDAVMGNPKVKAHGKKVLGAFSDGLAHLDNLKGTFATLSELHCDKLHVDPENFRLLGNVLVCVLAHHFGKEFTPPVQAAYQKVVAGVANALAHKYH 
Appendix Figure 3.1 b) SCW hydrolysis of β- globin at 300
0
C for 0 minutes. 
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Appendix Figure 3.1 c) SCW hydrolysis of untreated BSA at 160
0
C for 0 minutes. 
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DTHKSEIAHRFKDLGEEHFKGLVLIAFSQYLQQCPFDEHVKLVNELTEFAKTCVADESHAGCEKSLHTLFGDELCKVASLRETYGDMADCCEKQEPERNECFLSHKDDSPDLPKLKPDPNTLCDEFKADEKKFWGKYLYEIARRHP 
 
YFYAPELLYYANKYNGVFQECCQAEDKGACLLPKIETMREKVLASSARQRLRCASIQKFGERALKAWSVARLSQKFPKAEFVEVTKLVTDLTKVHKECCHGDLLECADDRADLAKYICDNQDTISSKLKECCDKPLLEKSHCIAEV 
 
EKDAIPENLPPLTADFAEDKDVCKNYQEAKDAFLGSFLYEYSRRHPEYAVSVLLRLAKEYEATLEECCAKDDPHACYSTVFDKLKHLVDEPQNLIKQNCDQFEKLGEYGFQNALIVRYTRKVPQVSTPTLVEVSRSLGKVGTRCCT 
 
KPESERMPCTEDYLSLILNRLCVLHEKTPVSEKVTKCCTESLVNRRPCFSALTPDETYVPKAFDEKLFTFHADICTLPDTEKQIKKQTALVELLKHKPKATEEQLKTVMENFVAFVDKCCAADDKEACFAVEGPKLVVSTQTALA 
DTHKSEIAHRFKDLGEEHFKGLVLIAFSQYLQQCPFDEHVKLVNELTEFAKTCVADESHAGCEKSLHTLFGDELCKVASLRETYGDMADCCEKQEPERNECFLSHKDDSPDLPKLKPDPNTLCDEFKADEKKFWGKYLYEIARRHP 
 
YFYAPELLYYANKYNGVFQECCQAEDKGACLLPKIETMREKVLASSARQRLRCASIQKFGERALKAWSVARLSQKFPKAEFVEVTKLVTDLTKVHKECCHGDLLECADDRADLAKYICDNQDTISSKLKECCDKPLLEKSHCIAEV 
 
DAI E L P T A G Y R I I  
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YFYAPELLYYANKYNGVFQECCQAEDKGACLLPKIETMREKVLASSARQRLRCASIQKFGERALKAWSVARLSQKFPKAEFVEVTKLVTDLTKVHKECCHGDLLECADDRADLAKYICDNQDTISSKLKECCDKPLLEKSHCIAEV 
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Appendix Figure 3.1 c) SCW hydrolysis of untreated BSA at 207
0
C for 20 minutes. 
DTHKSEIAHRFKDLGEEHFKGLVLIAFSQYLQQCPFDEHVK VNELTEFAKTCVADESHAGCEKSLHTLFGDELCKVASLRETYGDMADCCEKQEP N C L H D S D P L PDPNTLCDEFKADEKKFWGKYLYEIARRHP 
 
YFYAPELLYYANKYNGVFQECCQAEDKGACLLPKIETMREKVLASSARQRLRCASIQKFGERALKAWSVARLSQKFPKAEFVEVTKLVTDLTKVHKECCHGDLLECADDRADLAKYICDNQDTISSKLKECCDKPLLEKSHCIAEV 
 
EKDAIPENLPPLTADFAEDKDVCKNYQEAKDAFLGSFLYEYSRRHPEYAVSVLLRLAKEYEATLEECCAKDDPHACYSTVFDKLKHLVDEPQNLIKQNCDQFEKLGEYGFQNALIVRYTRKVPQVSTPTLVEVSRSLGKVGTRCCT 
 
KPESERMPCTEDYLSLILNRLCVLHEKTPVSEKVTKCCTESLVNRRPCFSALTPDETYVPKAFDEKLFTFHADICTLPDTEKQIKKQTALVELLKHKPKATEEQLKTVMENFVAFVDKCCAADDKEACFAVEGPKLVVSTQTALA 
DTHKSEIAHRFKDLGEEHFKGLVLIAFSQYLQQCPFDEHVKLVNELTEFAKTCVADESHAGCEKSLHTLFGDELCKVASLRETYGDMADCCEKQEPERNECFLSHKDDSPDLPKLKPDPNTLCDEFKADEKKFWGKYLYEIARRHP 
 
YFYAPELLYYANKYNGVFQECCQAEDKGACLLPKIETMREKVLASSARQRLRCASIQKFGERALKAWSVARLSQKFPKAEFVEVTKLVTDLTKVHKECCHGDLLECADDRADLAKYICDNQDTISSKLKECCDKPLLEKSHCIAEV 
 
EKDAIPENLPPLTADFAEDKDVCKNYQEAKDAFLGSFLYEYSRRHPEYAVSVLLRLAKEYEATLEECCAKDDPHACYSTVFDKLKHLVDEPQNLIKQNCDQFEKLGEYGFQNALIVRYTRKVPQVSTPTLVEVSRSLGKVGTRCCT 
 
KPESERMPCTEDYLSLILNRLCVLHEKTPVSEKVTKCCTESLVNRRPCFSALTPDETYVPKAFDEKLFTFHADICTLPDTEKQIKKQTALVELLKHKPKATEEQLKTVMENFVAFVDKCCAADDKEACFAVEGPKLVVSTQTALA 
DTHKSEIAHRFKDLGEEHFKGLVLIAFSQYLQQCPFDEHVKLVNELTEFAKTCVADESHAGCEKSLHTLFGDELCKVASLRETYGDMADCCEKQEPERNECFLSHKDDSPDLPKLKPDPNTLCDEFKADEKKFWGKYLYEIARRHP 
 
YFYAPELLYYANKYNGVFQECCQAEDKGACLLPKIETMREKVLASSARQRLRCASIQKFGERALKAWSVARLSQKFPKAEFVEVTKLVTDLTKVHKECCHGDLLECADDRADLAKYICDNQDTISSKLKECCDKPLLEKSHCIAEV 
 
A D F G FLYEYSRR K Y A L E CAKDDP K L D PQNLIKQNCDQFEK R T K P VSTPTLVEVSRSLGKVGTRCCT 
 
KPESERMPCTEDYLSLILNRLCVLHEKTPVSEKVTKCCTESLVNRRPCFSALTPDETYVPKAFDEKLFTFHADICTLPDTEKQIKKQTALVELLKHKPKATEEQLKTVMENFVAFVDKCCAADDKEACFAVEGPKLVVSTQTALA 
DTHKSEIAHRFKDLGEEHFKGLVLIAFSQYLQQCPFDEHVKLVNELTEFAKTCVADESHAGCEKSLHTLFGDELCKVASLRETYGDMADCCEKQEPERNECFLSHKDDSPDLPKLKPDPNTLCDEFKADEKKFWGKYLYEIARRHP 
 
YFYAPELLYYANKYNGVFQECCQAEDKGACLLPKIETMREKVLASSARQRLRCASIQKFGERALKAWSVARLSQKFPKAEFVEVTKLVTDLTKVHKECCHGDLLECADDRADLAKYICDNQDTISSKLKECCDKPLLEKSHCIAEV 
 
EKDAIPENLPPLTADFAEDKDVCKNYQEAKDAFLGSFLYEYSRRHPEYAVSVLLRLAKEYEATLEECCAKDDPHACYSTVFDKLKHLVDEPQNLIKQNCDQFEKLGEYGFQNALIVRYTRKVPQVSTPTLVEVSRSLGKVGTRCCT 
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Appendix Figure 3.1 c) SCW hydrolysis of untreated BSA at 253
0
C for 20 minutes. 
D S IAHRFKDLGEEHFKGLVLIAFSQYLQQCPFDEHVKLVNELTEFAKTCVADESHAGCEKSLHTLFGDELCKVASLRETYGDMADC EKQEPERNECFLSHKD SPDLPKLKPDPNTLCDEFKADEK FWGKYLYEIAR HP 
 
YFYAPELLYYANKYNGVFQECCQAEDKGACLLPKIETMREKVLASSARQRLRCASIQKFGERALKAWSVARLSQKFPKAEFVEVTKLVTDLTKVHKECCHGDLLECADDRADLAKYICDNQDTISSKLKECCDKPLLEKSHCIAEV 
 
EKDAIPENLPPLTADFAEDKDVCKNYQEAKDAFLGSFLYEYSRRHPEYAVSVLLRLAKEYEATLEECCAKDDPHACYSTVFDKLKHLVDEPQNLIKQNCDQFEKLGEYGFQNALIVRYTRKVPQVSTPTLVEVSRSLGKVGTRCCT 
 
KPESERMPCTEDYLSLILNRLCVLHEKTPVSEKVTKCCTESLVNRRPCFSALTPDETYVPKAFDEKLFTFHADICTLPDTEKQIKKQTALVELLKHKPKATEEQLKTVMENFVAFVDKCCAADDKEACFAVEGPKLVVSTQTALA 
DTHKSEIAHRFKDLGEEHFKGLVLIAFSQYLQQCPFDEHVKLVNELTEFAKTCVADESHAGCEKSLHTLFGDELCKVASLRETYGDMADCCEKQEPERNECFLSHKDDSPDLPKLKPDPNTLCDEFKADEKKFWGKYLYEIARRHP 
 
A K EFVEVTKLVTDLTKVHKECCHGDLLECADDRADLAKYICDNQDTIS KLKEC DKPL EKSHCIAEV 
 
EKDAIPENLPPLTADFAEDKDVCKNYQEAKDAFLGSFLYEYSRRHPEYAVSVLLRLAKEYEATLEECCAKDDPHACYSTVFDKLKHLVDEPQNLIKQNCDQFEKLGEYGFQNALIVRYTRKVPQVSTPTLVEVSRSLGKVGTRCCT 
 
KPESERMPCTEDYLSLILNRLCVLHEKTPVSEKVTKCCTESLVNRRPCFSALTPDETYVPKAFDEKLFTFHADICTLPDTEKQIKKQTALVELLKHKPKATEEQLKTVMENFVAFVDKCCAADDKEACFAVEGPKLVVSTQTALA 
DTHKSEIAHRFKDLGEEHFKGLVLIAFSQYLQQCPFDEHVKLVNELTEFAKTCVADESHAGCEKSLHTLFGDELCKVASLRETYGDMADCCEKQEPERNECFLSHKDDSPDLPKLKPDPNTLCDEFKADEKKFWGKYLYEIARRHP 
 
YFYAPELLYYANKYNGVFQECCQAEDKGACLLPKIETMREKVLASSARQRLRCASIQKFGERALKAWSVARLSQKFPKAEFVEVTKLVTDLTKVHKECCHGDLLECADDRADLAKYICDNQDTISSKLKECCDKPLLEKSHCIAEV 
 
ATLEECCAKDDPHACYSTVFDKLKHLVDEPQNLIKQNCDQFEKLGEYGFQNALIVRYTRKVPQVSTPTLVEVSRSLGKVGTRC T 
 
KPESERMPCTEDYLSLILNRLCVLHEKTPVSEKVTKCCTESLVNRRPCFSALTPDETYVPKAFDEKLFTFHADICTLPDTEKQIKKQTALVELLKHKPKATEEQLKTVMENFVAFVDKCCAADDKEACFAVEGPKLVVSTQTALA 
DTHKSEIAHRFKDLGEEHFKGLVLIAFSQYLQQCPFDEHVKLVNELTEFAKTCVADESHAGCEKSLHTLFGDELCKVASLRETYGDMADCCEKQEPERNECFLSHKDDSPDLPKLKPDPNTLCDEFKADEKKFWGKYLYEIARRHP 
 
YFYAPELLYYANKYNGVFQECCQAEDKGACLLPKIETMREKVLASSARQRLRCASIQKFGERALKAWSVARLSQKFPKAEFVEVTKLVTDLTKVHKECCHGDLLECADDRADLAKYICDNQDTISSKLKECCDKPLLEKSHCIAEV 
 
EKDAIPENLPPLTADFAEDKDVCKNYQEAKDAFLGSFLYEYSRRHPEYAVSVLLRLAKEYEATLEECCAKDDPHACYSTVFDKLKHLVDEPQNLIKQNCDQFEKLGEYGFQNALIVRYTRKVPQVSTPTLVEVSRSLGKVGTRCCT 
 
KPESERMPCTEDYLSLILNRLCVLHEKTPVSEKVTKCCTESLVNRRPCFSALTPDETYVPKAFDEKLFTFHADICTLPDTEKQIKKQTALVELLKHKPKATEEQLKTVMENFVAFVDKCCAADDKEACFAVEGPKLVVSTQTALA 
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Appendix Figure 3.1 c) SCW hydrolysis of untreated BSA at 300
0
C for 20 minutes. 
DTHKSEIAHRFKDLGEEHFKGLVLIAFSQYLQQCPFDEHVKLVNELTEFAKTCVADESHAGCEKSLHTLFGDELCKVASLRETYGDMADCCEKQEPERNECFLSHKDDSPDLPKLKPDPNTLCDEFKADEKKFWGKYLYEIARRHP 
 
YFYAPELLYYANKYNGVFQECCQAEDKGACLLPKIETMREKVLASSARQRLRCASIQKFGERALKAWSVARLSQKFPKAEFVEVTKLVTDLTKVHKECCHGDLLECADDRADLAKYICDNQDTISSKLKECCDKPLLEKSHCIAEV 
 
EKDAIPENLPPLTADFAEDKDVCKNYQEAKDAFLGSFLYEYSRRHPEYAVSVLLRLAKEYEATLEECCAKDDPHACYSTVFDKLKHLVDEPQNLIKQNCDQFEKLGEYGFQNALIVRYTRKVPQVSTPTLVEVSRSLGKVGTRCCT 
 
KPESERMPCTEDYLSLILNRLCVLHEKTPVSEKVTKCCTESLVNRRPCFSALTPDETYVPKAFDEKLFTFHADICTLPDTEKQIKKQTALVELLKHKPKATEEQLKTVMENFVAFVDKCCAADDKEACFAVEGPKLVVSTQTALA 
DTHKSEIAHRFKDLGEEHFKGLVLIAFSQYLQQCPFDEHVKLVNELTEFAKTCVADESHAGCEKSLHTLFGDELCKVASLRETYGDMADCCEKQEPERNECFLSHKDDSPDLPKLKPDPNTLCDEFKADEKKFWGKYLYEIARRHP 
 
YFYAPELLYYANKYNGVFQECCQAEDKGACLLPKIETMREKVLASSARQRLRCASIQKFGERALKAWSVARLSQKFPKAEFVEVTKLVTDLTKVHKECCHGDLLECADDRADLAKYICDNQDTISSKLKECCDKPLLEKSHCIAEV 
 
EKDAIPENLPPLTADFAEDKDVCKNYQEAKDAFLGSFLYEYSRRHPEYAVSVLLRLAKEYEATLEECCAKDDPHACYSTVFDKLKHLVDEPQNLIKQNCDQFEKLGEYGFQNALIVRYTRKVPQVSTPTLVEVSRSLGKVGTRCCT 
 
KPESERMPCTEDYLSLILNRLCVLHEKTPVSEKVTKCCTESLVNRRPCFSALTPDETYVPKAFDEKLFTFHADICTLPDTEKQIKKQTALVELLKHKPKATEEQLKTVMENFVAFVDKCCAADDKEACFAVEGPKLVVSTQTALA 
DTHKSEIAHRFKDLGEEHFKGLVLIAFSQYLQQCPFDEHVKLVNELTEFAKTCVADESHAGCEKSLHTLFGDELCKVASLRETYGDMADCCEKQEPERNECFLSHKDDSPDLPKLKPDPNTLCDEFKADEKKFWGKYLYEIARRHP 
 
YFYAPELLYYANKYNGVFQECCQAEDKGACLLPKIETMREKVLASSARQRLRCASIQKFGERALKAWSVARLSQKFPKAEFVEVTKLVTDLTKVHKECCHGDLLECADDRADLAKYICDNQDTISSKLKECCDKPLLEKSHCIAEV 
 
EKDAIPENLPPLTADFAEDKDVCKNYQEAKDAFLGSFLYEYSRRHPEYAVSVLLRLAKEYEATLEECCAKDDPHACYSTVFDKLKHLVDEPQNLIKQNCDQFEKLGEYGFQNALIVRYTRKVPQVSTPTLVEVSRSLGKVGTRCCT 
 
KPESERMPCTEDYLSLILNRLCVLHEKTPVSEKVTKCCTESLVNRRPCFSALTPDETYVPKAFDEKLFTFHADICTLPDTEKQIKKQTALVELLKHKPKATEEQLKTVMENFVAFVDKCCAADDKEACFAVEGPKLVVSTQTALA 
DTHKSEIAHRFKDLGEEHFKGLVLIAFSQYLQQCPFDEHVKLVNELTEFAKTCVADESHAGCEKSLHTLFGDELCKVASLRETYGDMADCCEKQEPERNECFLSHKDDSPDLPKLKPDPNTLCDEFKADEKKFWGKYLYEIARRHP 
 
YFYAPELLYYANKYNGVFQECCQAEDKGACLLPKIETMREKVLASSARQRLRCASIQKFGERALKAWSVARLSQKFPKAEFVEVTKLVTDLTKVHKECCHGDLLECADDRADLAKYICDNQDTISSKLKECCDKPLLEKSHCIAEV 
 
EKDAIPENLPPLTADFAEDKDVCKNYQEAKDAFLGSFLYEYSRRHPEYAVSVLLRLAKEYEATLEECCAKDDPHACYSTVFDKLKHLVDEPQNLIKQNCDQFEKLGEYGFQNALIVRYTRKVPQVSTPTLVEVSRSLGKVGTRCCT 
 
KPESERMPCTEDYLSLILNRLCVLHEKTPVSEKVTKCCTESLVNRRPCFSALTPDETYVPKAFDEKLFTFHADICTLPDTEKQIKKQTALVELLKHKPKATEEQLKTVMENFVAFVDKCCAADDKEACFAVEGPKLVVSTQTALA 
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Appendix Figure 3.1 c) BSA reduction pre- SCW hydrolysis at 160
0
C for 0 minutes. 
DTHKSEIAHRFKDLGEEHFKGLVLIAFSQYLQQCPFDEHVKLVNELTEFAKTCVADESHAGCEKSLHTLFGDELCKVASLRETYGDMADCCEKQEPERNECFLSHKD SPDLPKLKPDPNTLCDEFKADEKKFWGKYLYEIARRHP 
 
YFYAPELLYYANKYNGVFQECCQAEDKGACLLPKIETMREKVLASSARQRLRCASIQKFGERALKAWSVARLSQKFPKAEFVEVTKLVTDLTKVHKECCHGDLLECADDRADLAKYICDNQDTISSKLKECCDKPLLEKSHCIAEV 
 
EKDAIPENLPPLTADFAEDKDVCKNYQEAKDAFLGSFLYEYSRRHPEYAVSVLLRLAKEYEATLEECCAKDDPHACYSTVFDKLKHLVDEPQNLIKQNCDQFEKLGEYGFQNALIVRYTRKVPQVSTPTLVEVSRSLGKVGTRCCT 
 
KPESERMPCTEDYLSLILNRLCVLHEKTPVSEKVTKCCTESLVNRRPCFSALTPDETYVPKAFDEKLFTFHADICTLPDTEKQIKKQTALVELLKHKPKATEEQLKTVMENFVAFVDKCCAADDKEACFAVEGPKLVVSTQTALA 
DTHKSEIAHRFKDLGEEHFKGLVLIAFSQYLQQCPFDEHVKLVNELTEFAKTCVADESHAGCEKSLHTLFGDELCKVASLRETYGDMADCCEKQEPERNECFLSHKDDSPDLPKLKPDPNTLCDEFKADEKKFWGKYLYEIARRHP 
 
YFYAPELLYYANKYNGVFQECCQAEDKGACLLPKIETMREKVLASSARQRLRCASIQKFGERALKAWSVARLSQKFPKAEFVEVTKLVTDLTKVHKECCHGDLLECADDRADLAKYICDNQDTISSKLKECCDKPLLEKSHCIAEV 
 
EKDAIPENLPPLTADFAEDKDVCKNYQEAKDAFLGSFLYEYSRRHPEYAVSVLLRLAKEYEATLEECCAKDDPHACYSTVFDKLKHLVDEPQNLIKQNCDQFEKLGEYGFQNALIVRYTRKVPQVSTPTLVEVSRSLGKVGTRCCT 
 
KPESERMPCTEDYLSLILNRLCVLHEKTPVSEKVTKCCTESLVNRRPCFSALTPDETYVPKAFDEKLFTFHADICTLPDTEKQIKKQTALVELLKHKPKATEEQLKTVMENFVAFVDKCCAADDKEACFAVEGPKLVVSTQTALA 
DTHKSEIAHRFKDLGEEHFKGLVLIAFSQYLQQCPFDEHVKLVNELTEFAKTCVADESHAGCEKSLHTLFGDELCKVASLRETYGDMADCCEKQEPERNECFLSHKDDSPDLPKLKPDPNTLCDEFKADEKKFWGKYLYEIARRHP 
 
YFYAPELLYYANKYNGVFQECCQAEDKGACLLPKIETMREKVLASSARQRLRCASIQKFGERALKAWSVARLSQKFPKAEFVEVTKLVTDLTKVHKECCHGDLLECADDRADLAKYICDNQDTISSKLKECCDKPLLEKSHCIAEV 
 
EKDAIPENLP LTADFAEDKDVCKNYQEAKDAFLGSFLYEYSRRHPEYAVSVL RLAKEYEATLE C AKDDPHACYSTVFDKLKHLVDEPQNLIKQNCDQFEKLGEYGFQNALIVRYTRKVPQVSTPTLVEVSRSLGKVGTRCCT 
 
KPESERMPCTEDYLSLILNRLCVLHEKTPVSEKVTKCCTESLVNRRPCFSALTPDETYVPKAFDEKLFTFHADICTLPDTEKQIKKQTALVELLKHKPKATEEQLKTVMENFVAFVDKCCAADDKEACFAVEGPKLVVSTQTALA 
DTHKSEIAHRFKDLGEEHFKGLVLIAFSQYLQQCPFDEHVKLVNELTEFAKTCVADESHAGCEKSLHTLFGDELCKVASLRETYGDMADCCEKQEPERNECFLSHKDDSPDLPKLKPDPNTLCDEFKADEKKFWGKYLYEIARRHP 
 
YFYAPELLYYANKYNGVFQECCQAEDKGACLLPKIETMREKVLASSARQRLRCASIQKFGERALKAWSVARLSQKFPKAEFVEVTKLVTDLTKVHKECCHGDLLECADDRADLAKYICDNQDTISSKLKECCDKPLLEKSHCIAEV 
 
EKDAIPENLPPLTADFAEDKDVCKNYQEAKDAFLGSFLYEYSRRHPEYAVSVLLRLAKEYEATLEECCAKDDPHACYSTVFDKLKHLVDEPQNLIKQNCDQFEKLGEYGFQNALIVRYTRKVPQVSTPTLVEVSRSLGKVGTRCCT 
 
KPESERMPCTEDYLSLILNRLCVLHEKTPVSEKVTKCCTESLVNRRPCFSALTPDETYVPKAFDEKLFTFHADICTLPDTEKQIKKQTALVELLKHKPKATEEQLKTVMENFVAFVDKCCAADDKEACFAVEGPKLVVSTQTALA 
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Appendix Figure 3.1 c) BSA reduction pre- SCW hydrolysis at 207
0
C for 20 minutes. 
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Appendix Figure 3.1 c) BSA reduction pre- SCW hydrolysis at 253
0
C for 20 minutes. 
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Appendix Figure 3.1 c) BSA reduction pre- SCW hydrolysis at 300
0
C for 20 minutes. 
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Appendix Figure 3.1 c) BSA reduction post- SCW hydrolysis at 160
0
C for 0 minutes. 
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0
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Appendix Figure 3.1 d) SCW hydrolysis of β- casein at 160
0
C for 0 minutes. 
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Appendix Figure 
3.1 d) SCW 
hydrolysis of β- 
casein at 160
0
C for 
20 minutes. 
I I I I I I I I II  
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Appendix Figure 3.1 d) SCW hydrolysis of β- casein at 207
0
C for 20 
minutes. 
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Appendix Figure 3.1 d) SCW hydrolysis of β- casein at 253
0
C for 20 minutes. 
275 
 
 
RELEELNVPGEIVESLSSSEESITRINKKIEKFQSEEQQQTEDELQDKIHPFAQTQSLVYPFPGPIPNSLPQNIPPLTQTPVVVPPFLQPEVMGVSKVKEAMAPKHKEMPFPKYPVEPFTESQSLTLTDVENLHLPLPLLQSWMHQPHQPLPPTVMFPPQSVLSLSQSKVLPVPQKAVPYPQRDMPIQAFLLYQEPVLGPVRGPFPIIV 
Appendix Figure 3.1 d) SCW hydrolysis of β- casein at 300
0
C for 20 minutes. 
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Appendix Figure 4. 1 - ETD MS/MS spectrum of 4+ ions of [VQSIKADFLHYENPTWGR +O]. 
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Appendix Figure 4. 2 - ETD MS/MS spectrum of 4+ ions of [VQSIKADFLHYENPTWGR +O] 
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Appendix Figure 4. 3 - ETD MS/MS spectrum of 3+ ions of [VCFQYMDRGDR +O] 
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Appendix Figures 5.1 - 5.4. 
Appendix Figures 5.1 - 5.4. 
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Appendix Figures 5.5 - 5.8. 
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Appendix Figures 5.9 - 5.12. 
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Appendix Figures 5.13 - 5.16. 
Appendix Figures 5.13 - 5.16. 
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Appendix Figures 5.17 - 5.20. 
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Appendix Figures 5.21 - 5.22. 
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Appendix Figures 5.23 - 5.26. 
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Appendix Figures 5.27 - 5.30.  
Appendix Figures 5.27 - 5.30. 
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Appendix Figures 5.31 - 5.34.  
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Appendix Figures 5.35 - 5.38.  
289 
 
Appendix Figures 5.39 - 5.42.  
Appendix Figures 5.39 - 5.42. 
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Appendix Figures 5.43 - 5.46.  
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Appendix Figures 5.47 - 5.50.  
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Appendix Figures 5.51 - 5.54.  
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Appendix Figures 5.55 - 5.58.  
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Appendix Figures 5.59 - 5.60.  
Appendix Figures 5.59 - 5.60.  
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Appendix Figure 5.61 - Direct infusion ESI MS of BSA hydrolysed at 160oC for 0 minutes. 
Appendix Figure 5.62 - Direct infusion ESI MS of BSA hydrolysed at 160oC for 20 minutes. 
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Appendix Figure 5.63 - Direct infusion ESI MS of NTG hydrolysed at 160oC for 0 minutes. 
Appendix Figure 5.64 - Direct infusion ESI MS of NTG hydrolysed at 160oC for 20 minutes. 
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Appendix Figure 5.65 - Direct infusion ESI MS of BSG hydrolysed at 160oC for 0 minutes. 
Appendix Figure 5.66 - Direct infusion ESI MS of BSG hydrolysed at 160oC for 20 minutes. 
298 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix Figure 5.67- Direct infusion ESI MS of equimolar AA mixture. 
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Appendix Figure 5.68- Direct infusion ESI MS of equimolar AA mixture hydrolysed at 160oC for 0 minutes. 
Appendix Figure 5.69- Direct infusion ESI MS equimolar aa mixture hydrolysed at 160oC for 20 minutes. 
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m/z z 
Calculated 
mass (Da) 
Measured mass 
(Da) 
Peptide ΔPPM 
599.538 4 2394.1249 2394.1213 VQSIKCADFLHYMENPTWGR -1.5 
609.024 4 2432.0803 2432.0673 VQSIKCADFLHYMENPTWGR (+K) -5.3 
799.047 3 2394.1249 2394.1204 VQSIKCADFLHYMENPTWGR -1.9 
806.375 3 2416.1063 2416.102 
VQSIKCADFLHYMENPTWGR 
(+Na) 
-1.8 
811.696 3 2432.0803 2432.0668 VQSIKCADFLHYMENPTWGR (+K) -5.5 
1198.07 2 2394.1249 2394.1186 VQSIKCADFLHYMENPTWGR -2.6 
1209.06 2 2416.1063 2416.1008 
VQSIKCADFLHYMENPTWGR 
(+Na) 
-2.3 
 
  
 
 
 
Appendix Table 4. 1 - Ions identified from the direct infusion electrospray MS of untreated VQSIKCADFHYMENPTWGR. 
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Appendix Table 4. 2 - Peak assignments following ETD MS/MS of m/z 809.7136. 
 
c 
 
y z+1 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
117.1022   1 V 20 ---      
245.1608   2 Q 19 2328.0487   2313.0378 2313.0305 -3.1 
332.1928   3 S 18 2199.9901   2184.9792 2184.9718 -3.4 
445.2769 445.2767 -0.5 4 I 17 2112.9581   2097.9472 2097.9435 -1.7 
573.3719 573.3716 -0.5 5 K 16 1999.8740   1984.8631 1984.8591 -2 
708.3660 708.3708 6.9 6 c (2O) 15 1871.7790 1871.7778 -0.6 1856.7681   
779.4031 779.4075 5.7 7 A 14 1736.7850 1736.7795 -3.2 1721.7741 1721.7668 -4.2 
894.4350 894.4342 -4.8 8 D 13 1665.7478   1650.7369 1650.7325 -2.7 
1041.4984 1041.5027 4.2 9 F 12 1550.7209   1535.7100 1535.7070 -2 
1154.5825   10 L 11 1403.6525   1388.6416 1388.6401 -1.1 
1291.6414 1291.6453 3.1 11 H 10 1290.5684   1275.5575 1275.5565 -0.8 
1454.7047 1454.7082 2.4 12 Y 9 1153.5095   1138.4986 1138.4974 -1.1 
1585.7452 1585.7483 2.0 13 M 8 990.4462   975.4353 975.4345 -0.8 
1714.7878 1714.7876 -0.1 14 E 7 859.4057   844.3948 844.3942 -0.7 
---   15 N 6 730.3631   715.3522 715.3521 -0.1 
1925.8835 1925.8799 -1.8 16 P 5 616.3202   --- --- --- 
2026.9312 2026.9268 -2.1 17 T 4 519.2674   504.2565 504.2562 -0.6 
2213.0105   18 W 3 418.2197   403.2088 403.2086 -0.5 
2270.0320 2270.0223 -4.3 19 G 2 232.1404   217.1295   
---   20 R 1 175.1190   160.1081   
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c c+2O c+3O  
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
Calculated 
m/z 
Measured 
m/z 
ΔPPM  
117.1022   149.0920   165.0869   1 V 
245.1608   277.1506   293.1455   2 Q 
332.1928   364.1826   380.1775   3 S 
445.2769 445.2766 -0.7 477.2667   493.2616   4 I 
573.3719 573.3715 -0.7 605.3617   621.3566   5 K 
676.3811   708.3709 708.3704 -0.7 724.3658 724.3653 -0.7 6 C 
747.4182   779.4080 779.4075 -0.6 795.4029 795.4026 -0.4 7 A 
862.4451   894.4349 894.4342 -0.8 910.4298 910.4292 -0.7 8 D 
1009.5135   1041.5033 1041.5026 -0.7 1057.4982   9 F 
1122.5976   1154.5874   1170.5823 1170.5810 -1.1 10 L 
1259.6565   1291.6463 1291.6455 -0.6 1307.6412 1307.6399 -1.0 11 H 
1422.7198   1454.7096   1470.7045 1470.7012 -2.2 12 Y 
1553.7603   1585.7501   1601.7450 1601.7409 -2.6 13 M 
1682.8029   1714.7927   1730.7876 1730.7818 -3.4 14 E 
---         15 N 
1893.8986   1925.8884   1941.8833 1941.8758 -3.9 16 P 
1994.9463   2026.9361   2042.9310 2042.9211 -4.8 17 T 
2181.0256   2213.0154   2229.0103 2228.9990 -5.1 18 W 
2238.0471   2270.0369   2286.0318 2286.0160 -6.9 19 G 
---         20 R 
           
Appendix Table 4. 3 - Peak assignments following ETD MS/MS of m/z 815.0426. 
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  z z+O z+3O 
  
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
V 20 ---    ---    ---    
Q 19 2281.0529    2297.0478    2329.0376 2329.0229 -6.3 
S 18 2152.9943    2168.9892    2200.9790 2200.9640 -6.8 
I 17 2065.9623    2081.9572    2113.9470 2113.9398 -3.4 
K 16 1952.8782    1968.8731   2000.8629 2000.8530 -4.9 
C 15 1824.7832    1840.7781   1872.7679 1872.7579 -5.3 
A 14 1721.7741 1721.7679 -3.6 1737.7690 1737.7628 -3.6 1769.7588    
D 13 1650.7369 1650.7322 -2.8 1666.7318 1666.7266 -3.1 1698.7216    
F 12 1535.7100 1535.7068 -2.1 1551.7049 1551.7005 -2.8 1583.6947    
L 11 1388.6416 1388.6401 -1.1 1404.6365 1404.6346 -1.4 1436.6263    
H 10 1275.5575 1275.5562 -1.0 1291.5524 1291.5512 -0.9 1323.5422    
Y 9 1138.4986 1138.4972 -1.2 1154.4935 1154.4918 -1.5 1186.4833    
M 8 975.4353 975.4345 -0.8 991.4302 991.4295 -0.7 1023.4200    
E 7 844.3948 844.3943 -0.6 860.3897    892.3795    
N 6 715.3522 715.3521 -0.1 731.3471    763.3369    
P 5 ---    ---    ---    
T 4 504.2565 504.2562 -0.6 520.2514    552.2412    
W 3 403.2088 403.2085 -0.7 419.2037    451.1935    
G 2 217.1295    233.1244    265.1142    
R 1 160.1081    176.1030    208.0928    
Appendix Table 4. 3 (continued) - Peak assignments following ETD MS/MS of m/z 815.0426. 
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Appendix Table 4. 4 a - Peak assignments following LC CID MS/MS of m/z 815.0457 at RT ~16 min 45 s. 
 
 
b 
 
y y+2 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
---   1 V 20 ---   ---   
228.1343   2 Q 19 2344.0515   1172.5297   
315.1663 315.1671 2.5 3 S 18 2215.9929   1108.5004   
428.2504 428.2509 1.2 4 I 17 2128.9609   1064.9844   
556.3453 556.3457 0.7 5 K 16 2015.8768   1008.4423   
691.3443 691.3447 2.3 6 c (2o) 15 1887.7818   944.3948   
762.3814   7 A 14 1752.7809   876.8944 876.8939 -0.5 
877.4084   8 D 13 1681.7437   841.3758   
1024.4768   9 F 12 1566.7168   783.8623 783.8618 -0.7 
1137.5608   10 L 11 1419.6484   710.3281 710.3271 -1.4 
1274.6198   11 H 10 1306.5643 1306.5649 0.5 653.7861 653.7853 -1.2 
1437.6831   12 Y 9 1169.5054 1169.5048 -0.5 585.2566   
1568.7236   13 m(o) 8 1006.4421 1006.4405 -1.6 503.7250   
1697.7662   14 E 7 859.4057 859.4059 0.2 430.2065   
1811.8091   15 N 6 730.3631 730.3633 0.3 365.6852   
1908.8619   16 P 5 616.3202 616.3208 1.0 308.6637   
2009.9095   17 T 4 519.2674   260.1373   
2195.9888   18 W 3 418.2197 418.2205 2.0 209.6135   
2253.0103   19 G 2 232.1404   116.5738   
---   20 R 1 175.1190   88.06310   
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b 
 
y y+2 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
---   1 V 20 ---   ---   
228.1343   2 Q 19 2344.0515   1172.5297   
315.1663 315.1671 2.5 3 S 18 2215.9929   1108.5004 1108.4980 -2.2 
428.2504 428.2513 2.1 4 I 17 2128.9609   1064.9844 1064.9830 -1.7 
556.3453 556.3456 0.5 5 K 16 2015.8768   1008.4423 1008.4410 -1.8 
707.3422 707.3392 -4.2 6 c (3o) 15 1887.7818   944.3948 944.3935 -1.4 
778.3793 778.3765 -3.6 7 A 14 1736.7860   868.8970 868.8963 -0.7 
893.4063 893.4036 -3 8 D 13 1665.7488   833.3784 833.3782 -0.2 
1040.4747 1040.4715 -3.1 9 F 12 1550.7219   775.8649 775.8642 -0.8 
1153.5587   10 L 11 1403.6535 1403.6520 -0.1 702.3307 702.3304 -0.4 
1290.6177   11 H 10 1290.5694 1290.5660 -2.2 645.7887 645.7882 -0.7 
1453.6810   12 Y 9 1153.5105 1153.5080 -1.2 577.2592   
1584.7215   13 M 8 990.4472 990.4465 -0.3 495.7276   
1713.7641   14 E 7 859.4057 859.4061 0.5 422.2091   
1827.8070   15 N 6 730.3631 730.3635 0.5 365.6852   
1924.8598   16 P 5 616.3202 616.3204 0.3 308.6637   
2025.9074   17 T 4 519.2674 519.2682 1.5 260.1373   
2211.9867   18 W 3 418.2197 418.2202 1.2 209.6135   
2269.0082   19 G 2 232.1404   116.5738   
---   20 R 1 175.1190   88.06310   
 
Appendix Table 4. 4 b - Peak assignments following LC CID MS/MS of m/z 815.0457 at RT ~19 min. 
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c 
 
z+1 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
 
117.1022   1 V 20 ---   
245.1608   2 Q 19 2345.0316 2345.0199 -5.0 
332.1928   3 S 18 2216.9730 2216.9590 -6.3 
445.2769 445.2758 -2.5 4 I 17 2129.9410   
573.3719 573.3761 7.3 5 K 16 2016.8569 2016.8495 -3.7 
724.3658 724.3642 -2.2 6 c (3o) 15 1888.7619 1888.7554 -3.4 
795.4029 795.4012 -2.1 7 A 14 1737.7690 1737.7621 -4.0 
910.4298 910.4278 -2.2 8 D 13 1666.7318 1666.7242 -4.6 
1057.4982 1057.496 -2.1 9 F 12 1551.7049 1551.6987 -4.0 
1170.5823   10 L 11 1404.6365 1404.6420 3.9 
1307.6412 1307.6377 -2.7 11 H 10 1291.5524 1291.5487 -2.9 
1470.7045 1470.7001 -3.0 12 Y 9 1154.4935 1154.4901 -2.9 
1617.7399 1617.7358 -2.5 13 m (o) 8 991.4302 991.4276 -2.6 
1746.7825 1746.7744 -4.6 14 E 7 844.3948 844.3929 -2.3 
---   15 N 6 715.3522 715.3509 -1.8 
1957.8782 1957.8691 -4.6 16 P 5 ---   
2058.9259 2058.9164 -4.6 17 T 4 504.2565 504.2555 -2.0 
2245.0052   18 W 3 403.2088 403.2082 -1.5 
2302.0267 2302.0086 -7.9 19 G 2 217.1295   
---   20 R 1 160.1081   
 
Appendix Table 4. 5 - Peak assignments following ETD MS/MS of m/z 820.3787. 
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c 
 
z 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
Calculated 
m/z 
Measured 
 m/z 
ΔPPM 
165.1022   1 F 12 ---   
278.1863 278.1864 0.4 2 L 11 1387.6338 1387.6311 -2.0 
415.2452 415.2454 0.5 3 H 10 1274.5497 1274.5485 -0.9 
578.3085 578.3086 0.2 4 Y 9 1137.4908 1137.4904 -0.4 
709.3490 709.3490 0.0 5 M 8 974.4275 974.4273 -0.2 
838.3916 838.3917 0.1 6 E 7 843.3870 843.3871 0.1 
---   7 N 6 714.3444 714.3455 1.5 
1049.4873 1049.4873 0.0 8 P 5 ---   
1150.5350 1150.5343 -0.6 9 T 4 503.2487 503.2488 0.2 
1336.6143 1336.6129 -1.1 10 W 3 402.2010 402.2011 0.3 
1393.6358 1393.6341 -1.2 11 G 2 216.1217 216.1218 0.5 
---   12 R 1 159.1002 159.1005 1.9 
 
Appendix Table 4. 6 - Peak assignments following ETD MS/MS of m/z 517.5779. 
 
 
 
 
 
308 
 
 
 
 
 
 
 
 
 
 
 
Appendix Table 4. 7 - Peak assignments following ETD MS/MS of m/z 522.9105. 
 
 
 
 
 
c 
 
z 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
165.1022   1 F 12 ---   
278.1863 278.1865 0.7 2 L 11 1403.6287 1403.6267 -1.4 
415.2452 415.2453 0.2 3 H 10 1290.5446 1290.5453 0.5 
578.3085 578.3086 0.2 4 Y 9 1153.4857 1153.4853 -0.4 
725.3439 725.3440 0.1 5 m(O) 8 990.4224 990.4222 -0.2 
854.3865 854.3865 0.0 6 E 7 843.3870 843.3870 0.0 
---   7 N 6 714.3444 714.3444 0.00 
1065.4822 1065.4819 -0.3 8 P 5 ---   
1166.5299 1166.5295 -0.3 9 T 4 503.2487 503.2487 0.0 
1352.6092 1352.6077 -1.1 10 W 3 402.2010 402.2011 0.3 
1409.6307 1409.6290 -1.2 11 G 2 216.1217 216.1219 0.9 
---   12 R 1 159.1002 159.1005 1.9 
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b b+2 
 
y 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
---   ---   1 F 9 ---   
261.1598   ---   2 L 8 1019.4615   
398.2187 398.2208 5.3 199.6133   3 H 7 906.3774 906.3836 6.9 
561.2820   281.1449   4 Y 6 769.3185 769.3230 5.9 
708.3174 708.3216 5.9 354.6626   5 M 5 606.2552   
837.3600 837.3647 5.6 419.1839   6 E 4 459.2198   
951.4029 951.4080 5.4 476.2054   7 N 3 330.1772 330.1789 5.2 
1048.4557   524.7318 524.7348 5.8 8 P 2 216.1343 216.1354 5.2 
---   ---   9 t(Am) 1 119.0815   
 
 
 
 
Appendix Table 4. 8 - Peak assignments following CID MS/MS of m/z 583.7703. 
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Appendix Table 4. 9 - Ions identified from the direct infusion electrospray MS of iodoacetamide treated VQSIKCADFHYMENPTWGR. 
 
 
 
 
 
 
m/z z Calculated mass (Da) Measured mass (Da) Peptide ΔPPM 
463.8725 3 1388.5965 1388.5957 VCFQYMDRGDR -0.6 
469.2041 3 1404.5914 1404.5905 VCFQYMDRGDR (+O) -0.7 
695.3052 2 1388.5965 1388.5958 VCFQYMDRGDR -0.5 
703.3028 2 1404.5914 1404.5910 VCFQYMDRGDR (+O) -0.3 
706.2962 2 1410.5779 1410.5778 VCFQYMDRGDR (+ Na) 0 
717.2872 2 1432.5593 1432.5598 VCFQYMDRGDR (+2Na) 0.4 
728.2781 2 1454.5407 1454.5416 VCFQYMDRGDR (+3Na) 0.6 
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c 
 
z 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
117.1022   1 V 11 ---   
220.1114   2 C 10 1290.5116 1290.5073 -3.3 
367.1798 367.1792 -1.6 3 F 9 1187.5024   
495.2384   4 Q 8 1040.4340 1040.4337 -0.3 
658.3017   5 Y 7 912.3754 912.3750 -0.4 
805.3371   6 m (O) 6 749.3121 749.3128 0.9 
920.3641   7 D 5 602.2767 602.2766 -0.2 
1076.4652   8 R 4 487.2497 487.2501 0.8 
1133.4867   9 G 3 331.1486 331.1486 0.0 
1248.5136 1248.5167 2.5 10 D 2 274.1272 274.1274 0.7 
---   11 R 1 159.1002 159.1003 0.6 
 
 
 
Appendix Table 4. 10 - Peak assignments following ETD MS/MS of m/z 469.2041. 
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b 
 
y y+2 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
---   1 V 11 ---   ---   
235.0747 235.0747 0.0 2 c (2o) 10 1322.5252   661.7662 661.7665 0.4 
382.1431   3 F 9 1187.5262   594.2667 594.2665 -0.4 
510.2017   4 Q 8 1040.4578   520.7325 520.7313 -2.4 
673.2650   5 Y 7 912.3992   456.7032 456.7030 -0.5 
804.3055   6 M 6 749.3359   375.1716 375.1713 -0.8 
919.3324   7 D 5 618.2954   309.6513 309.6512 -0.4 
1075.4335   8 R 4 503.2685 503.2682 -0.6 252.1379   
1132.4550   9 G 3 347.1674 347.1671 -0.9 174.0873   
1247.4819   10 D 2 290.1459   145.5766   
---   11 R 1 175.1190 175.1189 -0.6 88.0631   
 
 
Appendix Table 4. 11 - Peak assignments following CID MS/MS of m/z 474.5359. 
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Appendix Table 4. 12 a - Peak assignments following LC ETD MS/MS of m/z 719.2973 at RT ~9min 30s. 
 
 
 
 
 
c-1 
 
z z+1 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
116.0944   1 V 11 ---   ---   
251.0934   2 c (2o) 10 1322.5014   1323.5092   
398.1618   3 F 9 1187.5024 1187.5022 -0.2 1188.5102   
526.2204   4 Q 8 1040.4340 1040.4336 -0.4 1041.4418   
689.2837   5 Y 7 912.3754   913.3832 913.3820 -1.3 
836.3191   6 m(o) 6 749.3121   750.3199 750.3195 -0.5 
951.3460   7 D 5 602.2767   603.2845 603.2840 -0.8 
1107.4472 1107.4457 -1.4 8 R 4 487.2497   488.2576 488.2571 -1.0 
1164.4686 1164.4673 -1.1 9 G 3 331.1486   332.1565   
1279.4956 1279.4950 -0.5 10 D 2 274.1272   275.1350   
---   11 R 1 159.1002   160.1081   
314 
 
c c-1  z+1 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
Calculated 
m/z 
Measured 
m/z 
ΔPPM  
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
117.1022   116.0944   1 V 11 ---   
268.0961   267.0883   2 c (3o) 10 1323.5092 1323.5084 -0.6 
415.1645   414.1567   3 F 9 1172.5153 1172.5138 -1.3 
543.2231   542.2153   4 Q 8 1025.4469 1025.4462 -0.7 
706.2864   705.2786   5 Y 7 897.3883 897.3876 -0.8 
837.3269   836.3191   6 M 6 734.3250 734.3245 -0.7 
952.3539   951.3460   7 D 5 603.2845 603.2841 -0.7 
1108.4550   1107.4472   8 R 4 488.2576 488.2571 -1.0 
1165.4764 1165.4745 -1.6 1164.4686   9 G 3 332.1565 332.1561 -1.2 
1280.5034   1279.4956 1279.4957 0.1 10 D 2 275.1350 275.1349 -0.4 
---   ---   11 R 1 160.1081   
 
 
 
Appendix Table 4.12 a – Peak assignments following LC ETD MS/MS of m/z 719.2973 at RT ~11 min 30s. 
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c-1 
 
z z+1 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
116.0944   1 V 11 ---   ---   
267.0883   2 c (3o) 10 1338.4963 1338.4951 -0.9 1339.5041   
414.1567   3 F 9 1187.5024   1188.5102 1188.5094 -0.7 
542.2153   4 Q 8 1040.4340   1041.4418 1041.4414 -0.4 
705.2786   5 Y 7 912.3754   913.3832 913.3829 -0.3 
852.3140   6 m (o) 6 749.3121   750.3199 750.3195 -0.5 
967.3409   7 D 5 602.2767   603.2845 603.2841 -0.7 
1123.4421 1123.4415 -0.5 8 R 4 487.2497   488.2576 488.2572 -0.8 
1180.4635 1180.4629 -0.5 9 G 3 331.1486   332.1565 332.1562 -0.9 
1295.4905 1295.4895 -0.8 10 D 2 274.1272   275.1350 275.1349 -0.4 
---   11 R 1 159.1002   160.1081   
 
 
 
Appendix Table 4. 13 - Peak assignments following ETD MS/MS of m/z 727.2950. 
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c c + 2O 
 Calculated 
m/z 
Measured 
m/z 
ΔPPM 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
117.1022   149.0920   1 V 
220.1114   252.1012   2 C 
367.1798   399.1696 399.1695 -0.3 3 F 
495.2384   527.2282 527.2279 -0.6 4 Q 
658.3017   690.2915 690.2917 0.3 5 Y 
789.3422   821.3320 821.3313 -0.9 6 M 
904.3692   936.3590 936.3583 -0.7 7 D 
1060.4703   1092.4601 1092.4593 -0.7 8 R 
1117.4917   1149.4815 1149.4808 -0.6 9 G 
1232.5187   1264.5085   10 D 
---      11 R 
 
 
 
Appendix Table 4. 14 - Peak assignments following ETD MS/MS of m/z 468.2838. 
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c + 2O - H2O c + 2O - 2H2O 
 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
131.0815   113.0709   1 V 
234.0907   216.0801   2 C 
381.1591   363.1485   3 F 
509.2177   491.2071   4 Q 
672.2810   654.2704   5 Y 
803.3215   785.3109   6 M 
918.3485 918.3475 -1.0 900.3379   7 D 
1074.4496 1074.4486 -0.9 1056.4390   8 R 
1131.4710 1131.4702 -0.7 1113.4604   9 G 
1246.4980 1246.4977 -0.2 1228.4874   10 D 
      11 R 
 
 
Appendix Table 4.14 (continued) - Peak assignments following ETD MS/MS of m/z 468.2838. 
 
318 
 
 
z z - H2O z - 2H2O 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
V 11 ---         
C 10 1274.5167   1256.5062   1238.4956   
F 9 1171.5075   1153.4970 1153.4960 -0.8 1135.4864   
Q 8 1024.4391   1006.4286 1006.4269 -1.6 988.4180   
Y 7 896.3805   878.3700 878.3697 -0.3 860.3594   
M 6 733.3172   715.3067   697.2961 697.2958 -0.4 
D 5 602.2767   584.2662 584.2657 -0.8 566.2556   
R 4 487.2497 487.2493 -0.8 469.2392 469.2387 -1.0 451.2286   
G 3 331.1486 331.1486 0.0 313.1381 313.1380 -0.2 295.1275   
D 2 274.1272 274.1269 -1.1 256.1167 256.1164 -1.0 238.1061   
R 1 159.1002 159.1001 -0.6 141.0897   123.0791   
 
 
Appendix Table 4.14 (continued) - Peak assignments following ETD MS/MS of m/z 468.2838. 
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z- H2O+ 2O z - 2H2O + 2O 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
V 11 ---   ---   
C 10 1288.49595   1270.4854   
F 9 1185.48675   1167.4762   
Q 8 1038.41835   1020.4078   
Y 7 910.35975   892.3492   
M 6 747.29645   729.2859   
D 5 616.25595   598.2454   
R 4 501.22895   483.2184   
G 3 345.12785   327.1173   
D 2 288.10645   270.0959   
R 1 173.07945   155.0689   
 
 
 
 
Appendix Table 4.14 (continued) - Peak assignments following ETD MS/MS of m/z 468.2838. 
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c c + 2O c + 3O 
 Calculated 
m/z 
Measured 
m/z 
ΔPPM 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
117.1022   149.0920   165.0869   1 V 
220.1114   252.1012   268.0961   2 C 
367.1798   399.1696   415.1645   3 F 
495.2384   527.2282   543.2231   4 Q 
658.3017   690.2915   706.2864   5 Y 
789.3422   821.3320   837.3269   6 M 
904.3692   936.3590   952.3539   7 D 
1060.4703   1092.4601   1108.4550 1108.4525 -2.3 8 R 
1117.4917   1149.4815   1165.4764 1165.4710 -4.6 9 G 
1232.5187   1264.5085   1280.5034   10 D 
---   ---   ---   11 R 
 
 
 
Appendix Table 4. 15 - Peak assignments following ETD MS/MS of m/z 710.2924. 
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c + 2O - H2O c + 2O - 2H2O 
 
 Calculated 
m/z 
Measured 
m/z 
ΔPPM 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
131.0815   113.0709   1 V 
234.0907   216.0801   2 C 
381.1591   363.1485   3 F 
509.2177   491.2071   4 Q 
672.2810   654.2704   5 Y 
803.3215   785.3109   6 M 
918.3485   900.3379   7 D 
1074.4496   1056.4390   8 R 
1131.4710   1113.4604   9 G 
1246.4980   1228.4874   10 D 
---   ---   11 R 
 
 
 
Appendix Table 4.15 (continued) - Peak assignments following ETD MS/MS of m/z 710.2924. 
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c + 3O - H2O c + 3O - 2H2O 
 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
147.0764   129.0658   1 V 
250.0856   232.0750   2 C 
397.1540   379.1434   3 F 
525.2126   507.2020   4 Q 
688.2759   670.2653   5 Y 
819.3164   801.3058   6 M 
934.3434   916.3328   7 D 
1090.4445   1072.4339   8 R 
1147.4659 1147.4635  1129.4553   9 G 
1262.4929 1262.4875  1244.4823   10 D 
---      11 R 
 
Appendix Table 4.15 (continued) - Peak assignments following ETD MS/MS of m/z 710.2924. 
 
 
 
 
 
 323 
 
 
z z+1 - H2O z+1 - 2H2O 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
V 11 ---   ---   ---   
C 10 1274.5167   1257.5140   1239.5034   
F 9 1171.5075   1154.5048 1154.5024 -2.1 1136.4942   
Q 8 1024.4391   1007.4364 1007.4356  989.4258   
Y 7 896.3805   879.3778 879.3772  861.3672   
M 6 733.3172   716.3145 716.3141  698.3039   
D 5 602.2767   585.2740 585.2730  567.2634 567.2625 -1.6 
R 4 487.2497   470.2470 470.2465  452.2364   
G 3 331.1486   314.1459 314.1456  296.1353   
D 2 274.1272   257.1245 257.1242  239.1139   
R 1 159.1002   142.0975   124.0869   
 
 
Appendix Table 4.15 (continued) - Peak assignments following ETD MS/MS of m/z 710.2924. 
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z+1- H2O+ O z+1 - 2H2O + O 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
V 11 ---   ---   
C 10 1273.5089   1255.4983   
F 9 1170.4997   1152.4891 1152.4871 -1.8 
Q 8 1023.4313 1023.4287 -2.5 1005.4207 1005.4189 -1.8 
Y 7 895.3727 895.3702 -2.8 877.3621 877.3592 -3.3 
M 6 732.3094 732.3079 -2.0 714.2988   
D 5 601.2689   583.2583   
R 4 486.2419   468.2313   
G 3 330.1408   312.1302   
D 2 273.1194   255.1088   
R 1 158.0924   140.0818   
 
 
Appendix Table 4.15 (continued) - Peak assignments following ETD MS/MS of m/z 710.2924. 
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z+1 - H2O + 3O z+1 - H2O + 3O 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
V 11 ---   ---   
C 10 1305.4987 1305.4911 -5.8 1287.4881   
F 9 1202.4895   1184.4789   
Q 8 1055.4211   1037.4105   
Y 7 927.3625   909.3519   
M 6 764.2992   746.2886   
D 5 633.2587   615.2481   
R 4 518.2317   500.2211   
G 3 362.1306   344.1200   
D 2 305.1092   287.0986   
R 1 190.0822   172.0716   
 
Appendix Table 4.15 (continued) - Peak assignments following ETD MS/MS of m/z 710.2924. 
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m/z z 
Calculated 
mass (Da) 
Measured mass 
(Da) 
Peptide ΔPPM 
541.0273 4 2160.0752 2160.0801 VQSIKADFLHYENPTWGR 2.3 
550.5151 4 2198.0306 2198.0313 VQSIKADFLHYENPTWGR (+K) 0.3 
721.0335 3 2160.0752 2160.0787 VQSIKADFLHYENPTWGR 1.6 
728.3627 3 2182.0566 2182.0663 VQSIKADFLHYENPTWGR (+Na) 4.4 
733.6844 3 2198.0306 2198.0314 VQSIKADFLHYENPTWGR (+K) 0.4 
1081.0487 2 2160.0752 2160.0828 VQSIKADFLHYENPTWGR 3.5 
 
 
Appendix Table 4. 16 - Ions identified from the direct infusion electrospray MS of untreated VQSIKADFHYENPTWGR. 
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c  z z+1 
Calculated 
m/z 
Measured 
m/z 
ΔPPM  
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
117.1022   1 V 18 ---   ---   
245.1608 245.1598 -4.1 2 Q 17 2061.9903   2062.9981 2062.9825 -7.6 
332.1928 332.1914 -4.2 3 S 16 1933.9317   1934.9395 1934.9273 -6.3 
445.2769 445.2750 -4.3 4 I 15 1846.8997   1847.9075 1847.8981 -5.1 
573.3719 573.3694 -4.4 5 K 14 1733.8156   1734.8234 1734.8144 -5.2 
644.4090 644.4062 -4.3 6 A 13 1605.7206   1606.7285 1606.7207 -4.9 
759.4359 759.4362 0.4 7 D 12 1534.6835   1535.6914 1535.6844 -4.6 
906.5043 906.5003 -4.4 8 F 11 1419.6566   1420.6644 1420.6578 -4.6 
1019.5884 1019.5839 -4.4 9 L 10 1272.5882   1273.5960 1273.5907 -4.2 
1156.6473 1156.6420 -4.6 10 H 9 1159.5041   1160.5119 1160.5063 -4.8 
1319.7106 1319.7063 -3.3 11 Y 8 1022.4452 1022.4407 -4.4 1023.4530   
1448.7532 1448.7477 -3.8 12 E 7 859.3819 859.3781 -4.4 860.3897   
---   13 N 6 730.3393 730.3362 -4.2 731.3471   
1659.8489 1659.8420 -4.2 14 P 5 ---   ---   
1760.8966 1760.8907 -3.4 15 T 4 519.2436 519.2412 -4.6 520.2514   
1962.9708 1962.9630 -4 16 w(O) 3 418.1959 418.1940 -4.5 419.2037   
2019.9878 2019.9820 -2.9 17 G 2 232.1166   233.1244   
---   18 R 1 175.0951   176.1030   
 
Appendix Table 4. 17 - Peak assignments following ETD MS/MS of m/z 545.0272 
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b b+2 b+3 
 Calculated 
m/z 
Measured 
m/z 
ΔPPM 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
---   ---   ---   1 V 
228.1343 228.1333 -4.4 ---   ---   2 Q 
315.1663 315.1659 -1.3 ---   ---   3 S 
428.2504   ---   ---   4 I 
556.3453   278.6766   ---   5 K 
627.3824   314.1951   ---   6 A 
742.4094 742.4059 -4.7 371.7086 371.7065 -5.7 ---   7 D 
889.4778 889.4733 -5.1 445.2428   ---   8 F 
1002.5619   501.7849   ---   9 L 
1139.6208   570.3143 570.3113 -5.3 380.5455   10 H 
1302.6841   651.8460   434.8999   11 Y 
1431.7267   716.3673 716.3679 0.9 477.9141   12 E 
1545.7696   773.3887 773.385 -4.8 515.9284   13 N 
1642.8224   821.9151   548.2794   14 P 
1743.8701   872.4390   581.9619 581.9588 -5.4 15 T 
1961.9392   981.4735   654.6516   16 w(2O) 
2018.9606   1009.9842   673.6588   17 G 
---   ---   ---   18 R 
Appendix Table 4. 18 - Peak assignments following CID MS/MS of m/z 549.0260 
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  y y+2 y+3 
  Calculated 
m/z 
Measured 
m/z 
ΔPPM 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
Calculated 
m/z 
Measured 
m/z 
ΔPPM   
V 18 ---   ---   ---   
Q 17 2094.0039   1047.5059   698.6732 698.6695 -5.3 
S 16 1965.9453   983.4766   655.9870 655.9839 -4.7 
I 15 1878.9133   939.9606   626.9763   
K 14 1765.8292   883.4185   589.2816   
A 13 1637.7343   819.3711   546.5833   
D 12 1566.6972   783.8525   522.9043   
F 11 1451.6702   726.3390 726.3356 -4.7 484.5620   
L 10 1304.6018   652.8048   435.5392   
H 9 1191.5177   596.2628   397.8445   
Y 8 1054.4588   527.7333   ---   
E 7 891.3955   446.2017   ---   
N 6 762.3529 762.3492 -4.9 381.6804   ---   
P 5 648.3100 648.3071 -4.5 324.6589   ---   
T 4 551.2572   276.1325   ---   
w(2O) 3 450.2095 450.2075 -4.4 225.6087   ---   
G 2 232.1404 232.1394 -4.3 116.5741   ---   
R 1 175.1190   88.0634   ---   
 
Appendix Table 4. 18 (continued) - Peak assignments following CID MS/MS of m/z 549.0260 
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c 
 
z+1 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
117.1022   1 V 18 ---   
245.1608   2 Q 17 2028.9927 2028.9880 -2.3 
332.1928   3 S 16 1900.9341 1900.9305 -1.9 
445.2769 445.2779 2.3 4 I 15 1813.9021 1813.8998 -1.2 
573.3719 573.3730 1.9 5 K 14 1700.8180 1700.8164 -0.9 
644.4090 644.4102 1.9 6 A 13 1572.7231 1572.7200 -1.9 
741.4254 741.4268 2.0 7 
d (-
H2O) 
12 1501.6860 1501.6835 -1.6 
888.4938 888.4952 1.6 8 F 11 1386.6590   
1001.5779 1001.5794 1.5 9 L 10 1257.6011 1257.6013 0.2 
1138.6368 1138.6382 1.3 10 H 9 1144.5170 1144.5128 -3.7 
1301.7001 1301.7009 0.7 11 Y 8 1007.4581 1007.4598 1.7 
1430.7427 1430.7432 0.4 12 E 7 844.3948 844.3971 2.7 
---   13 N 6 715.3522   
1641.8384 1641.8367 -1.0 14 P 5 ---   
1742.8861 1742.8847 -0.8 15 T 4 504.2565 504.2575 2.0 
1928.9654 1928.9595 -3.0 16 W 3 403.2088 403.2097 2.2 
1985.9869 1985.9817 -2.6 17 G 2 217.1295 217.1303 3.7 
---   18 R 1 160.1081   
 
Appendix Table 4. 19 - Peak assignments following CID MS/MS of m/z 715.0316 
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m/z z 
Calculated 
mass (Da) 
Measured 
mass (Da) 
Peptide ΔPPM 
613.7934 4 2451.1464 2451.1445 VQSIKCADFLHYMENPTWGR (+ C2H5ON) -0.8 
619.2887 4 2473.1278 2473.1257 VQSIKCADFLHYMENPTWGR (+ C2H5ON) + Na -0.8 
818.0553 3 2451.1464 2451.1441 VQSIKCADFLHYMENPTWGR (+ C2H5ON) -0.9 
825.3826 3 2473.1278 2473.126 VQSIKCADFLHYMENPTWGR (+ C2H5ON) + Na -0.7 
1226.579 2 2451.1464 2451.1434 VQSIKCADFLHYMENPTWGR (+ C2H5ON) -1.2 
 
 
Appendix Table 4. 20 - Ions identified from the direct infusion electrospray MS of iodoacetamide treated VQSIKCADFHYMENPTWGR. 
 
 
 
 
 
 
 
 
 
 332 
 
b 
 
y y+2 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
---   1 V 20 ---   ---   
228.1343   2 Q 19 2353.0862   1177.0470   
315.1663   3 S 18 2225.0276   1113.0177 1113.0187 0.9 
428.2504 428.2514 2.3 4 I 17 2137.9956   1069.5017 1069.5031 1.4 
556.3453 556.3464 2.0 5 K 16 2024.9115   1012.9597 1012.9607 1.0 
716.3541   6 
c 
(+C2H5ON) 
15 1896.8165 1896.8167 0.1 948.9122   
787.4140 787.4146 0.7 7 A 14 1736.7850 1736.7866 0.9 868.8964   
902.4410 902.4417 0.7 8 D 13 1665.7478 1665.7499 1.3 833.3778   
1049.5094 1049.5104 0.9 9 F 12 1550.7209 1550.7223 0.9 775.8644   
1162.5934   10 L 11 1403.6525 1403.6550 1.8 702.3302   
1299.6524 1299.6535 0.8 11 H 10 1290.5684 1290.5706 1.7 645.7881   
1462.7157 1462.7175 1.2 12 Y 9 1153.5095 1153.5113 1.6 577.2587   
1593.7562 1593.7575 0.8 13 M 8 990.4462 990.4481 1.9 495.7270   
1722.7988 1722.7995 0.4 14 E 7 859.4057 859.4074 2.0 430.2068   
1836.8417 1836.8421 0.2 15 N 6 730.3631 730.3645 1.9 365.6855   
1933.8945 1933.8955 0.5 16 P 5 616.3202 616.3214 1.9 308.6640   
2034.9421   17 T 4 519.2674 519.2686 2.3 260.1376   
2221.0214   18 W 3 418.2197 418.2207 2.4 209.6138   
2278.0429   19 G 2 232.1404   116.5741   
---   20 R 1 175.1190   88.0634   
Appendix Table 4. 21 - Peak assignments following ETD MS/MS of m/z 818.0553. 
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c 
 
z+1 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
117.1022   1 V 20 ---   
245.1608   2 Q 19 2354.0693 2354.0515 -7.5 
332.1928   3 S 18 2226.0107 2225.9960 -6.6 
445.2769   4 I 17 2138.9787 2138.9654 -6.3 
573.3719 573.3694 -4.4 5 K 16 2025.8946 2025.8829 -5.8 
733.4026 733.3995 -4.2 6 
c 
(+C2H5ON) 
15 1897.7996   
804.4397 804.4362 -4.3 7 A 14 1737.7690 1737.7594 -5.5 
919.4666 919.4627 -4.2 8 D 13 1666.7318 1666.7228 -5.4 
1066.5350 1066.5306 -4.1 9 F 12 1551.7049 1551.6972 -5.0 
1179.6191 1179.6135 -4.7 10 L 11 1404.6365 1404.6304 -4.3 
1316.6780 1316.6725 -4.1 11 H 10 1291.5524 1291.5471 -4.1 
1479.7412 1479.7351 -4.2 12 Y 9 1154.4935 1154.4881 -4.7 
1626.7767 1626.7691 -4.6 13 m(O) 8 991.4302 991.4259 -4.3 
1755.8193 1755.8100 -5.3 14 E 7 844.3948 844.3914 -4.0 
---   15 N 6 715.3522 715.3493 -4.1 
1966.9150 1966.9036 -5.8 16 P 5 ---   
2067.9627 2067.9499 -6.2 17 T 4 504.2565 504.2543 -4.4 
2254.0420 2254.0235 -8.2 18 W 3 403.2088 403.2071 -4.2 
2311.0635 2311.0470 -7.1 19 G 2 217.1295   
---   20 R 1 160.1081   
Appendix Table 4. 22 - Peak assignments following ETD MS/MS of m/z 823.3905. 
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b b + C2H3ON b + 2(C2H3ON) 
 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
---         1 V 
228.1343   285.1557   342.1772   2 Q 
315.1663 315.1649 -4.4 372.1877 372.1860 -4.7 429.2092   3 S 
428.2504 428.2486 -4.2 485.2718 485.2696 -4.6 542.2933   4 I 
556.3453 556.3430 -4.1 613.3667 613.3641 -4.3 670.3882   5 K 
659.3545   716.3759 716.3728 -4.4 773.3974 773.3940 -4.4 6 C 
730.3916   787.4130 787.4093 -4.8 844.4345 844.4309 -4.3 7 A 
845.4186   902.4400 902.4359 -4.6 959.4615 959.4571 -4.6 8 D 
992.4870   1049.5084 1049.5038 -4.4 1106.5299 1106.5247 -4.7 9 F 
1105.5710   1162.5924 1162.5871 -4.6 1219.6139 1219.6088 -4.2 10 L 
1242.6300   1299.6514   1356.6729   11 H 
1405.6933   1462.7147   1519.7362 1519.7301 -4.0 12 Y 
1536.7338   1593.7552   1650.7767   13 M 
1665.7764   1722.7978   1779.8193   14 E 
1779.8193   1836.8407   1893.8622   15 N 
1876.8721   1933.8935   1990.9150   16 P 
1977.9197   2034.9411   2091.9626   17 T 
2163.9990   2221.0204   2278.0419   18 W 
2221.0205   2278.0419   2335.0634   19 G 
---         20 R 
Appendix Table 4. 23 - Peak assignments following CID MS/MS of m/z 837.0585. 
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(b+ C2H3ON) +2 (b  + 2(C2H3ON)) +2 
 Calculated 
m/z 
Measured 
m/z 
ΔPPM 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
---   ---   1 V 
---   ---   2 Q 
---   ---   3 S 
---   ---   4 I 
307.1873   335.6980   5 K 
358.6919   387.2026   6 C 
394.2104   422.7212   7 A 
451.7239   480.2347 480.2342 -1.0 8 D 
525.2581   553.7689 553.7661 -5.0 9 F 
581.8001   610.3109 610.3080 -4.7 10 L 
650.3296 650.3264 -5.0 678.8404 678.8370 -5.0 11 H 
731.8613   760.3720 760.3682 -5.0 12 Y 
797.3815   825.8923 825.8882 -4.9 13 M 
861.9028   890.4136 890.4091 -5.0 14 E 
918.9243   947.4350 947.4303 -5.0 15 N 
967.4507   995.9614   16 P 
1017.9745   1046.4852   17 T 
1111.0141   1139.5249   18 W 
1139.5249   1168.0356   19 G 
---   ---   20 R 
 
Appendix Table 4. 23 (continued) - Peak assignments following ETD MS/MS of m/z 837.0585. 
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y y + C2H3ON  
 Calculated 
m/z 
Measured 
m/z 
ΔPPM 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
---      V 20 
2296.0638   2353.0852   Q 19 
2168.0052   2225.0266   S 18 
2080.9732   2137.9946   I 17 
1967.8891   2024.9105   K 16 
1839.7941   1896.8155   C 15 
1736.7850   1793.8064   A 14 
1665.7478 1665.7394 -5.0 1722.7692   D 13 
1550.7209 1550.7136 -4.7 1607.7423 1607.7357 -4.1 F 12 
1403.6525 1403.6462 -4.5 1460.6739 1460.6669 -4.8 L 11 
1290.5684 1290.5629 -4.3 1347.5898 1347.5840 -4.3 H 10 
1153.5095 1153.5041 -4.7 1210.5309 1210.5252 -4.7 Y 9 
990.4462 990.4417 -4.5 1047.4676 1047.4628 -4.6 M 8 
859.4057 859.4017 -4.7 916.4271 916.4230 -4.5 E 7 
730.3631 730.3598 -4.5 787.3845   N 6 
616.3202 616.3178 -3.9 673.3416   P 5 
519.2674 519.2651 -4.4 576.2888   T 4 
418.2197 418.2178 -4.5 475.2411   W 3 
232.1404   289.1618   G 2 
175.1190   232.1404   R 1 
 
Appendix Table 4. 23 (continued) - Peak assignments following ETD MS/MS of m/z 837.0585. 
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y+2 (y + C2H3ON) +2 (y + 2(C2H3ON)) +2 
 Calculated 
m/z 
Measured 
m/z 
ΔPPM 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
---         V 20 
1148.5355   1177.0465 1177.0399  1205.5572   Q 19 
1084.5062   1113.0172 1113.0117  1141.5279 1141.5222 -5.0 S 18 
1040.9902   1069.5012 1069.4957  1098.0119 1098.0066 -4.9 I 17 
984.4482   1012.9592 1012.9543  1041.4699 1041.4647 -5.0 K 16 
920.4007   948.9117 948.9071 -4.8 977.4224 977.4176 -4.9 C 15 
868.8961 868.8919 -4.8 897.4071 897.4028 -4.8 925.91786   A 14 
833.3776   861.8885 861.8843 -4.9 890.39926   D 13 
775.8641 775.8604 -4.8 804.3751 804.3711 -5.0 832.8858   F 12 
702.3299 702.3267 -4.6 730.8409   759.3516   L 11 
645.7878 645.7849 -4.5 674.2988 674.2954 -5.1 702.8096   H 10 
577.2584 577.256 -4.2 605.7694   634.2801   Y 9 
495.7267   524.2377   552.7485   M 8 
430.2065   458.7175   487.2282   E 7 
365.6852   394.1962   422.7069   N 6 
308.6637   337.1747   365.6855   P 5 
260.1373   288.6483   317.1591   T 4 
209.6135   238.1245   266.6352   W 3 
116.5738   145.0848   173.5956   G 2 
88.0631   116.5741   145.0849   R 1 
Appendix Table 4. 23 (continued) - Peak assignments following ETD MS/MS of m/z 837.0585. 
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b b+C7H6 
 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
---      1 V 
228.1343 228.1343  318.1813   2 Q 
315.1663 315.1663 0.0 405.2133   3 S 
428.2504 428.2503 0.2 518.2974   4 I 
556.3453 5556.3453 0.0 646.3923   5 K 
659.3545 659.3545 0.0 749.4015   6 C 
730.3916 730.3917 -0.1 820.4386   7 A 
845.4186 845.4186 0.0 935.4656   8 D 
992.4870 992.4871 -0.1 1082.5340 1082.5349 -0.9 9 F 
1105.5710 1105.5714 -0.4 1195.6180 1195.6184 -0.4 10 L 
1242.6300 1242.6299 0.1 1332.6770   11 H 
1405.6933   1495.7403   12 Y 
1536.7338   1626.7808   13 M 
1665.7764   1755.8234   14 E 
1779.8193   1869.8663   15 N 
1876.8721   1966.9191   16 P 
1977.9197   2067.9667   17 T 
2163.9990   2254.0460   18 W 
2221.0205   2311.0675   19 G 
---   ---   20 R 
 
Appendix Table 4. 24 - Peak assignments following CID MS/MS of m/z 622.0462. 
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b +2 (b+C7H6) +2 
 Calculated 
m/z 
Measured 
m/z 
ΔPPM 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
---   ---   1 V 
---   ---   2 Q 
---   ---   3 S 
---   ---   4 I 
278.6763   323.6998   5 K 
330.1809   375.2044   6 C 
365.6994   410.7229   7 A 
423.2129   468.2364   8 D 
496.7471   541.7706   9 F 
553.2891 553.2893 -0.3 598.3126 598.3098 4.7 10 L 
621.8186   666.8421 666.8420 0.2 11 H 
703.3503 703.3522 -2.7 748.3738 748.3747 -1.3 12 Y 
768.8705 768.8712 -0.9 813.8940 813.8939 0.1 13 M 
833.3918 833.3913 0.6 878.4153 878.4149 0.5 14 E 
890.4133 890.4133 0.0 935.4368 935.4365 0.3 15 N 
938.9397   983.9632   16 P 
989.4635 989.4637 -0.2 1034.4870   17 T 
1082.5031 1082.5039 -0.7 1127.5266   18 W 
1111.0139   1156.0374   19 G 
---   ---   20 R 
 
Appendix Table 4. 24 (continued) - Peak assignments following CID MS/MS of m/z 622.0462. 
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y y+C7H6 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
Calculated 
m/z 
Measured 
m/z 
ΔPPM 
V 20 ---      
Q 19 2296.0638   2386.1108   
S 18 2168.0052   2258.0522   
I 17 2080.9732   2171.0202   
K 16 1967.8891   2057.9361   
C 15 1839.7941   1929.8411   
A 14 1736.7850   1826.8320   
D 13 1665.7478   1755.7948   
F 12 1550.7209   1640.7679   
L 11 1403.6525   1493.6995   
H 10 1290.5684 1290.5675 0.7 1380.6154   
Y 9 1153.5095 1153.5090 0.4 1243.5565   
M 8 990.4462 990.4462 0.0 1080.4932   
E 7 859.4057 859.4061 -0.5 949.4527 949.4535 -0.9 
N 6 730.3631 730.3635 -0.5 820.4101 820.4110 -1.2 
P 5 616.3202 616.3203 -0.2 706.3672 706.3676 -0.6 
T 4 519.2674 519.2676 -0.4 609.3144 609.3146 -0.4 
W 3 418.2197 418.2197 0.0 508.2667 508.2667 -0.1 
G 2 232.1404 232.1404  322.1874   
R 1 175.1190   ---   
 
Appendix Table 4. 24 (continued) - Peak assignments following CID MS/MS of m/z 622.0462. 
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m/z 
Calculated mass 
(Da) 
Measured mass 
(Da) 
Formula Structure ΔPPM 
Relative 
abundance 
84.96 n/a n/a solvent n/a n/a 100 
102.97 n/a n/a solvent n/a n/a 81.55 
116.99 n/a n/a solvent n/a n/a 6.3 
Appendix Table 5.15 - Ions observed following SCW hydrolysis of BSA at 160 °C for 0 min.  
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m/z 
Calculated mass 
(Da) 
Measured mass 
(Da) 
Formula Structure ΔPPM 
Relative 
abundance 
78.9968 n/a n/a solvent n/a n/a 11.37 
84.9595 n/a n/a solvent n/a n/a 100 
86.9925 n/a n/a solvent n/a n/a 8.59 
93.0125 unassigned n/a n/a n/a n/a 18.88 
97.0074 n/a n/a solvent n/a n/a 8.03 
101.0595 102.0681 102.0679 C5H10O2 
 
-2.2 13.18 
102.9701 n/a n/a solvent n/a n/a 61.51 
106.9918 n/a n/a solvent n/a n/a 9.98 
111.0231 unassigned n/a n/a n/a n/a 7.16 
114.0912 n/a n/a solvent n/a n/a 23.02 
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116.0704 115.0633 115.0631 C5H9O2N 
 
-1.5 10.57 
116.9858 n/a n/a solvent n/a n/a 13.11 
121.0075 n/a n/a solvent n/a n/a 12.02 
130.0497 129.0426 129.0424 C5H7O3N 
 
-1.4 10.47 
132.1018 131.0946 131.0945 C4H9O2N3 
 
-0.6 5.56 
134.9868 n/a n/a solvent n/a n/a 7.55 
148.0603 147.0532 147.0530 C5H9O4N 
 
-1.2 6.39 
149.0024 unassigned n/a n/a n/a n/a 21.18 
Appendix Table 5.16 - Ions observed following SCW hydrolysis 
of BSA at 160 °C for 20 min.  
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m/z 
Calculated mass 
(Da) 
Measured mass 
(Da) 
Formula Structure ΔPPM 
Relative 
abundance 
78.9971 n/a n/a solvent n/a n/a 8.13 
84.9597 n/a n/a solvent n/a n/a 100 
86.9928 n/a n/a solvent n/a n/a 18.06 
97.0077 n/a n/a solvent n/a n/a 5.32 
102.1279 101.1205 101.1206 C6H15N 
 
1.2 39.33 
102.9704 n/a n/a solvent n/a n/a 81.9 
106.9921 n/a n/a solvent n/a n/a 7.93 
110.0089 n/a n/a solvent n/a n/a 9.05 
114.0915 n/a n/a solvent n/a n/a 23.64 
118.0865 117.0790 117.0792 C5H11O2N 
 
1.9 6.17 
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125.9865 n/a n/a solvent n/a n/a 32.12 
134.9872 n/a n/a solvent n/a n/a 6.35 
Appendix Table 5.17 - Ions observed following SCW hydrolysis of NTG at 160 °C for 0 min.  
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m/z 
Calculated mass 
(Da) 
Measured mass 
(Da) 
Formula Structure ΔPPM 
Relative 
abundance 
84.9598 n/a n/a Solvent n/a n/a 46.32 
86.9928 n/a n/a Solvent n/a n/a 25.41 
96.9870 n/a n/a Solvent n/a n/a 12.37 
101.0599 n/a n/a Solvent n/a n/a 5.36 
102.1279 101.1205 101.1206 C6H15N 
 
1.2 100 
102.9704 n/a n/a Solvent n/a n/a 42.36 
105.9923 n/a n/a Solvent n/a n/a 12.16 
114.0916 n/a n/a Solvent n/a n/a 24.05 
116.0708 115.0633 115.0635 C5H9O2N 
 
1.9 11.49 
118.0865 117.0790 117.0792 C5H11O2N 
 
1.9 16.94 
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125.9865 n/a n/a Solvent n/a n/a 6.69 
132.1022 131.0946 131.0949 C6H13O2N 
 
2.3 9.65 
134.0451 n/a n/a Solvent n/a n/a 8.76 
Appendix Table 5.18 - Ions observed following SCW hydrolysis of NTG at 160 °C for20 min.  
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m/z 
Calculated mass 
(Da) 
Measured mass 
(Da) 
Formula Structure ΔPPM 
Relative 
abundance 
68.9826 n/a n/a solvent n/a n/a 11.57 
82.0144 n/a n/a solvent n/a n/a 22.31 
84.9603 n/a n/a solvent n/a n/a 74.39 
86.0971 85.0892 85.0898 C5H11N 
 
7.3 11.6 
86.9934 n/a n/a solvent n/a n/a 100 
87.9942 n/a n/a solvent n/a n/a 13.12 
88.9909 n/a n/a solvent n/a n/a 15.57 
90.5076 n/a n/a solvent n/a n/a 11.72 
102.1285 101.1205 101.1212 C6H15N 
 
7.2 73.96 
102.9711 n/a n/a solvent n/a n/a 74.11 
104.1078 103.0997 103.1005 C5H13ON Unassigned  19.5 
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105.0041 n/a n/a solvent n/a n/a 23.16 
114.0923 n/a n/a solvent n/a n/a 31.01 
116.0716 115.0633 115.0643 C5H9O2N 
 
8.9 50.56 
118.0872 117.0790 117.0799 C5H11O2N 
 
7.9 16.65 
122.0822 Unassigned n/a n/a n/a n/a 15.23 
128.987 n/a n/a solvent n/a n/a 11.66 
130.051 129.0426 129.0437 C5H7O3N 
 
8.7 19.79 
131.1303 130.1226 130.1230 C7H16ON Unassigned  11.09 
146.9978 n/a n/a solvent n/a n/a 11.62 
Appendix Table 5.19 - Ions observed following SCW hydrolysis of BSG at 160 °C for0 min.  
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m/z 
Calculated mass 
(Da) 
Measured mass 
(Da) 
Formula Structure ΔPPM 
Relative 
abundance 
84.9598 n/a n/a Solvent n/a n/a 46.32 
86.9928 n/a n/a Solvent n/a n/a 25.41 
96.9870 n/a n/a Solvent n/a n/a 12.37 
101.0599 n/a n/a Solvent n/a n/a 5.36 
102.1279 101.1205 101.1206 C6H15N 
 
1.2 100 
102.9704 n/a n/a Solvent n/a n/a 42.36 
105.9923 n/a n/a Solvent n/a n/a 12.16 
114.0916 n/a n/a Solvent n/a n/a 24.05 
116.0708 115.0633 115.0635 C5H9O2N 
 
1.9 11.49 
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118.0865 117.079 117.0792 C5H11O2N 
 
1.9 16.94 
125.9865 n/a n/a Solvent n/a n/a 6.69 
132.1022 131.0946 131.0949 C6H13O2N 
 
2.3 9.65 
134.0451 n/a n/a Solvent n/a n/a 8.76 
137.0093 n/a n/a Solvent n/a n/a 12.59 
Appendix Table 5.20 - Ions observed following SCW hydrolysis of BSG at 160 °C for 20 min.  
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m/z 
Calculated mass 
(Da) 
Measured mass 
(Da) 
Formula Structure PPM 
Relative 
abundance 
86.0965 85.0892 85.0892 C5H11N 
 
0.3 25.22 
106.0500 105.0426 105.0427 C5H11N 
 
1.2 7.24 
116.0708 115.0633 115.0635 C5H9O2N 
 
2.0 49.69 
118.0864 117.0790 117.0791 C5H11O2N 
 
1.1 25.77 
120.0657 119.0582 119.0584 C4H9O3N 
 
1.9 7.92 
120.0809 119.0735 119.0736 C8H9N 
 
1.1 8.73 
122.0272 121.0197 121.0199 C3H7O2NS 
 
1.5 1.4 
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132.1021 131.0946 131.0948 C6H14ON2 
 
1.7 100 
133.0610 132.0535 132.0537 C4H8O3N2 
 
1.7 7.26 
134.0450 133.0375 133.0377 C7H7O4N 
 
1.7 4.53 
147.0767 146.0691 146.0694 C5H10O3N2 
 
2.2 7.31 
147.1131 146.1055 146.1058 C6H14O2N2 
 
2.2 9.27 
148.0607 147.0532 147.0534 C5H9O4N 
 
1.5 6.58 
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150.0586 149.0511 149.0513 C5H11O2NS 
 
1.5 17.56 
156.0770 155.0695 155.0697 C6H9O2N3 
 
1.5 17.41 
166.0866 165.0790 165.0793 C9H11O2N 
 
2.0 17.22 
175.1193 174.1118 174.1120 C6H14O4N2 
 
1.3 10.16 
182.0816 181.0739 181.0743 C9H11O3N 
 
2.4 0.326 
205.0976 204.089874 204.0903 C11H12O2N2 
 
2.1 9.71 
 
 
Appendix Table 5.21 - Ions observed from an equimolar AA mixture incubated at room temperature. 
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m/z 
Calculated mass 
(Da) 
Measured mass 
(Da) 
Formula Structure ΔPPM 
Relative 
abundance 
84.9598 n/a n/a Solvent n/a n/a 26.23 
86.0965 85.0892 85.0892 C5H11N 
 
0.3 22.74 
90.0551 89.0477 89.0478 C3H7NO2 
 
1.4 7.53 
102.9705 n/a n/a Solvent n/a n/a 26.26 
106.0501 105.0426 105.0428 C3H7NO3 
 
2.1 18.68 
114.0916 n/a n/a Solvent n/a n/a 7.20 
116.0708 115.0633 115.0635 C5H9O2N 
 
2.0 88.56 
118.0865 117.0790 117.0792 C5H11O2N 
 
1.9 19.24 
120.0658 119.0582 119.0585 C4H9O3N 
 
2.7 14.67 
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120.0810 119.0735 119.0737 C8H9N 
 1.9 12.34 
122.0814 Unasssigned n/a n/a n/a n/a 10.79 
130.0503 129.0426 129.0430 C5H7O3N 
 
3.3 8.01 
130.0866 129.0790 129.0793 C6H11O2N 
 
2.5 6.92 
132.1022 131.0946 131.0949 C6H14ON2 
 
2.5 100.00 
134.0451 133.0375 133.0378 C7H7O4N 
 
2.5 43.58 
147.0768 146.0691 146.0695 C5H10O3N2 
 
2.7 7.92 
 357 
 
147.1132 146.1055 146.1059 C6H14O2N2 
 
2.9 30.28 
148.0608 147.0532 147.0535 C5H9O4N 
 
2.2 17.97 
150.0587 149.0511 149.0514 C5H11O2NS 
 
2.2 36.74 
156.0771 155.0695 155.0698 C6H9O2N3 
 
2.1 15.24 
166.0866 165.0790 165.0793 C9H11O2N 
 
2.0 42.09 
175.1193 174.1118 174.1120 C6H14O4N2 
 
1.3 16.05 
Appendix Table 5.22 - Ions Observed following SCW hydrolysis of an equimolar amino acid mixture at 160 °C for 0 minutes. 
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m/z 
Calculated mass 
(Da) 
Measured mass 
(Da) 
Formula Structure ΔPPM 
Relative 
abundance 
86.0966 85.0892 85.0893 C5H11N 
 
1.5 20.72 
90.0551 89.0477 89.0478 C3H7NO2 
 
1.4 9.64 
106.0501 105.0426 105.0428 C3H7NO3 
 
2.1 22.13 
114.0916 n/a n/a Solvent n/a n/a 12.04 
116.0709 115.0633 115.0636 C5H9O2N 
 
2.8 77.79 
118.0865 117.0790 117.0792 C5H11O2N 
 
1.9 17.68 
120.0658 119.0582 119.0585 C4H9O3N 
 
2.7 26.17 
120.081 119.0735 119.0737 C8H9N 
 1.9 12.92 
130.0503 129.0426 129.0430 C5H7O3N 
 
3.3 13.63 
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130.0866 129.0790 129.0793 C6H11O2N 
 
2.5 7.14 
132.1022 131.0946 131.0949 C6H14ON2 
 
2.5 100 
134.0451 133.0375 133.0378 C7H7O4N 
 
2.5 22.07 
147.1132 146.1055 146.1059 C6H14O2N2 
 
2.9 32.97 
150.0587 149.0511 149.0514 C5H11O2NS 
 
2.2 38.84 
156.0771 155.0695 155.0698 C6H9O2N3 
 
2.1 16.68 
 360 
 
166.0866 165.0790 165.0793 C9H11O2N 
 
2.0 53.66 
175.1193 174.1118 174.1120 C6H14O4N2 
 
1.3 31.16 
Appendix Table 5.23 - Ions Observed following SCW hydrolysis of an equimolar amino acid mixture at 160 °C for 20 minutes. 
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